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Summary
Cystic Fibrosis (CF) results from the defective function of CF Transmembrane 
Conductance Regulator (CFTR), an ion channel which facilitates epithelial chloride 
secretion. Previous observations o f dry eye and abnormal visual function in CF 
subjects have been considered secondary manifestations due to associated vitamin A 
deficiency (VAD) and CF-related diabetes (CFRD). However, CFTR is 
fundamentally present in the corneal, conjunctival and retinal pigment epithelium and 
the comeal endothelium. The hypothesis for this thesis was that abnormal chloride 
secretion in CF causes reduced basal tear secretion and abnormal photoreceptor 
function: these investigations aimed to identify primary and secondary ocular 
manifestations of CF.
Fluorescein tear break-up time was significantly reduced in adult CF subjects 
compared to healthy controls. Increased signs o f ocular surface inflammation and 
higher tear feming grades were recorded in CF subjects, although differences failed to 
reach significance. Tear film stability was further reduced in CF adults with VAD 
suggesting the aetiology of dry eye appears to be a combination of primary and 
secondary manifestations of the disease.
Visual function was essentially normal in CF juveniles but was adversely affected in 
CF adults compared to controls. Impaired distance and near visual acuity (DVA and 
NVA), contrast sensitivity (CS), dark adaptation (DA) and colour vision (CV) 
appeared to be a primary manifestation as differences were exaggerated in subjects 
with predicted increased levels o f CFTR disruption and disease severity. These 
results provide support for the hypothesis and suggest normal rod and cone 
photoreceptor function are compromised by abnormal CFTR action. DVA, NVA, CS 
and DA were significantly affected by CFRD status and DA and CV were similarly 
reduced in VAD subjects. Therefore, abnormal visual function in CF is further 
modulated by secondary disease characteristics.
These findings present the distinction between primary and secondary ocular 
manifestations of CF, which is novel to this investigation.
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Chapter 1 Cystic Fibrosis
Chapter 1 
Cystic Fibrosis
1.1 Introduction
Cystic Fibrosis (CF) is the most common life-threatening inherited disease in the 
Caucasian population with a frequency o f approximately 1 in every 2,500 live births 
(Ratjen and Doring, 2003). This autosomal recessive disease currently affects over 
8,000 babies, children and young adults in the United Kingdom (Dodge et al., 2007), 
and in the order of 30,000 individuals in the United States of America (Morgan et al., 
1999).
1.2 Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR)
CF is caused by the abnormal function of a membrane protein known as Cystic 
Fibrosis Transmembrane Conductance Regulator (CFTR) (Rommens et al., 1989). 
Located on the apical membrane of epithelial cells such as those of the sweat glands, 
the pancreas and the lungs, its primary function is to regulate the flow of chloride ions 
(CF) across such epithelia (Schwiebert et al., 1999). CFTR is unusual in its ability to 
regulate the conductance of other ion channels within the membrane including 
positive regulation of the outwardly rectifying chloride channel (ORCC) and negative 
regulation of the epithelial sodium channel (ENaC) (Mall et al., 2004). Therefore, the 
overall effect o f defective CFTR function in CF is reduced epithelial CF permeability 
and enhanced sodium ion (Na+) permeability o f the cell membrane (Ashcroft, 2000).
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1.2.1 CFTR structure
CFTR is composed of five different domains or three-dimensional folded protein 
structures (Sheppard and Welsh, 1999) (Figure. 1.1). Each membrane-spanning 
domain (MSD) consists o f six transmembrane segments that form the channel pore 
(Conley, 2000). Attached to each MSD is a single nucleotide-binding domain (NBD), 
the function of which is to regulate channel gating. The two MSD-NBD units are 
linked by the regulatory (R) domain. Initially thought to regulate CFTR by closing 
the channel, the R domain contains multiple potential phosphorylation sites and is 
now known to exert a stimulatory effect (Ashcroft, 2000). The channel is activated or 
opened by the catalyst protein kinase A (PKA) which binds to the R domain with 
adenosine triphosphate (ATP) initiating phosphorylation (Hwang et al., 1994). Once 
this has occurred channel gating is then regulated by a cycle of ATP hydrolysis at the 
NBDs (Sheppard and Welsh, 1999). The channel is closed when enzymes, known as 
phosphotases, dephosphorylate the R domain (Hwang et al., 1994). Therefore, whilst 
channel opening is controlled by cellular ATP and PKA levels, channel closing is 
controlled by the level of phophatase activity within the cell (Schwiebert et al., 1999).
MSD1 MSD2
( ^
ATP. ATPNBD1 NBD2domain
ADP
V Pi
ADP( 
+ PI *
ATP & PKA
Figure 1.1 Diagram of proposed domain structure of CFTR (Adapted from Sheppard 
and Welsh, 1999)
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1.2.2 CFTR classification
To date, over 1500 gene mutations of CFTR have been identified (Farrell et al., 2008). 
Mutations fall into five different classifications depending on the effect of CFTR 
function (Geddes and Alton, 1999). Class 1 mutations, resulting in complete absence 
of CFTR synthesis, are rare affecting only approximately 7% of CF patients (Table 
1.1). The most common Class 2 mutations, such as that causing the AF508 mutation, 
affect approximately 85% of CF patients (Moss, 2001). The defect results in 
production of misfolded CFTR, which cannot be processed to reach the membrane 
surface. Class 3 mutations also result in production of defective CFTR, although the 
protein reaches the surface membrane it causes abnormal regulation of the ion channel 
(Ratjen and Doring, 2003). These mutations are rare affecting less than 3% of CF 
patients. Class 4 mutations are similar, the defective CFTR reaches the membrane 
surface but causes an altered conductance of the channel. Class 5 mutations result in 
reduced levels of CFTR synthesis (Kulczycki et al., 2003). The incidence of Type 4 
and 5 mutations are rare, collectively accounting for approximately 5% of CF patients 
(Geddes and Alton, 1999).
Table 1.1 Classification of CFTR gene mutations (Kulczycki et al., 2003)
Class Effect Incidence within CF 
population (%)
1 CFTR is not synthesised 7
2 Defective CFTR processing 85
3 Defective CFTR regulation 3
4 Altered CFTR conductance 5
5 Reduced CFTR synthesis
3
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1.2.3 CF genotype and phenotype
CF shows incredible variation in both genotype and phenotype; primarily depending 
on how the mutation disrupts CFTR function (Farrell and Fost, 2002). If CFTR is 
processed incorrectly it may be completely absent from the surface membrane 
resulting in a total loss of channel activity and a severe form of CF. Mutations which 
result in a reduced chloride ion conductance, such as the class 5 mutations, are 
associated with milder forms of the disease. Therefore, phenotypic differences can be 
related to the functional classification of the CFTR genotype (McKone et al., 2003).
Genotype-phenotype studies have demonstrated the degree of correlation between 
CFTR genotype and CF phenotype is highest for pancreatic involvement and lowest 
for pulmonary function (Zielenski, 2000). Therefore, the degree of lung pathology 
and its rate of progression is less easily defined by genotype and the CF genotype 
cannot accurately predict disease severity (Gilljam et al., 2004, Kulczycki et al.,
2003). There is substantial disease variability within patients with identical genotypes 
(McKone et al., 2003) suggesting environmental factors and modifying genes, apart 
from CFTR, may contribute to CF disease severity (Gilljam et al., 2004, Mekus et al., 
2000, Mickle and Cutting, 2000, Zielenski, 2000).
1.2.3.1 AF508
The most common CFTR mutation, AF508, accounts for approximately 70% of CF 
chromosomes worldwide (Morral et al., 1994). This is caused by a three base pair 
deletion that removes a phenylalanine residue at position 508 resulting in a 
particularly severe form of the disease (Morales-Machin et al., 2004). In a recent 
study of UK CF patients, 74.1% were found to have at least one AF508 mutation 
(McCormick et al., 2002). Homozygous patients have a high frequency of pancreatic 
insufficiency at an earlier age (McKone et al., 2003). There is a larger variation in 
lung function however and often a wide phenotypic variation even in homozygous 
individuals (Lester et al., 1994). In heterozygous individuals the milder mutation is 
dominant over the AF508 mutation resulting in a milder phenotype (Kerem and 
Kerem, 1995). Therefore, phenotype and mortality are mainly determined by the 
effects of the non-AF508 mutation (McKone et al., 2003).
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1.2.3.2 Variability w ith populations and ethnicity
Studies have revealed different populations or racial groups have a different 
prevalence of genotypes. Whilst AF508 homozygotes account for 57.5% of the UK 
Caucasian CF patients, only 24.7% of the UK Indian Subcontinent CF population are 
AF508 homozygotes (McCormick et al., 2002). It has been observed that often 
individual or family specific mutations occur within non-caucasian patients (Malone 
et al., 1998). As the prevalence of different mutations varies between different 
populations and ethnic groups genetic screening tests must be adapted for the target 
population (Gilljam et al., 2004).
1.3 Major characteristics of Cystic Fibrosis
1.3.1 Elevated sodium chloride sweat concentration
In the sweat gland, sodium chloride (NaCl) enters the duct lumen by a process of 
filtration (Ashcroft, 2000). Sodium ions (Na+) are reabsorbed via the apical 
membrane due to an electrochemical gradient for Na+ created by the activity of the 
Sodium/Potassium-ATPase (Na/K-ATPase) channel in the basolateral membrane. 
Chloride ions (CF) then follow passively via CFTR in the apical membrane leaving a 
dilute NaCl solution in the sweat duct lumen. In CF, epithelial CF absorption via 
CFTR is defective. Continued Na+ uptake via the apical cell surface causes 
membrane depolarisation which limits further reabsorption of Na+ (Massie et al., 
2000). The net effect is elevated levels of NaCl in the sweat of patients with CF 
(Figure. 1.2). This characteristic forms the basis of the sweat test used to diagnose 
CF.
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Figure 1.2 Simplified diagram of a normal (a) and CF (b) sweat duct cell
1.3.2 L u n g  d isease
In the lungs, the thickness of the airway surface liquid (ASL) layer lining the ciliated 
epithelia is determined by osmosis. It is balanced by fluid uptake accompanying CF 
efflux via CFTR and fluid secretion accompanying Na+ absorption via ENaC (Frizzell 
and Pilewski, 2004). In CF, CF efflux is reduced with an accompanying reduction in 
fluid secretion via the apical membrane (Ashcroft, 2000). However, because the 
normal inhibitory influence of CFTR on ENaC is also lost the absorption of Na+ and 
accompanying fluid uptake is increased (Schwiebert et al., 1999) (Figure 1.3). 
Therefore, both processes cause a depleted ASL volume resulting in a thick 
hyperviscous mucus layer containing trapped bacteria, deoxyribonucleic acid (DNA)
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and immune cells (Gibson et al., 2003) (Figure 1.4). This results in impaired 
mucociliary clearance, mucus plugging, infection, neutrophil-dominated airway 
inflammation and fibrosis, which ultimately leads to respiratory failure (Ratjen and 
Doring, 2003). However, it is uncertain whether CFTR dysfunction itself directly 
causes increased infection susceptibility or if hyper-inflammation is a primary 
manifestation of the disease (Jacquot et al., 2008). CF lung disease is further 
complicated by bacterial colonisation leading to frequent pulmonary exacerbations 
(Gibson et al., 2003). The most common pathogen is Pseudomonas (P.) aeruginosa 
although other pathogens include Staphylococcus (S.) aureus, Burkholderia (B.) 
cepacia infection and Haemophilus (H) Influenzae (Ratjen and Doring, 2003). At 
present, chronic pulmonary P. aeruginosa infection is responsible for the greatest 
mortality in CF (Hoiby et al., 2005).
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CFTR inhibits ENaC
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tight cell 
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H ,0  ASL
membraneCFTR cannot
inhibit ENaC
membrane 
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Figure 1.3 Simplified diagram of a normal (a) and CF (b) lung submucosal gland cell
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Figure 1.4 Simplified diagram of a normal (a) and CF (b) airway surface layer
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Although there is evidence of disrupted Cl’ and Na+ transport in CF lung epithelia, the 
mechanism by which they contribute to the pathogenesis of CF lung disease is 
unresolved. It has been suggested that the high NaCl concentration of the ASL 
deactivates antimicrobial peptides resulting in chronic infection (Zabner et al., 1998) 
or the low ASL volume causes ineffective mucociliary clearance (Mall et al., 1998). 
This is further complicated by hypotheses that CF may modify epithelial 
inflammatory responses (Heeckeren et al., 1997).
CFTR knockout mice do not demonstrate pulmonary disease that mimics the human 
disease and cannot be used to study the pathogenesis (Frizzell and Pilewski, 2004). 
However, a recent investigation found that increased Na+ absorption via the epithelia 
of the lung alone could initiate CF lung disease in mice with airway-specific 
overexpression of ENaC (Mall et al., 2004). Accelerated Na+ absorption resulted in 
reduced ASL volume that ultimately caused decreased mucous transport, increased 
airway mucus obstruction, inflammation and reduced bacterial clearance (Frizzell and 
Pilewski, 2004). In conclusion it was hypothesised that reduced ASL volume and 
impaired mucous clearance (due to mucous adhesion of the cilia and ineffective 
coughing) of the airways play a key role (Mall et al., 2004, Boucher, 2007). 
Therefore, these findings suggest that loss o f the normal inhibitory regulatory effect of 
CFTR on ENaC may be more influential to the pathogenesis of CF lung disease than 
the reduced efflux of C f by CFTR itself.
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1.3.3 Pancreatic insufficiency
The normal pancreas secretes digestive enzymes, which must be carried by a watery 
fluid secretion into the small intestine to facilitate digestion. Pancreatic cells secrete a 
watery fluid into the duct lumen that is high in bicarbonate (HCCV) concentration 
(Ashcroft, 2000). The apical cell membrane contains a HCO3/CI exchanger that 
transports HCO3’ out from within the cell in exchange for Cf. Cf is returned to the 
lumen via CFTR channels to maintain the negative electrochemical gradient necessary 
to allow Na+ to diffuse through extracellular spaces into the lumen. This subsequent 
increase in ion concentration of the lumen contents results in the movement of water 
from the blood stream into the lumen by a process of osmosis to produce a dilute, 
watery secretion (Taylor and Aswani, 2002). In CF however, the normal negative 
electrochemical gradient cannot be achieved due to the absence or presence of 
defective CFTR (Figure 1.5). Although the pancreatic enzymes are released normally 
there is an insufficient fluid vehicle to carry the enzymes to the duodenum (Schibli et 
al., 2002). The result of reduced pancreatic secretion is impaired digestion and 
absorption of lipids and lipid-soluble vitamins (specifically vitamin A, D and E), 
potentially resulting in malnutrition, growth failure and developmental delay 
(Sinaasappel et al., 2002). Also, obstruction of the pancreatic ducts may occur as 
pancreatic enzymes become concentrated within the ducts causing atrophy of the 
pancreatic acinar tissue (Brennan et al., 2004), potentially leading to pancreatic 
destruction.
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Figure 1.5 Simplified diagram of a normal (a) and CF (b) pancreatic duct cell
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1.3.3.1 Vitamin A deficiency
Vitamin A deficiency (VAD) is common in subjects with CF due to impaired 
digestion and absorption with pancreatic insufficiency (Lancellotti et al., 1996) and 
despite supplementation many subjects maintain low serum vitamin A concentration 
(Feranchak et al., 1999). Vitamin A is essential for numerous physiological functions 
such as maintenance of the retinoid cycle, cellular differentiation and membrane 
integrity, mucin production and immunity (Sommer, 1998). There are two main 
dietary sources of vitamin A: pre-formed vitamin A (retinyl esters), from meat and 
dairy products, or carotenoids, from fruit and vegetables (da Silva Diniz and Santos, 
2000). Carotenoids, such as beta-carotene, are precursors or inactive forms of vitamin 
A. Of the 600 known carotenoids, 50 are referred to as pro-vitamin A compounds as 
they can be converted to vitamin A within the body (Bellovino et al., 2003).
Ingested vitamin A is stored in the liver and transported to specific target receptors in 
the body by a carrier protein known as retinol binding protein (RBP). Serum levels 
can remain low despite adequate liver stores, suggesting defective vitamin A release 
from the liver in CF (Underwood and Denning, 1972). Furthermore, liver stores may 
be depleted in subjects with CF-related liver disease (see section 1.5.5) (Cheng et al., 
2000). Therefore, circulating serum vitamin A levels are frequently a poor indicator 
of vitamin A status (Tsinopoulos et al., 2000).
1.3.4 Cystic Fibrosis-Related Diabetes (CFRD)
Cystic Fibrosis-Related Diabetes (CFRD) is distinctly different from Type 1 and Type 
2 Diabetes Mellitus although it does share features of both forms (Moran, 2002). The 
aetiology and development of CFRD is not fully understood. Hyperglycaemia is 
proposed to be the result of decreased insulin secretion due to blockage of the 
pancreatic duct and subsequent atrophy and fibrosis of pancreatic islet cells (Brennan 
et al., 2004). Insulin resistance as a result of the CFTR mutation and prolonged 
steroid use is also thought to contribute. Female subjects with CFRD have a poorer 
prognosis compared with male subjects suggesting gender may also be a contributing 
factor (Milla et al., 2005). It is also proposed that different genotypes may result in
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different severities of CFRD, most commonly in those individuals homozygous for 
the AF508 mutation (Koch et al., 2001).
As well as micro and macrovascular complications typically associated with diabetes, 
individuals with CFRD also exhibit decreased body mass index, reduced pulmonary 
function and rapid decline in clinical status ultimately resulting in an increased 
mortality rate (Fredericksen et al., 1996). Due to some residual islet cell function, 
ketoacidosis is extremely rare in CF at diagnosis or throughout the course of the 
disease. The incidence of CFRD increases with age (Lanng, 2001). By 20 years of 
age, 70% of CF patients have impaired glucose tolerance (IGT) and 45% CFRD 
(Bismuth et al., 2008). This rises to 82% and 70% respectively at 30 years of age 
(Bismuth et al., 2008). As life expectancy continues to increase more individuals will 
develop CFRD and the associated complications.
1.3.4.1 Diagnosis o f CFRD
The oral glucose tolerance test is considered to be the gold standard for the detection 
of diabetes mellitus (Brennan et al., 2004). After overnight fasting, a glucose solution 
is administered orally and blood glucose concentration measured at regular intervals 
(Moran, 2002). After two hours blood glucose concentration <8.8  mmol/1 indicates 
normal glucose tolerance (NGT), 8.9-11.1 mmol/1 indicates impaired glucose 
tolerance (IGT) and >11.2 mmol/1 is diagnostic of CFRD (Moran, 2002). Elevated 
levels of plasma glucose cause glycosylation of haemoglobin within the erythrocytes 
(Mansour, 2000). Gylcosylated haemoglobin (HbAlc) concentration is increased 
proportionally to the degree of chronic hyperglycaemia and can be used to indirectly 
measure the average blood glucose concentration over the previous six to ten weeks 
(McDonald and Davis, 1979). Normal levels range between 2.6-5.8%. HbAlc is now 
a widely used method for monitoring long term glucose control in subjects with 
CFRD as well as in Type 1 and 2 diabetes (Brennan et al., 2004).
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1.3.4.2 Treatment of CFRD
Treatment is always indicated in patients with CFRD (Allen et al., 1998) although for 
patients with IGT the benefit of glycaemic control is unclear (Lanng, 2001). The 
stabilisation of blood glucose in subjects with CFRD should be controlled by insulin 
and or oral hypoglycaemic drugs rather than any dietary restriction due to 
malabsorption and malnutrition typically associated with CF (Porter and Barrett,
2004). Evidence suggests hyperglycaemic treatment with insulin before CFRD has 
even developed may benefit the clinical status and pulmonary function of CF patients 
(Rolon et al., 2001).
1.4 Diagnosis of Cystic Fibrosis
Early and accurate diagnosis has been shown to improve prognosis significantly, 
especially for long term nutritional status and growth indices (Farrell et al., 2001). 
Neonatal screening was introduced in Wales in 2004 and a positive diagnosis of CF is 
typically made before four weeks of age (Southern et al., 2007). Neonatal screening 
methods include analysing dried blood for immunoreactive trypsin (IRT) which is 
known to be significantly elevated in newborns with CF (Crossley et al., 1979). A 
two-tiered protocol combining IRT and DNA analysis for 20 to 30 of the most 
common CFTR mutations in patients with elevated IRT, results in rapid diagnosis and 
improved sensitivity (Gregg et al., 1997). “Sweat Testing” is currently the gold 
standard for the diagnosis of CF and is generally used to confirm diagnosis of 
neonates identified during newborn screening programmes, or in patients presenting 
with clinical features suggestive of CF (Beauchamp and Lands, 2005). Pilocarpine is 
applied to a small area on the arm or leg then a weak electrical current applied to the 
area to stimulate sweating. The sweat is collected and the sample analysed for 
chloride concentration (Crossley et al., 1979).
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1.5 Treatment of Cystic Fibrosis
1.5.1 Patient-centred CF services
Patients attend regular hospital outpatient appointments and are assessed by members 
of a multi-disciplinary team that typically involves a specialised respiratory 
consultant, CF specialist nurse, physiotherapist, dietician and psychotherapist. 
Because of potential patient-to-patient transmission, protocols such as separate clinics 
for individuals with the same isolated infection, such as P. aeruginosa, have been 
introduced to CF clinics to minimise the risk of cross infection (Schewe et al., 2005).
1.5.2 Nutrition and supplements
The achievement of normal growth and adequate nutrition in CF patients provides a 
constant challenge (Shepherd, 2002). Typical energy requirements are believed to be 
up to be 33 to 50% higher than normals (Marin et al., 2004). Generally, a balanced, 
high-calorie diet with plenty of fat and protein is advocated. Dietary interventions 
such as oral supplements or enteral tube feeding at night may also be utilised.
Supplementation of the fat soluble vitamins A, D and E is essential (Borowitz et al.,
2002). Empirically, the aim is to maintain plasma levels at the upper limit of the 
normal range. Vitamin K supplementation is also typical as deficiency is common in 
patients with pancreatic insufficiency (Cheng et al., 2000).
1.5.3 Physiotherapy
Physiotherapy has a pivotal role in the respiratory management of CF and there are 
various techniques available to facilitate mucociliary clearance and maintain lung 
function (Davidson, 2002). Airway clearance techniques consist of postural drainage 
and a combination of manual techniques, including percussion, chest shaking and 
chest vibrations (Samuels, 2000). The forced expiration technique, a combination of 
relaxed breathing control and huffing, allow the movement of secretions from smaller 
airways (Bradley et al., 2005).
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1.5.4 Pancreatic enzyme replacement therapy
Pancreatic insufficiency affects approximately 85% of CF patients and is the primary 
cause of malnutrition due to maldigestion and malabsorption (Schibli et al., 2002). A 
wide variety of pancreatic enzyme extracts, containing lipase, protease and amylase, 
are commercially available (Beverley et al., 1987). Modern enteric-coated 
preparations ensure the enzyme is not deactivated by gastric acid and released at 
optimum pH in the intestine (Anthony et al., 1999). Contained within the capsule, 
variable sized microspheres or microtablets allow an even distribution throughout 
gastric emptying (Durie et al., 1998).
1.5.5 Pharmaceutical therapy
The basis of CF management is the control of respiratory infection (Schidlow, 2000). 
Many centres treat all patients with prophylactic antibiotics in an attempt to prevent or 
delay early colonisation (Robinson, 2001). Further oral, intravenous or nebulised 
antibiotic therapy may be administered for the treatment of pulmonary exacerbations 
where lung function is decreased due to infection and/or inflammation (Gibson et al., 
2003).
Inflammation is a primary characteristic of CF lung disease (Ratjen, 2006). 
Corticosteroid anti-inflammatory therapy is limited due to adverse side effects 
(Robinson, 2001). However, treatment with inhaled steroidal bronchodilators is 
common. More recently, recombinant DNAase or Pulmozyme has been used to 
decrease the viscoelasticity of mucus by cleaving neutrophil derived DNA (Schidlow, 
2000). Inhalation of nebulised hypertonic saline draws water into the ASL, improving 
mucociliary clearance and lung function (Ratjen, 2006). Up to 20% of patients 
develop CF-related liver disease (CFLD), caused by abnormal bile secretion and 
blockage of the bile ducts causing liver cirrhosis (Cheng et al., 2000). A relatively 
new natural bile acid, ursodeoxycholic acid, has been introduced to improve liver 
function in these patients.
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1.5.6 Gene therapy
Gene therapy involves the addition of a correct, functioning copy of CFTR into 
epithelial cells and is a promising new treatment. Current transfer vectors, to 
transport the gene to the desired site, include adenovirus, adeno-associated viruses and 
liposomes (Schidlow, 2000). However, gene transfer vectors are faced by a number 
of extracellular barriers within the airways including mucus, a low number of receptor 
sites and immune responses (Ferrari et al., 2002). Unfortunately, despite significant 
developments the suitability of gene therapy for the treatment of CF remains limited 
(Griesenbach and Alton, 2009).
1.5.7 Protein repair therapy
Protein repair therapy involves treatment with compounds which induce normal 
production, transport or function of CFTR within the cell (Lim and Zeitlin, 2001). 
However, therapy is likely to be specific for each different CFTR mutation (Kerem, 
2006). For example, gentamicin has been shown to suppress some class 1 mutations 
by allowing normal transcription of messenger ribonucleic acid (mRNA) (Schidlow, 
2000). Long term effectiveness and safety are currently under investigation.
1.5.8 Organ transplantation
Organ transplantation, such as heart-lung, liver or pancreatic transplants, are the only 
definitive treatment for patients with CF (Wise et al., 2001). Due to a shortage of 
donor organs, waiting times for transplantation are routinely up to two years (Mayer- 
Hamblett et al., 2002). In the United States only approximately 135 lung transplants 
are performed in subjects with CF annually (www.cff.org/treatments; accessed on 
28/01/2009). Unfortunately transplant associated morbidity increases with age; in the 
United Kingdom survival decreases from 82% at one year to 53% at 10 years 
following lung transplant (Meachery et al., 2008). Failure of transplantation is 
typically due to infection or rejection (Schidlow, 2000).
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1.6 Life expectancy
Life expectancy for CF patients has continued to increase; in 1964 the average life 
expectancy was only five years of age. Today however, in the UK 11% of the CF 
population are over 30 years of age (McCormick et al., 2002), and worldwide a 
significant number of patients are surviving beyond 40 years of age (Hodson et al., 
2008). Females have been shown to have a shorter survival rate suggesting gender is 
a prognostic factor (Lai et al., 2002). In the UK, CF population the male/female ratio 
significantly increases with age from approximately 1.2:1 below five years of age to 
approximately 1.6:1 above 35 years of age (McCormick et al., 2002). With 
increasingly sophisticated therapy and interventions it is expected that patients bom in 
2000 can expect survival beyond 50 years of age, even in the absence of functional 
gene therapy (Dodge et al., 2007).
1.7 Cause of death
The major cause of death in CF is progressive pulmonary disease (Kulczycki et al., 
2003). P. aeruginosa respiratory infection particularly has been found to be a major 
cause of mortality (Elkin and Geddes, 2003, Emerson et al., 2002). CFTR has been 
characterised as a receptor for P. aeruginosa, which when functioning normally, 
internalises and destroys the pathogen (Zaidi et al., 2004). Untreated patients 
generally become chronically infected and even with intensive antibiotic regimens the 
infection cannot be eradicated due to poor antibiotic penetration and resistance due to 
mutated strains (Worlitzsch et al., 2002). Lung transplantation is ultimately the only 
option for patients with this type of advanced pulmonary disease (Kerem et al., 1992). 
Consequently, prevention of bacterial lung infection is paramount for all CF patients.
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1.8 Summary
CF remains the most common life-threatening inherited disease in the Caucasian 
population. The major disease characteristics are summarised in Table 1.2. With 
improved patient care and therapeutics, CF survival rates are steadily increasing. 
Therefore, healthcare professionals, such as optometrists, are more likely to encounter 
these patients. An awareness o f the ocular abnormalities associated with CF is 
imperative and these are reviewed in Chapter 2.
Table 1.2 Summary of major CF disease characteristics
Feature Cause Potential outcomes
Lung Disease Abnormal airway surface 
(ASL) layer regulation
Impaired mucociliary 
clearance, mucus plugging, 
infection and inflammation 
= Respiratory failure
Pancreatic
Insufficiency
Insufficient fluid vehicle 
secretion
Abnormal digestive enzyme 
secretion 
= Malnutrition
Sweat Abnormal CF absorption 
from sweat duct lumen
Elevated sweat NaCl levels 
= Electrolyte imbalance
CF-Related Diabetes 
(CFRD)
Reduced insulin secretion 
and increased insulin 
resistance
Abnormal blood sugar 
regulation 
= Hyperglycaemia
CF-Related Liver 
Disease (CFLD) Abnormal bile secretion
Impaired lipid digestion, 
blockage of bile ducts 
= Liver cirrhosis
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Chapter 2 
Cystic Fibrosis and the Eye
2.1 Introduction
This chapter reviews previously published evidence of ocular associations of Cystic 
Fibrosis (CF) on the eye and visual function which ultimately forms the background 
and foundation for this thesis. The initial section reviews the literature identifying the 
presence of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in the 
ocular epithelia, and the chapter concludes by reviewing previous studies of ocular 
characteristics in subjects with CF.
2.2 Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) and the eye
The abnormal function or complete absence o f the membrane protein CFTR is known 
to cause CF (see section 1.2). Initially discovered in 1989 (Rommens, 1989), CFTR 
has more recently been identified in certain layers o f ocular epithelia (of various 
animal species and cultured cells) including the corneal epithelium and endothelium, 
the conjunctival epithelium and the retinal pigment epithelium. However, it is not 
present in the ciliary epithelium (Mitchell, 1998, Coca-Prados, 1995) and does not 
contribute to aqueous humour production (Do, 2004, McCannel, 1992). Active 
chloride transport across the ocular epithelia is known to generate the osmotic 
gradient necessary to drive fluid transport (Levin and Verkman, 2006). CFTR is 
known to be an essential CF channel in many epithelia (Sheppard and Welsh, 1999); 
therefore, abnormal CFTR function in the ocular epithelia may adversely affect fluid 
transport in the eye.
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2.2.1 CFTR and the corneal epithelium
The studies that have identified the presence of CFTR in the corneal epithelium are 
summarised in Table 2.1. Although the precise location of CFTR in comeal epithelial 
cells is not known, it provides a major pathway for comeal epithelial CF efflux (Levin 
and Verkman, 2005).
Table 2.1 Detection of CFTR in the comeal epithelium
Author and 
Year
Species Method and Observations
(Zaidi et al., 
1999)
Wild-type 
mouse cells
Presence o f CFTR detected by immunofluorescence 
microscopy. Confirmation of CFTR mRNA 
expression by RT-PCR analysis.
Cultured 
human cells
Similar finding as above
AF508 
heterozygous 
mouse cells
Lower abundance of CFTR detected
AF508 
homozygous 
mouse cells
CFTR completely absent
(Al-Nakkash 
and Reinach, 
2 0 0 1 )
Rabbit cells
Patch clamp techniques confirmed CFTR 
biophysical characteristics. RT-PCR confirmation of 
CFTR mRNA expression.
(Levin and 
Verkman, 
2005)
Wild type 
mouse cells*
Open-circuit potential differences used to identify 
CFTR channel function, then characterised by 
response to CFTR various transport agonists and 
inhibitors.
CF mouse 
cells*
Absence of such responses in CF mice.
* measurements recorded from the mouse ocular surface (cornea and conjunctiva)
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2.2.1.1 Chloride channels in the corneal epithelium
The comeal stroma has a tendency to imbibe fluid. Although major compensation 
comes from the comeal endothelium, the epithelium also contributes to fluid 
transport, via various ion channels, from the stroma to the pre-comeal tear film 
(Candia, 2004, Yang et al., 2000). In addition to CFTR, numerous other CF channels 
have been found to be present in the comeal epithelium (Figure 2.1). Located on the 
basolateral membrane the sodium:potassium:chloride (Na+:K+:2CF) co-transporter 
functions in parallel with the sodium:potassium (Na+:K+) pump resulting in CF influx 
(Bildin et al., 2001). The rate o f secretion by these channels is regulated by the CF 
conductance of the apical membrane (Itoh et al., 2000). In addition to CFTR, calcium 
activated CF channels (CLCA2) are also thought to contribute to CF efflux. Various 
C1C channels, a family of voltage gated CF channels, have also been detected in the 
cornea (Davies et al., 2004). However, their location and contribution to CF transport 
in unknown. The epithelial sodium channel, ENaC, has been detected and located to 
the apical membrane (Mirshahi et al., 1999) where it is believed to facilitate Na+ 
absorption (Levin et al., 2006). P2 Y2 receptors are a family of membrane molecules 
that exert various biological functions. These receptors have been found to be present 
in the comeal epithelium, where they regulate cellular functions such as ion and fluid 
transport (Cowlen et al., 2003).
Active trans-epithelial CF transport is known to provide the driving force for 
subsequent osmotically driven fluid secretion that follows via the apical membrane 
(Yang et al., 2000). Aquaporins (AQP) are a family of epithelial water channels 
which facilitate water secretion down an osmotic gradient (Agre, 2004). AQP5, and 
to a lesser extent AQP3 (Hamann et al., 1998, Thiagarajah and Verkman, 2002, Patil 
et al., 1997), are known to enable fluid secretion from the comeal stroma (Levin and 
Verkman, 2006) through the epithelium and could facilitate basal tear production 
(Hamann et al., 1998, Levin and Verkman, 2004, Verkman, 2003).
CF conductance therefore, plays an essential role in comeal epithelial fluid transport, 
maintaining normal comeal integrity and contributing to basal tear production (Candia 
and Zamudio, 1995, Yang et al., 2000, Dartt, 2004, Dartt, 2002). CFTR provides a 
major pathway for comeal epithelial CF secretion from the ocular surface (Levin and
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Verkman, 2005). In CF patients, with hypothesised defective CF efflux from the 
comeal epithelium (unless other CF channels compensate) basal tear production could 
be abnormal, contributing to the condition of dry eye.
STROMA
Na+ K+ Cl- 2K+
WBasal m em brane3Na+
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CFTR CLCA2
TEAR FILM
Apical m em brane
Figure 2.1 Diagram of a simplified comeal epithelial cell
2.2.1.2 CFTR, the corneal epithelium and pseudom onas aeruginosa
Previous studies have shown CFTR to act as a cellular receptor for Pseudomonas (P.) 
aeruginosa in the lung (Pier et al., 1997). CFTR has also demonstrated this function 
in experimental murine keratitis (Zaidi et al., 1999). Immunoelectron microscopy 
showed correctly functioning CFTR bound to the bacteria and ingested within the 
comeal epithelium and stroma. AF508 heterozygous mice had an 85% reduction of 
ingested P. aeruginosa and significantly less comeal pathology compared to wild-type 
mice. AF508 homozygous mice were nearly completely resistant to P. aeruginosa 
ingestion and had little subsequent pathology. Under hypoxic conditions increased 
binding and subsequent internalisation of the bacteria was observed and thought to be 
caused by increased CFTR expression (Zaidi et al., 2004). The authors concluded 
CFTR appears to be critical in the pathogenesis of experimental P. aeruginosa 
keratitis (Zaidi et al., 1999). However, a later study concluded CFTR is not the sole 
receptor responsible for P. aeruginosa binding (Yamamoto et al., 2006).
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2.2.2 CFTR and the corneal endothelium
CFTR, located on the apical membrane, appears to facilitate CF efflux from the 
comeal endothelium (Sun and Bonanno, 2002). The studies that have identified the 
presence of endothelial CFTR are reviewed in Table 2.2.
Table 2.2 Detection o f CFTR in the comeal endothelium
Author and 
Year
Species Method and Observations
(Bonanno 
and Srinivas, 
1997)
Cultured 
bovine cells
Investigated anion conductance and identified the 
presence of a cyclic adenosine monophosphate 
(cAMP) activated anion channel
(Sun et al., 
2 0 0 1 )
Human, 
bovine, rabbit 
and cultured 
bovine cells
Investigated anion transport proteins and concluded 
the presence of CFTR. Expression of CFTR mRNA 
confirmed by RT-PCR analysis.
(Sun and 
Bonanno, 
2 0 0 2 )
Fresh and 
cultured 
bovine cells
Identified location of CFTR to apical endothelial 
membrane by indirect immunofluorescence confocal 
microscopy. Further confirmed by examining 
changes in CF permeability with various CFTR 
transport agonists and inhibitors.
2.2.2.1 Chloride channels in the corneal endothelium
Fluid transport across the endothelium, to counteract stromal swelling is secondary to 
ionic flux (Hara et al., 1999). The Na+:K+:2CF co-transporter, present on the 
basolateral membrane, loads endothelial cells with CF from the stroma (Jelamskii et 
al., 2000). The sodium ibicarbonate (Na+:HC0 3 _) co-transporter, also located on the 
basolateral membrane, similarly loads endothelial cells with bicarbonate ions (HCO3') 
(Sun et al., 2000). Thus intracellular levels of CF and HCO3’ are above the 
electrochemical equilibrium (Sun et al., 2001). CFTR is an important channel for CF 
transport via the apical membrane and is also found to directly facilitate HCO3' flux 
(Sun and Bonanno, 2002). Calcium activated CF channels (CLCA) are also present in
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the apical corneal endothelium and are similarly permeable to Cl* and HCCV 
(Bonanno, 2003). ENaC is proposed to be located at the apical membrane although 
its specific contribution to sodium transport is unclear (Rauz et al., 2003). Five 
members of the C1C family o f voltage gated Cl* channels are also present in comeal 
endothelial cells, although the precise location has not been established, these 
channels are likely to be involved in chloride efflux (Davies et al., 2004). AQP1 
channels, present in the basal and apical membranes, (Thiagarajah and Verkman, 
2002, Patil et al., 1997, Hamann et al., 1998, Levin and Verkman, 2004) facilitate 
water movement from the endothelium to regulate cell volume and maintain comeal 
transparency (Levin and Verkman, 2006, Verkman et al., 2008). Similarly, P2 Y2 
receptors in the endothelium are likely to regulate fluid secretion (Cowlen et al.,
2003). The principle comeal endothelial ion channels are shown in Figure 2.2.
It is well established that both Cl* and HCO3' are essential for trans-endothelial fluid 
transport and the subsequent maintenance of comeal transparency (Riley et al., 1995, 
Hodson and Miller, 1976). Therefore, unless other Cl* channels compensate, CF 
patients with anticipated defective Cl* efflux from the comeal endothelium could 
experience reduced levels of comeal transparency.
STROM A
Na+ K+ Cl- 2K+
ci-
2HCO,- Na+
L ^ J  Bassm mFI 'ial m em brane
3N a+
ci- HCO,"
 | |  |fc + )
CFTR W W CLCA ^  W 1 ^ ^  ApiCal membrane
ci-
AQU EO US
Figure 2.2 Diagram of a simplified comeal endothelial cell
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2 2 .2.2 Morphologic analysis of the corneal endothelium in CF
Lass and colleagues (1985) investigated comeal endothelial morphological features in 
subjects with CF, CF-related diabetes (CFRD) and controls with and without Type 1 
diabetes. Mean comeal thickness was significantly greater in the CF and CFRD 
groups compared to both control groups (Table 2.3) and comeal endothelial 
permeability and mean relative pump rate were significantly higher in the two CF 
groups and the Type 1 diabetic group. The two CF groups also had significantly 
higher mean endothelial cell densities and lower mean endothelial cell areas compared 
to the controls. The increased corneal thickness observed in the CF group suggests 
there is only partial compensation by the increased pump rate for the increased 
permeability (Lass et al., 1985). The authors hypothesised that the comeal 
endothelium in CF is under considerable stress which may be exacerbated by CFRD.
This study was carried out before the discovery of CFTR at the apical comeal 
endothelial membrane; however these morphological differences could be a sign of 
compensation for, or adaptation to, the absence of CFTR. The consequence of 
increased cell density could be greater membrane surface area and greater 
concentration of other compensatory transporters (Sun and Bonanno, 2002).
Table 2.3 The comeal endothelium in Type 1 diabetes mellitus and CF (Lass et al., 
1985)
Clinical Characteristics Normal
Controls
Type 1 
Diabetes
CF CFRD
Mean cell permeability 2.14 ± 2.80 ± 3.80 ± 4.50 ±
(cm/min x 104) 0.29 0.52 0.80 1.30
Mean relative endothelial 100  ± 1.33 ± 148 ± 160 ±
pump rate (% of normal) 2 1 .2 34.7 46.0 45.5
Mean corneal thickness 0.52 ± 0.51 ± 0.54 ± 0.54 ±
(mm) 0.033 0.17 0.017 0.033
Mean endothelial cell 2855 ± 2813 ± 3314 ± 3500 ±
density (cells/mm2) 253.9 636.0 651.2 392.3
Mean endothelial cell area 353 ± 370 ± 311 ± 288 ±
(pm2) 28.6 71.9 51.0 31.7
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2.2.3 CFTR and the conjunctival epithelium
Similar to the comeal epithelium, CFTR has been located to the apical conjunctival 
epithelial membrane (Turner et al., 2002) where it mediates CF secretion from the 
ocular surface (Levin and Verkman, 2005). The studies that have identified 
conjunctival CFTR are reported in Table 2.4.
Table 2.4 Detection of CFTR in the conjunctival epithelium
Author and 
Year
Species Method and Observations
(Itoh et al., 
2 0 0 0 )
Human cells Identified the presence of CFTR mRNA by RT-PCR 
analysis.
(Turner and 
Candia, 
2 0 0 1 )
Rabbit and 
pig cells
Identified cAMP stimulated CF channel. Concluded 
to be CFTR following immunofluorescent and RT- 
PCR analysis.
(Turner et al., 
2 0 0 2 )
Rabbit, pig 
and rat cells
Presence identified in bulbar and palpebral 
conjunctival epithelium of all species. Position 
located on apical membrane of all species. 
CFTR absent from goblet cells.
(Shiue et al., 
2 0 0 2 )
Rabbit cells Identified presence of CFTR by Western blot, 
immunostaining microscopy and RT-PCR analysis.
(Levin and 
Verkman, 
2005)
Wild type 
mouse cells*
Open-circuit potential differences used to identify 
CFTR channel function, then characterised by 
response to CFTR various transport agonists and 
inhibitors.
CF mouse 
cells*
Absence o f such responses in CF mice.
* measurements recorded from the mouse ocular surface (cornea and conjunctiva)
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2.2.3.1 Chloride channels in the conjunctival epithelium
The bulbar and palpebral conjunctival epithelium transports Cl" across the basal 
membrane via the N+:K+:CC' co-transporter in conjunction with the Na+:K+ pump to 
maintain intracellular chloride above equilibrium (Turner and Candia, 2001, Turner et 
al., 2000). CFTR, located at the apical membrane in both the bulbar and palpebral 
conjunctiva, then facilitates CF efflux into the tear film (Turner et al., 2002). CLCA2 
also contributes to this CT secretion via the apical membrane (Itoh et al., 2000; Levin 
et al., 2006). C1C channels have also been identified within the conjunctiva, although 
their specific contribution to Cl' transport is unclear (Itoh et al., 2000). Subsequently, 
the conjunctiva secretes fluid secondary to this active chloride transport (Shiue et al., 
2000). ENaC is proposed to facilitate Na+ absorption at the apical membrane (Levin 
et al., 2006).
As the conjunctival epithelium has both the surface area and presence of transporters 
it appears plausible that it is responsible for the secretion of basal tear fluid (Candia, 
2004, Dartt, 2002, Shiue et al., 2000, Li et al., 2001). Therefore, it appears that 
chloride transport has a critical role in the maintenance o f the normal tear film (Shi 
and Candia, 1995). Aquaporin AQP3 is present in the conjunctival epithelium 
(Hamann et al., 1998, Patil et al., 1997, Levin and Verkman, 2004) and has been 
suggested to contribute to basal tear production (Hamann et al., 1998). However, 
unlike in the cornea, osmotically driven water movement across the epithelium is not 
aquaporin dependant (Levin and Verkman, 2004). P2 Y2 receptors have also been 
detected in the conjunctival epithelium (Cowlen et al., 2003, Jumblatt and Jumblatt, 
1998): this receptor is known to mediate Cl' efflux and net fluid secretion by the 
conjunctiva, and stimulation of the P2 Y2 receptors has been shown to increase tear 
fluid secretion from the rabbit epithelium (Li et al., 2001, Hosoya et al., 1999, 
Murakami et al., 2000, Shiue et al., 2000). The principal conjunctival epithelial 
channels are shown in Figure 2.3.
Conjunctival CFTR mediates CT efflux from the ocular surface (Levin and Verkman,
2005) which could facilitate basal tear production. Therefore, CFTR is likely to have 
a direct role in tear film homeostasis and CFTR agonists could even be a potential 
treatment for dry eye (Levin and Verkman, 2005). However, considering subjects
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with CF, with predicted defective CF efflux from the conjunctival epithelium, basal 
tear production is likely to be abnormal unless other CF channels, such as CLCA2 or 
C1C, allow for compensation.
SCLERA 
Na+ K+ Cl* 2K+
: r~Wi WBasal m em brane3N a+
Cl Cl-
CFTR CLCA2 <► Apical m em brane
TEAR FILM
Figure 2.3 Diagram of a simplified conjunctival epithelial cell
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2.2.4 CFTR and the retinal pigment epithelium
A number of studies have identified the presence and location of CFTR in the retinal 
pigment epithelium (RPE), these are summarised in Table 2.5. CFTR is believed to 
be located on the basal membrane (Peterson et al., 1997) and may in part mediate the 
apical RPE membrane CF secretion (Weng et al., 2002, Wills et al., 2000b).
Table 2.5 Detection of CFTR in the retinal pigment epithelium
Author and 
Year
Species Method and Observations
(Miller et al., 
1992)
Human and 
bovine cells
Detected expression of CFTR by Western blot. 
CFTR absent from choroid.
(Peterson et 
al., 1997)
Bovine cells Identified CFTR RT-PCR and Western blot and 
located CFTR predominantly near the basal 
membrane by immunocytochemistry techniques.
(Wills et al., 
2 0 0 0 a)
Cultured 
foetal cells
Identified CFTR presence by immunocytochemical 
and RT-PCR analysis.
(Wills et al., 
2 0 0 1 )
Donor human 
adult cells
Identified CFTR presence by immunocytochemical 
and RT-PCR analysis.
(Weng et al., 
2 0 0 2 )
Human adult 
cells
Expression of CFTR confirmed by RT-PCR and 
Western blot. CFTR located near apical and basal 
membranes by immunofluorescence microscopy.
(Blaug et al., 
2003)
Fresh foetal 
human cells
CFTR localised to both apical and basolateral 
membranes by immuno-histochemistry.
(Loewen et 
al., 2003)
Canine cells CF efflux via CFTR demonstrated by Ussing 
chamber electrophysiology.
(Reigada and 
Mitchell, 
2005)
Cultured 
human and 
fresh bovine 
cells
Investigated involvement of CFTR in ATP release. 
Suggested insertion of CFTR into RPE membrane by 
vesicular transport is necessary for ATP release.
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2.2.4.1 Chloride channels in the retinal pigment epithelium
The area between the RPE and the photoreceptors, known as the subretinal space 
(SRS), is occupied by the inter-photoreceptor matrix (IPM). The IPM is essential for 
RPE and photoreceptor interaction and facilitates the exchange of nutrients, ions and 
metabolites (Wimmers et al., 2007) and is thought to assist photoreceptor maintenance 
(Mieziewska, 1996). Continuous fluid absorption from the SRS via the RPE is also 
critical for retinal adhesion (Hamann, 2002, Marmor, 1990). Maintenance of the 
volume and chemical composition of the SRS and IPM is largely achieved by trans- 
epithelial transport of CT, and the subsequent passive movement of water, via the RPE 
to the choroid (Marmor and Wolfensberger, 1998). The N+:K+:CC" co-transporter, 
which functions in parallel with the N+:K+ pump, located on the apical RPE 
membrane, contributes to CT influx (Kennedy, 1990, Hu et al., 1996, Miller and 
Edelman, 1990, Quinn and Miller, 1992). The N+ :K+:CC" co-transporter is directly 
activated by a decrease in intracellular RPE volume and is suggested to be critical to 
the regulation of cell volume (Kennedy, 1994, Kennedy, 1990). A Na+:HC0 3 _ co­
transporter is present on the apical membrane (Hughes et al., 1989) and a number of 
C1C channels have also been detected in RPE cells (Weng et al., 2002, Wills et al., 
2000b, Wills et al., 2000a, Wills et al., 2001). CLCA channels are also present on the 
basal membrane and thought to have substantially greater conductance compared to 
CFTR (Loewen et al., 2003). ENaC has a widespread distribution in RPE cells 
(Mirshahi et al., 1999) although its function is currently not understood (Golestaneh et 
al., 2000). Aquaporins have been identified in the retina, however their exact 
expression in the RPE is also unknown (Verkman et al., 2008). P2 Y2 receptors have 
also been identified in the RPE (Cowlen et al., 2003, Sullivan et al., 1997) and 
stimulation has been shown to increase RPE fluid transport (Maminishkis et al., 
2002). The principle RPE epithelial ion channels are shown in Figure 2.4.
The basal RPE membrane utilises a “recycling” mechanism via the chloride: 
bicarbonate (Cl'iHCCV) exchanger (Gallemore et al., 1997). Thus, CF is recycled at 
the basolateral membrane and net movement is determined by the balance of efflux, 
thought to be via CFTR and CLCA, and influx via the Cl'iHCOs' exchanger. When 
considering the presence of Cl" channels it is apparent that Cl" transport is imperative 
for the maintenance of normal RPE integrity (Gallemore et al., 1997). Therefore,
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unless there is compensation from other CF channels in CF subjects, the anticipated 
defective CF efflux and reduced fluid transport via the RPE could result in impaired 
regulation of the SRS. Subsequently, this could cause serous retinopathy, retinal 
detachment or abnormal RPE-photoreceptor interaction potentially leading to 
impaired visual function.
SUBRETINAL SPA CE
Na+ K+ Cl- 2K+ Na+ 2HCOv
■ ■  Apical m em branes r-
HCO,-
Basal m em brane
CHOROID
Figure 2.4 Diagram of a simplified retinal pigment epithelial (RPE) cell
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2.2.4.2 CFTR and the electro-oculogram
The electro-oculogram (EOG) measures the light response of the RPE (Marmor and 
Zrenner, 1993). The initial response to light stimulation is shown by a series of 
oscillations in the standing potential. Light stimulation causes a reduction of 
potassium (K+) ion concentration in the SRS with the consequence of hyperpolarising 
the apical RPE membrane (Wu et al., 2004). This results in a modulation of CF 
transport, subsequently hyperpolarising the basal RPE membrane causing a reduction 
in the standing potential, known as the fast oscillation (FO) (Marmor, 1991). 
Accordingly, the FO is considered dependent on transepithelial CF transport 
(Gallemore and Steinberg, 1993). Miller and colleagues recorded EOG’s among 
subjects with CF and controls and observed the FO was significantly reduced in the 
CF individuals (Miller et al., 1992). These findings indicate the FO is mediated by 
CFTR activity and that CFTR must be located at the basal RPE membrane (Blaug et 
al., 2003, Miller et al., 1992). However, a further investigation concluded that CFTR 
is not the sole CF channel to generate the response (Wu et al., 2004).
Further electrophysiology studies o f subjects with CF are summarised in Table 2.18.
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2.3 Ocular associations of Cystic Fibrosis
2.3.1 Anterior eye
2.3.1.1 CF and blepharitis
A number of studies have investigated the incidence of blepharitis in subjects with 
CF. The findings indicate some conflict and are summarised in Table 2.6. Sheppard 
et al. (1989) also assessed eyelid cultures from the two groups. Despite a significantly 
higher incidence of blepharitis in the CF group no pathogenic organisms were 
detected. As 60% of the CF group with blepharitis were taking antibiotics, the 
authors concluded staphylococcal infection did not appear to be a contributing factor 
to the incidence of blepharitis (Sheppard et al., 1989). Mrugacz et al. (2005b) 
suggested increased blepharitis could indicate lipid dysfunction in CF and that 
meibomian dysfunction was consistent with the glandular dysfunction observed in CF 
(Mrugacz et al., 2005b).
Table 2.6 Summary of the prevalence o f blepharitis in CF studies
Author Number Incidence Significant
difference
(Sheppard et al., 
1989)
17 CF,
17 controls
88% CF, 
33% controls
Yes
p=0.001
(Kalayci et al., 1996) 23 CF, 
20 controls
13% CF, 
5% controls
No
(Mrugacz et al., 
2005b)
15 CF,
15 controls
60% CF, 
7% controls
Yes
p=0.03
(Mrugacz et al., 
2007c)
25 CF,
25 controls
20% CF, 
16% controls
No
(Mrugacz et al., 
2007b)
24 CF, 
24 controls
21% CF, 
17% controls
No
(Mrugacz et al., 
2007d)
25 CF,
25 controls
44% CF, 
16% controls
No statistical 
comparison
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2.3.1.2 CF and xerophthalmia
Malabsorption of fat-soluble vitamins, especially vitamin A, is a common 
characteristic of CF (Tsinopoulos et al., 2000). Xerophthalmia refers to the group of 
ocular signs and symptoms related to Vitamin A deficiency (VAD) (Sommer, 1998). 
The main clinical manifestations in the ocular system affect the retina, conjunctiva 
and cornea (da Silva Diniz and Santos, 2000). These include; impaired dark 
adaptation, conjunctival and corneal xerosis and xerophthalmic fundus (Wamsley et 
al., 2005).
Dark adaptation is discussed further in Section 2.3.4.4
2.3.1.2.1 Xerosis
Conjunctival xerosis (Figure 2.5a) is characterised by keratinisation and drying of the 
conjunctiva due to loss o f goblet cells and basal cell proliferation (Sommer, 1998). 
Comeal xerosis (Figure 2.5b) occurs following prolonged VAD and is characterised 
by punctate keratopathy, comeal haze and keratinisation which potentially leads to 
comeal ulceration (Hatchell and Sommer, 1984). The incidence of conjunctival 
xerosis in CF is summarised in Table 2.7. Despite vitamin A supplementation in all 
subjects of these two studies (Neugebauer et al., 1989, Rayner et al., 1989) the 
prevalence of xerosis suggests that prescribed values were inadequate for some 
subjects, or non-compliance may have been an issue.
A number o f case reports have indicated xerosis to be a presenting sign in the late 
diagnosis of CF (Brooks et al., 1990, Lindenmuth et al., 1989, Wamsley et al., 2005, 
Joshi et al., 2008). A further case study also reported xerosis following poor dietary 
and supplementary compliance in a subject with CF (Campbell et al., 1998). These 
case studies highlight the importance of considering VAD in patients with CF 
presenting with ocular complaints.
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Figure 2.5 Conjunctival xerosis (a) and corneal xerosis (b) observed in vitamin A 
deficiency (from www.province.moph.go.th and www.unu.edu respectively, accessed 
on 20/04/2009)
Table 2.7 Summary of the prevalence o f conjunctival xerosis in CF studies
Author Group Incidence
(Neugebauer et al., 
1989)
31 CF patients - all 
receiving vitamin 
A supplementation
10% had conjunctival xerosis, despite no 
ocular symptoms
(Rayner et al., 
1989)
43 CF patients - all 
receiving vitamin 
A supplementation
19% had conjunctival xerosis, associated 
with reduced vitamin A and retinol 
binding protein concentration
2.3.1.2.2 Im pression cytology
Impression cytology (IC) is a method used to collect and assess conjunctival epithelial 
cells and goblet cells. IC has many applications including aiding the diagnosis, 
differentiation and assessment of various ocular disorders (including conjunctival 
xerosis) and to allow grading of the extent of conjunctival squamous metaplasia 
(Singh et al., 2005). Squamous metaplasia refers to the pathologic transition from a 
non-keratinised squamous epithelium to a non-secretory keratinised epithelium. The 
process involves a decrease and eventual loss of goblet cells with subsequent 
increased stratification and keratinisation (Calonge et al., 2004). The use of IC in CF 
studies is reviewed in Table 2.8.
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Table 2.8 Summary o f impression cytology in CF studies
Author Group Incidence
(Sheppard 
et al., 1989)
17 CF,
17 controls
No evidence of xerosis; many specimens inadequate for 
goblet cell density analysis
(Morkeberg 
et al., 1995) 32 CF
Normal goblet cell density 
42% samples indicated cellular characteristics of dry eye
(Castagna 
et al., 2001)
40 CF, 
24 controls
80% CF; 0% controls abnormal conjunctival cytology. 
67.5% CF mild-moderate metaplasia; 12.5% severe. 
Conjunctival metaplasia positively correlated with 
Schirmer’s test and tear break-up time (BUT)
(Mrugacz 
et al., 
2007a)
20 CF, 
20 controls
Significantly greater metaplasia; lower goblet cell 
densities in CF compared to controls 
20% CF samples had inflammatory cells- typically 
neutrophils
Mrugacz and colleagues investigated the expression o f human leukocyte antigen-DR 
(HLA-DR) and intracellular adhesion molecule-1 (ICAM-1) in conjunctival epithelial 
cells (collected by IC) from CF patients and controls that were all vitamin A sufficient 
or receiving vitamin A supplementation (Mrugacz et al., 2007b, Mrugacz et al., 
2007c, Mrugacz et al., 2006b). HLA-DR is over-expressed by epithelial cells during 
immune-driven inflammatory responses (Tsubota et al., 1999) and ICAM-1 allows 
communication between cells during the immune response (Imhof and Dunon, 1997). 
HLA-DR and ICAM-1 concentration were significantly increased in conjunctival 
epithelial cells in CF patients compared to controls. HLA-DR expression was 
positively correlated with Schirmer results and BUT, suggesting the conjunctival 
epithelium may be subject to an inflammatory response in subjects with CF (Mrugacz 
et al., 2007c). Inflammation plays a critical role in the pathogenesis of dry eye and is 
both the “cause and consequence” o f ocular surface cellular damage (Baudouin, 
2001, Johnson and Murphy, 2004). Therefore, the evidence of sub-clinical ocular 
surface inflammation in vitamin A sufficient subjects with CF suggests that dry eye is 
likely to be a primary manifestation o f the disease.
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2.3.2 Tear film
The precorneal tear film offers many functions including; the provision of a smooth 
optical surface, lubrication, and the supply of nutrients and oxygen to the avascular 
cornea. Traditionally, the normal tear film is thought to be composed of three distinct 
layers (Wolff, 1946). The thin superficial lipid layer, which is secreted primarily by 
the meibomian glands, retards evaporation (Korb et al., 2002). The thick, 
intermediate aqueous layer contains numerous electrolytes, proteins, enzymes and 
metabolites. The underlying mucous layer, primarily secreted by the conjunctival 
goblet cells, provides a wettable surface to facilitate tear film adherence. Reflex or 
stimulated tears are secreted from the lacrimal gland. Basal tears were originally 
thought to be solely derived from the accessory glands of Krause and Wolfring. 
However, recent studies have demonstrated that corneal and conjunctival epithelial 
fluid transport may be of more significance to basal tear production (Candia, 2004, 
Dartt, 2002, Candia and Zamudio, 1995, Dartt, 2004, Yang et al., 2000, Li et al., 
2001, Shiue et al., 2000).
Dry eye is a common eye disease that can be classified into two main categories 
namely an aqueous tear deficient state or an evaporative state (Lemp, 1995). Reduced 
tear film stability and/or increased tear film evaporation in dry eye contributes to tear 
film hyperosmolarity, ocular surface epithelial damage and inflammation (Baudouin, 
2001, Bron, 2001, Gilbard et al., 1988).
A number of clinical methods have been used to assess the integrity of the ocular 
surface and tear film quality in subjects with CF. These are discussed below:
2.3.2.1 CF and dry eye
2.3.2.1.1 Ocular surface staining
Ocular surface staining is a convenient and readily available method to assess ocular 
surface damage as a consequence of dry eye disorders (Korb et al., 2002). Tables 2.9- 
2.11 summarise the incidence o f corneal and conjunctival staining in the literature. 
The results indicate a wide variance between individual studies and the staining 
criterion in each study may not be comparable.
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Table 2.9 Summary of the prevalence of corneal Sodium Fluorescein staining in CF
studies
Author Number Incidence Significant
difference
(Botelho et al., 
1973)
15 CF,
11 unaffected 
siblings
mild/moderate staining 
60% CF and 10% 
controls initially; 73% 
and 30% on follow up
No statistical 
comparison
(Sheppard et al., 
1989)
17 CF,
17 controls
> 2 punctates 
82% CF and 12% 
controls
Yes
p=0.002
(Kalayci et al., 
1996)
23 CF, 
20 controls
mild punctates 
9% CF, 0% controls
No
(Castagna et al., 
2001)
40 CF, 
24 controls
epithelial defects 10% 
CF, ? controls
No statistical 
comparison
(Mrugacz et al., 
2005b)
15 CF,
15 controls
60% CF, 
13% controls
No
Table 2.10 Summary of the prevalence of Rose Bengal staining in CF studies
Author Number Incidence Significant
difference
(Sheppard et al., 
1989)
17 CF,
17 controls
mild staining 
30% CF, 12% 
controls
No
(Morkeberg et al., 
1995)
35 CF, 
no controls
23% CF No statistical 
comparison
(Ansari et al., 1999) 28 CF,
25 controls
7% CF, 
0% controls
No statistical 
comparison
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Table 2.11 Summary of the prevalence of conjunctival Lissamine Green staining in 
CF studies
Author Number Incidence Significant
difference
(Mrugacz et al., 
2007d)
25 CF, 
25 controls
Abnormal staining 
28% CF, 8% 
controls*
No statistical 
comparison
(Mrugacz et al., 
2007b)
24 CF, 
24 controls
0.49 CF, 
0.52 controlsA
No
staining classified according to van Bijsterveld scoring system
A lissamine green score- no description o f  detailed m ethodology
Unfortunately, a number of studies did not report ocular surface staining in controls or 
did not apply any statistical comparisons. Therefore, only the investigation of 
Sheppard et al. (1989) report significantly greater corneal sodium fluorescein staining 
in subjects with CF compared to controls. Conjunctival IC was normal and no 
significant difference was found for rose bengal staining indicating vitamin A 
sufficiency. Therefore, the authors suggested tear film aqueous deficiency could be 
responsible for the increased corneal staining (Sheppard et al., 1989). Reduced basal 
tear film secretion and/or increased tear evaporation in dry eye contributes to tear film 
hyperosmolarity (Bron, 2001) resulting in ocular surface epithelial damage (Gilbard et 
al., 1988). The indication of increased ocular surface staining in subjects with CF 
suggests reduced basal tear secretion could be a primary manifestation of CF due to 
reduced C f conductance of CFTR in the corneal and conjunctival epithelia. However, 
further detailed investigation in subjects with known vitamin A status is necessary.
2.3.2.1.2 Tear break-up time
The tear break-up time (BUT) is recorded as the time taken for an interruption in the 
fluorescein fluorescence to occur following a blink and indicates tear film stability 
(Figure 2.6). Generally, a BUT below 10 seconds is considered abnormal and 
indicative of dry eye (Lemp et al., 1970). Table 2.12 summarises differences in BUT 
from the literature.
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Table 2.12 Summary of CF studies featuring Sodium Fluorescein tear break-up time
(BUT)
Author Number Details Significant
difference
(Sheppard et al., 
1989)
17 CF,
17 controls
Mean 27 seconds 
(s) CF, 17s controls
No
(Morkeberg et al., 
1995)
35 CF, 
no controls
49% CF 
abnormal*
No statistical 
comparison
(Ansari et al., 1999) 28 CF, 
25 controls
7% CF, 0% 
controls abnormal*
No statistical 
comparison
(Castagna et al., 
2001)
40 CF, 
24 controls
BUT decreased as level of conjunctival 
metaplasia increased
(Mrugacz et al., 
2005b)
15 CF,
15 controls
53% CF, 13% 
controls abnormal*
No
(Mrugacz et al., 
2007c)
25 CF, 
25 controls
Mean 5.3s CF, 
9.9s controls
Yes
pO.OOOl
(Mrugacz et al., 
2007d)
25 CF,
25 controls
Mean 5.4s CF,
11.2s controls 
60% CF, 4% 
controls abnormal*
Yes
(Mrugacz et al., 
2007b)
24 CF, 
24 controls
Mean 5.4s CF, 
9.7s controls
Yes
pO.OOOl
Abnormal BUT < 10 seconds
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Whilst the results of Castagna et al. (2001) indicate tear film stability is adversely 
affected by an indirect measure of VAD, significantly reduced BUT’s were also 
observed in CF subjects with reported vitamin A sufficiency (Morkeberg et al., 1995, 
Mrugacz et al., 2007b, Mrugacz et al., 2007c, Mrugacz et al., 2007d). Tear film 
instability is associated with tear deficiency (Lemp and Hamill, 1973) and BUT 
correlates with tear film thickness (Creech et al., 1998). Morkeberg et al. (1995) 
suggested increased tear film instability could be a primary manifestation of CF and 
that the disease could affect any part of the tear production system. Tear film 
instability is associated with ocular surface inflammation in subjects with dry eye 
(Khurana et al., 1987) and likewise in CF, increased measures of conjunctival 
inflammation have been observed in subjects with reduced tear film stability 
(Mrugacz et al., 2007b, Mrugacz et al., 2007c, Mrugacz et al., 2007d). Therefore, 
increased levels of tear film instability in subjects with CF gives further support for 
the hypothesis that dry eye is a primary manifestation of CF.
Figure 2.6 Fluorescein tear break-up time (FBUT) (from www.eyeworld.org, 
accessed on 20/04/2009)
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2.3.2.1.3 Schirmer’s test
Schirmer’s test is used to assess tear secretion or flow. A wetting length less than 
15mm within a period o f 5 minutes is considered suspect, and a wetting length less 
than 5mm is clearly indicative o f dry eye (Zierhut et al., 2005). A value of 3mm or 
below confirms the diagnosis of aqueous deficient dry eye (Korb et al., 2002). Table 
2.13 summarises differences in Schirmer Test scores between subjects with CF and 
controls from the literature. There is considerable variance between methodologies for 
the studies making direct comparison difficult.
A number of studies indicate significantly reduced tear film secretion in subjects with 
CF compared to controls. The results o f Castagna et al. (2001) indicate a correlation 
of Schirmer wetting and vitamin A status. However, reduced tear secretion was 
similarly recorded in CF subjects with vitamin A sufficiency (Morkeberg et al., 1995, 
Mrugacz et al., 2007c, Mrugacz et al., 2007b, Mrugacz et al., 2007d). These findings 
again provide evidence to suggest impaired tear secretion may be a primary 
manifestation of the disease.
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Table 2.13 Summary o f CF studies featuring Schirmer’s Test
Author Group Incidence Significant
difference
(Fulton et al., 1982) 56 CF, 
no controls
All results in normal 
range
No statistical 
comparison
(Rolando et al., 1988) 13 CF,
13 controls
31.07mm CF, 
29.07mm controls
No
(Sheppard et al., 
1989)
17 CF,
17 controls
9.5mm CF, 
16.0mm controls*
Yes
p=0.002
(Morkeberg et al., 
1995)
35 CF, 
no controls
31% abnormal wetting No statistical 
comparison
(Kalayci et al., 1996) 13 CF,
19 controls
19.1mm CF, 
23.1mm controls
No
(Ansari et al., 1999) 28 CF, 
25 controls
0% CF and controls 
abnormal^
No statistical 
comparison
(Castagna et al., 
2001)
40 CF, 
24 controls
Wetting decreased as level of 
conjunctival metaplasia increased. 
48% CF abnormal
(Mrugacz et al., 
2005b)
15 CF,
15 controls
33% CF, no controls 
abnormal*
No
(Mrugacz et al., 
2005a)
18 CF,
18 controls
9.6mm CF 
25.0mm controls
Yes
(Mrugacz et al., 
2007c)
25 CF, 
25 controls
9.68mm CF, 
25.21mm controls
Yes
pO.OOOl
(Mrugacz et al., 
2007d)
25 CF,
25 controls
4.6mm CF, 
20.12mm controls#
No statistical 
comparison
(Mrugacz et al., 
2007b)
24 CF, 
24 controls
9.65mm CF, 
25.15mm controls*
Yes
pO.OOl
wetting in 5 minutes with topical anaesthetic 
A abnormal defined as wetting less that 10mm in 5 m inutes 
# abnormal defined as wetting less than 5m m  in 5 minutes without anaesthesia
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2.3.2.1.4 The prevalence of dry eye
The Copenhagen criterion is a standard commonly used by ophthalmologists to detect 
the presence of dry eye (Jacobsson et al., 1989). Dry eye is present if at least two of 
the following tests are positive; BUT, Rose Bengal staining and Schirmer’s Test. 
Table 2.13 summarises differences in the prevalence of dry eye from the literature.
Table 2.14 Summary of the presence of dry eye according to the Copenhagen 
criterion in CF studies
Author Group Incidence Significant
difference
(Sheppard et al., 
1989)
17 CF,
17 controls
18% CF, 
12% controls
No statistical 
comparison
(Morkeberg et al., 
1995)
35 CF, 
no controls
26% CF No statistical 
comparison
(Ansari et al., 
1999)
28 CF, 
25 controls
7% CF, 
0% controls
No statistical 
comparison
(Mrugacz et al., 
2005b)
15 CF,
15 controls
33% CF, 
? controls
No statistical 
comparison
(Mrugacz et al., 
2007d)
25 CF,
25 controls
48% CF, 
? controls
No statistical 
comparison
The results from the previous studies using tear film tests indicate a considerable 
incidence of clinical signs of dry eye in subjects with CF. Morkeberg et al. (1995) 
suggested CF could affect individual or multiple parts of the tear production system 
with the consequence of increased tear film osmolarity or abnormal mucin production, 
similar to that of the lung in CF (Morkeberg et al., 1995). Individual aqueous, mucin 
or lipid tear component abnormalities, or in combination, could account for the dry 
eye and corneal epithelial disturbance (Sheppard et al., 1989).
Mrugacz and colleagues (2005) observed lower plasma retinol binding protein, a 
specific plasma transport protein for vitamin A, in their CF patients (Mrugacz et al., 
2005b). It was suggested this factor could be associated with the moderate levels of 
dry eye (33%) observed in the study. A similar conclusion was reached by Castagna
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et al. (2001) thereby suggesting dry eye in CF is secondary to VAD. However, dry 
eye has also been observed in CF patients with normal vitamin A status suggesting 
dry eye could be a primary manifestation of the disease (Ansari et al., 1999, 
Morkeberg et al., 1995).
Considering recent discoveries o f the presence of CFTR in the corneal and 
conjunctival epithelium (Turner et al., 2002, Al-Nakkash and Reinach, 2001) and 
expected subsequent reduced basal tear secretion in subjects with CF, it is plausible 
that dry eye is a primary manifestation of CF. However, to confirm this hypothesis, 
further detailed research into the tear film composition and ocular surface in a large 
cohort of subjects with CF and known vitamin A status is necessary.
2.3.2.2 CF and tear film analysis
2.3.2.2.1 Tear lysozym e concentration
The concentration of lysozyme, a tear film enzyme with antimicrobial activity, is 
known to decrease with both age and dry eye (Seal et al., 1986). Tear lysozyme 
concentration has been found to be significantly lower in subjects with CF compared 
to controls (Sheppard et al., 1989). Significantly reduced Schirmer’s test was also 
recorded in this study indicating considerable tear aqueous deficiency in the CF 
group. Incidentally, no significant difference in total protein concentration and tear 
pH was observed between the two groups (Sheppard et al., 1989).
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2.3.2.2.2 Tear electrolyte levels
Tear film electrolytes are responsible for the osmolarity of the tears (Botelho, 1964), 
and are essential for the maintenance of normal epithelial integrity (Korb et al., 2002). 
Botelho et al. (1973) investigated electrolyte concentrations in tear samples collected 
from subjects with CF and their unaffected siblings (Botelho et al., 1973). Whilst C f , 
Na+ and K+ concentration was the same in both groups, Na+ concentration was 
significantly reduced and calcium (Ca2+) concentration was higher in the CF patients 
compared to their siblings (Botelho et al., 1973).
The authors suggested excessive calcium secretion could result in abnormal mucous 
production, possibly causing the impaired corneal epithelium wetting indicated by the 
high level of corneal fluorescein staining (60 and 73%) observed in the CF group 
(Botelho et al., 1973). This study was conducted several years before the discovery of 
CFTR. However, it is interesting that chloride ion concentration was the same in both 
groups considering the primary function o f CFTR is to regulate the flow of this ion 
across epithelia (Schwiebert et al., 1999).
2.3.2.2.3 Tear ferning
Tear ferning (TF) is a novel diagnostic test for the presence of dry eye. Dried tear 
samples are viewed with a light microscope and classified according to their 
characteristic fern-like appearance. Whilst Type 1 and 2 are considered normal, Type 
3 and 4 are abnormal and indicative of dry eye. TF is discussed in further detail in 
Chapter 3.
Rolando, Baldi and Calabria (1988) investigated TF in 13 subjects with CF and 13 
controls and concluded that whilst tear samples from a CF cohort typically 
corresponded to Type 3 or 4, those samples from controls were typically of Type 1 
appearance (Rolando et al., 1988) and the difference was statistically significant. As a 
normal secretion rate (Schirmer’s Test) had been observed in the CF group it was 
suggested an increased electrolyte concentration could alter the normal tear mucus 
properties resulting in abnormal TF.
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Kalayci and colleagues (1996) investigated TF in 23 subjects with CF and 20 controls 
and similarly observed a significantly higher frequency of Type 3 and 4 ferning in CF 
subjects compared to healthy controls. A negative correlation was found between TF 
patterns and Shwachman score (a measure of CF clinical disease status). No 
significant correlation was detected between ferning and vitamin A status. Therefore, 
it was concluded abnormal TF was the result of primary alteration of the tear fluid by 
the disease rather than an association with vitamin A levels (Kalayci et al., 1996).
2.3.2.2.4 Tear film inflam m atory cytokines
Cytokines are a group of signalling molecules that communicate between cells, 
including those of the immune system (Hamblin, 1993). Individual cytokines have 
several different, and apparently unrelated, functions and can be responsible for both 
harmful and beneficial effects during the immune response (Playfair and Chain,
2001). Inflammation is an important procedure in this response and cytokines are 
known to mediate the inflammatory process. Cytokines and their role in ocular 
surface inflammation are discussed in further detail in Chapter 4.
A number of cytokines, Interferon-y (IFN-y), Interleukin-8 (IL-8) and macrophage 
inflammatory protein-la (MIP-la), have been observed in higher concentrations in 
tear samples from subjects with CF compared to controls (n=15 to 25) (Mrugacz et 
al., 2005c, Mrugacz et al., 2006c, Mrugacz et al., 2007d, Mrugacz et al., 2006a). 
Disease severity (Shwachman score) correlated significantly with cytokine 
concentration, and a positive correlation between cytokine concentration and dry eye 
findings was also observed. The authors suggested the increased cytokine 
concentration could be an important factor in the pathogenesis of dry eye in patients 
with CF. It has been suggested tear film concentration of IFN-y and IL-8 could 
function as indicators in the evaluation of CF disease clinical status (Mrugacz et al., 
2006a). However, further investigation into the presence of a wide profile of pro- 
inflammatory cytokines in the tear film of patients with CF would be beneficial.
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2.3.3 Posterior eye
2.3.3.1 Cystic Fibrosis and the crystalline lens
Majure and colleagues (1989) detected posterior subcapsular cataract formation in 
two subjects of a cohort of 15 CF patients receiving steroid treatment. However, 
steroid dose, duration and linear growth pattern during steroid therapy were not 
predictive factors for cataract development (Majure et al., 1989).
Lens transparency, measured with a Lens Opacity Meter, was assessed in 40 CF and 
24 control subjects. Although no clinical evidence of lens opacity was detected by slit 
lamp examination, lens transparency was significantly higher in the control group 
compared to that of the CF group. Lens transparency was observed to decrease as the 
level of conjunctival xerosis and digestive insufficiency increased (Fama et al., 1998, 
Castagna et al., 2001). As xerosis is a direct manifestation of VAD the authors 
speculated low serum vitamin A levels could be responsible for the decreased lens 
transparency (Castagna et al., 2001, Fama et al., 1998). Unfortunately, vitamin A 
levels were not recorded in this investigation.
Vitamin supplements have been implicated as having a protective function against the 
development and progression of cataract (Brown et al., 1998). Antioxidants, such as 
vitamins A, C and E, are associated with reduced cataract formation (Wu and Leske, 
2000). Therefore, vitamin deficiency, secondary to pancreatic insufficiency in CF, 
could contribute to reduced lens transparency. Diabetes also has a long standing 
association with cataract formation (Harding, 1991, Tan et al., 2008, Leske et al., 
1999, Klein et al., 1998). CF subjects with CFRD or fat soluble vitamin deficiency 
are therefore likely to be at risk from a reduction in lens transparency. To fully 
understand the effect of CF on crystalline lens transparency further detailed studies in 
CF patients with known diabetic and vitamin A status and steroid history are 
necessary.
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2.3.3.2 Cystic Fibrosis and macula pigment density
Macular pigment is largely derived from two carotenoids, lutein and zeaxanthin. 
Schupp et al. (2004) hypothesised that the combined association of reduced 
carotenoid absorption and increased oxidative stress in CF could result in a decreased 
serum concentration of these carotenoids. Serum lutein and zeaxanthin concentration 
and macular pigment optical density were observed to be significantly lower in a CF 
group compared to controls (Schupp et al., 2004). However, no significant difference 
in visual function was recorded. Reduced serum and retinal carotenoid concentration 
is associated with an increased incidence of AMD. In the study by Schupp et al. 
(2004) the age range of the CF patients was 21-47 years of age. However, AMD 
typically causes visual loss in older individuals (Smith et al., 2001). The authors 
concluded it would be appropriate to conduct the same protocol longitudinally in CF 
patients over the age of 50 to investigate the incidence of AMD (Schupp et al., 2004). 
As the survival rate of individuals with CF continues to increase it could be expected 
the incidence of AMD, secondary to reduced carotenoid uptake, at an earlier age in 
these individuals may also increase. As a consequence, recommendation of a 
supplement containing lutein and zeaxanthin to all CF patients may be pertinent.
2.3.3.3 Cystic Fibrosis and diabetic retinopathy
The incidence of diabetic retinopathy (DR) in CFRD is summarised in Table 2.15. 
The prevalence of CFRD increases with age; at 30 years of age 50% of patients with 
CF are diabetic (Lanng, 2001). As the survival rate of patients with CF continues to 
increase the incidence of CFRD is similarly likely to increase. The incidence of DR 
following diabetes duration of 10 years ranges between 67-89% for American Type 2 
and Type 1 diabetics respectively (Klein et al., 1994). Whilst Anderson et al. (2006) 
observed a 10 year incidence o f DR in 36% subjects with CFRD, Schwarzenberg et 
al. (2007) recorded DR in only 16%. Although the incidence of DR in CFRD appears 
to be lower than that observed in Type 1 or 2 diabetes, the findings indicate the 
importance of regular optometric and/or ophthalmological examinations, especially in 
those with CFRD duration of 10 years or more.
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Table 2.15 Summary of diabetic retinopathy (DR) in subjects with CFRD
Author CFRD Group Incidence
(Rodman et al., 
1983) 24
2 subjects (8%) had DR- one with 
microaneurysm, one with macular 
oedema
(Spaide et al., 
1987)
5 1 subject (20%) DR; vitreous 
haemorrhage & macular oedema.
(Sullivan and 
Denning, 1989)
19 patients 
reviewed during 9 
year period
1 subject (5%) -  reportedly poorly 
compliant developed DR
(Scott et al., 2000) Case report 1 subject with proliferative DR 
requiring laser therapy
(Lanng, 2001) 79 2 (3%) subjects had DR
(Yung et al., 1998)
34 patients 
CFRD > 5 years, 
all insulin treated
5 subjects (15%) had DR; 3 
background, 1 maculopathy, 1 
proliferative. 23% incidence of DR in 
CFRD duration > 10 years
(Andersen et al., 
2006)
38 patients, all 
insulin treated
9 subjects (24%) had DR; 6 mild, 1 
mod, 2 proliferative. 36% incidence of 
DR in CFRD duration > 10 years
(Schwarzenberg et 
al., 2007)
84 7% DR. 16% incidence of DR in CFRD 
duration > 10 years
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2.3.4 Visual function
2.3.4.1 Cystic Fibrosis and visual acuity, refractive error and binocular 
vision
A number of studies have recorded reduced visual acuity (VA) in individuals with CF. 
Suggested causes have included: chloramphenicol associated optic neuritis (Spaide et 
al., 1987), VAD (Campbell et al., 1998, O'Donnell and Talbot, 1987, Suttle and 
Harding, 1998) and diabetic retinopathy (Spaide et al., 1987). Other investigations 
have recorded normal VA (6/6 or 20/20 and above) in the vast majority of the 
participants (Fama et al., 1998, Fulton et al., 1982, Castagna et al., 2001, Morkeberg 
et al., 1995). However, no study has directly compared VA in subjects with CF to 
matched healthy controls. Fama et al. (1998) and Morkeberg et al. (1995) reported 
refractive error in CF patients: 28% myopic and 13% hypermetropic; and 31% 
myopic respectively (Fama et al., 1998, Morkeberg et al., 1995). Similarly, no 
comparisons were made to a control group. Whilst a number of studies have recorded 
CF subjects with strabismus and/or amblyopia there has been no detailed study to 
compare binocular vision status in CF subjects and controls (Fulton et al., 1982, 
Morkeberg et al., 1995, Spaide et al., 1987).
CF is associated with prematurity and low birth weight (Festini et al., 2005, Muller et 
al., 1999), which are themselves associated with a greater incidence of ametropia, 
strabismus and amblyopia (Huynh et al., 2006, O'Connor et al., 2006, Robaei et al., 
2006a). Therefore, a large scale investigation of visual acuity, refractive and 
binocular vision status in a large cohort o f CF patients and controls would be 
invaluable for clinical management.
2.3.4.2 Cystic Fibrosis and colour vision
Some form of colour vision defect is observed in approximately 8% male and 0.5% 
females within a normal Caucasian population (Tovee, 1994). However, Spaide et al. 
(1987) recorded colour vision (CV) deficiencies in 29% subjects with CF. These 
patients had been treated with the antibiotic chloramphenicol, had reduced VA and
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hyperaemic optic discs. Therefore, the defects were believed to be caused by 
chloramphenicol associated optic neuritis (Spaide et al., 1987). Morkeberg et al. 
(1995) reported three male patients had CV deficiencies. These included; a 
deuteranormal, a deuteranope and a protanope (Morkeberg et al., 1995). However, it 
was not indicated if these were congenital or acquired defects. Tinley et al. (2008) 
reported a case study where a vitamin A deficient subject complained of abnormal 
colour perception where “colours assumed a green hue” (Tinley et al., 2008). 
However, no diagnostic CV test was performed. More recently, CV was assessed in a 
small CF cohort (n=10) with a computerised Cambridge Colour Test. Whilst one 
deuteranomalous subject was excluded all remaining subjects had normal CV (Schupp 
et al., 2004).
Although it is not believed any patients in these previous studies had CFRD, diabetes 
is known to adversely affect colour vision, even in the absence of diabetic retinopathy 
(Stavrou and Wood, 2003, Di Leo et al., 1992, North et al., 1997, Banford et al.,
1994). To examine if CFRD has a similar effect, further detailed studies investigating 
CV in CF patients with known diabetic status is necessary.
2.3.4.3 Cystic Fibrosis and contrast sensitivity
A number of studies have recorded reduced levels of contrast sensitivity (CS) in 
subjects with CF. These are reviewed in Table 2.16 later in the chapter. In the study 
by Spaide et al. (1987), even after the exclusion of nine CF patients with decreased 
VA, CS remained significantly reduced. The authors suggested optic nerve disease 
could be responsible, which could be a primary effect of CF itself or a secondary 
effect from other factors including; antibiotics, vitamin deficiencies, hypoxia (Spaide 
et al., 1987). In the Leguire case study, CS was shown to significantly improve 
following vitamin A supplementation (Leguire et al., 1991). Therefore, the authors 
suggested the observations of both their case report and Spaide et al. were caused by 
subtle loss of photoreceptor function secondary to VAD (Leguire et al., 1991). 
However, subjects with good vitamin A status have also been shown to have 
significantly reduced CS (Morkeberg et al., 1995, Ansari et al., 1999). It was 
suggested the abnormal pre-comeal tear film observed in many patients with CF could
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cause a glare phenomenon adversely affecting the CS function (Morkeberg et al., 
1995). However, no significant correlation between the incidence of dry eye and 
reduced CS was observed in this study. More recently, a smaller study found no 
significant difference in CS between subjects with CF and controls (Schupp et al., 
2004).
A number of other factors beside VAD could contribute to abnormal CS in subjects 
with CF. A reduction in CS in Type 1 and Type 2 diabetics, even in the absence of 
diabetic retinopathy has been observed (North et al., 1997, Di Leo et al., 1992, Dosso 
et al., 1996). This could similarly be observed in subjects with CFRD. CS is also 
reduced in patients who have reduced lens transparency due to increased light scatter, 
even though high contrast visual acuity may remain unchanged (Thomson, 2002, 
Brown, 1993, Elliott et al., 1989, Cheng et al., 2001) and reduced lens transparency 
and cataract have been observed in CF previously (Fama et al., 1998, Castagna et al., 
2001, Majure et al., 1989). It is unknown if any of the previous studies included 
subjects with CFRD or lens abnormalities. Therefore, a detailed study of CS in 
patients with known vitamin A and diabetic status and crystalline lens physiology 
would be invaluable.
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Table 2.16 Summary of contrast sensitivity (CS) in CF studies
Author Groups Method Results
(Spaide et al., 
1987)
29 CF,
12 controls
Bekesy interactive CS technique, measured 
at 6 spatial frequencies (sf) range 0.5-22.8 
cycles/degree (cpd)
CS decreased at every sf in CF. CS still 
reduced when subjects with reduced VA were 
excluded (p<0.1)
(Leguire et al., 
1991)
case report, 16 year 
old CFRD subject
Wall mounted chart; 8 contrast levels at 5 
sf. Compared to CS of 15 controls
CS abnormal at all sf. CS improved by 94% 
following vitamin A supplementation
(Morkeberg et al., 
1995)
35 CF
Mesopter, using Landolt ring at 2
•y
luminance levels (0.1 & 0.03cd/m ) also 
measured after 10 second “blinding” light 
Results compared to reference population
CS significantly reduced in CF for all tests 
(p<0.001), CS was most affected by light 
“blinding”
(Ansari et al., 
1999)
28 CF, 
25 controls
Vistech chart, measured at 5 sf range 1.5-18 
cpd
8 (29%) CF patients had reduced CS at 
intermediate and high sf.
(Schupp et al., 
2004)
10 CF,
10 controls
Gratings presented on computer screen at 
0.55, 1.125, 2.25, 2.5, 9 & 18 cpd
No significant difference in CS for all sf
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2.3.4.4 Cystic Fibrosis and dark adaptation
The earliest clinical manifestation of xerophthalmia is impaired dark adaptation (DA) 
and night blindness (Brooks et al., 1990). Initially, a decrease in the rate of DA and 
the rate of pigment regeneration in the rod system is observed (Lamb and Pugh, 
2004). As the deficiency continues DA becomes slowed and thresholds elevated. 
Following prolonged and severe deficiency the photoreceptors degenerate. Provided 
the deficiency has not been too severe or prolonged the effects can be typically 
reversed within days following vitamin A supplementation (Congdon and West,
2002). Table 2.17 summarises a number o f studies that have investigated DA in CF 
later in this chapter.
Several studies have reported reduced serum vitamin A levels in CF patients with 
abnormal DA (Fulton et al., 1982, Neugebauer et al., 1989, Rayner et al., 1989). DA 
thresholds have been shown to improve following vitamin A supplementation in a 
number of subjects with CF (Fulton et al., 1982, Huet et al., 1997, Rayner et al., 
1989). A number of case reports have been published indicating abnormal DA in 
vitamin A deficient CF patients that has been reversed following intervention (Eid et 
al., 1990, Brooks et al., 1990, O'Donnell and Talbot, 1987, Joshi et al., 2008).
Considering the more recent investigations (Ansari et al., 1999, Morkeberg et al.,
1995), the incidence of abnormal DA secondary to VAD appears to have significantly 
reduced. This undoubtedly reflects modem supplementary management and 
appropriate intervention. However, assessment of DA appears to be a relatively 
simple method to evaluate and monitor the effects and subsequent improvement of 
VAD in patients with CF.
There is no recorded indication o f CFRD in any subjects with abnormal dark 
adaptation, however there is substantial evidence that individuals with diabetes 
generally have abnormal dark adaptation thresholds (Holopigian et al., 1997) and take 
longer to adapt (Henson and North, 1979) even in the absence of diabetic retinopathy 
(Arden et al., 1998). Consequently, it is of interest to compare dark adaptation 
thresholds in CF patients, with normal vitamin A levels, both with and without CFRD.
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Table 2.17 Summary of dark adaptation (DA) in CF studies
Author Group Method Results
(Fulton et al., 1982) 56 CF,
8 controls
Maxwellian-view adaptometer Average thresholds & vitamin A lower in CF 
group (p<0.05 & p<0.001).
(Neugebauer et al., 
1989)
31 CF, 
28 controls
Friedmann Field Analyser and in house 
computer system. DA abnormal if threshold 
>2 standard deviation above controls
19% CF abnormal DA
(Rayner et al., 
1989)
43 CF,
4 controls
Modified Friedmann Field Analyser and 
computer system
19% CF abnormal DA, vitamin A & RBP 
significantly lower in affected patients
(Huet et al., 1997) 10 CF Beyne optometer 3 CF poor and 2 CF pathological DA 
90% subjects low vitamin A levels
(Morkeberg et al., 
1995)
35 CF
Goldmann-Weekers Adaptometer. 
Threshold determined after 15 minutes 
adaptation. Values below 20pcd/m2 normal
All subjects normal vitamin A levels & 
normal DA
(Ansari et al., 
1999)
28 CF Friedmann Field Analyser, pupils dilated, 
30 minute test period
All subjects normal vitamin A levels & 
normal DA
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2.3.4.5 Cystic Fibrosis and electrophysiology
A summary of electrophysiological studies in subjects with CF is presented in Table 
2.18 later in this chapter. The visual evoked potential (VEP) is an 
electrophysiological response to light or pattern stimulation recorded from 
encephalographic activity and can be used to assess the functional integrity of the 
visual system (Odom et al., 2004). Reduced VEP’s in CF subjects treated with 
chloramphenicol supports the theory that the antibiotic causes optic nerve disease in 
CF (Spaide et al., 1987). There is limited use of chloramphenicol in CF patients 
currently (Schupp et al., 2004). Therefore, the incidence of chloramphenicol 
associated optic neuritis has certainly reduced. A number of studies highlight the 
electrophysiological consequences o f VAD in CF, indicating abnormal photoreceptor 
function (Leguire et al., 1991, Leguire et al., 1992).
Vitamin E deficiency also appears to have detrimental consequences, particularly for 
the VEP (Messenheimer et al., 1984, Kaplan et al., 1988, Willison et al., 1985). The 
antioxidant vitamin provides retinal protection from free radical damage and oxidative 
destruction of stored vitamin A (Lu et al., 2006). Tinley et al. (2008) reported a case 
study where a vitamin A deficient CF subject showed restoration of the rod response 
(scotopic electroretinogram (ERG)) following zinc supplementation (Tinley et al., 
2008). Zinc deficiency has been implicated in rod dysfunction and may cause 
secondary VAD (Christian and West, 1998). These studies indicate vitamin A is not 
the sole nutrient essential for normal ocular physiology.
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Table 2.18 Summary of Electrophysiology in CF studies
Author Groups Method Results
(Messenheimer 
et al., 1984)
case report, vitamin E 
deficient subject
VEP Pattern reversal VEP abnormal, became normal after 2 month 
period of vitamin E administration
(Willison et al., 
1985)
case report, vitamin A & E 
deficient subject
VEP & ERG VEP’s bilaterally delayed 
Pattern reversal ERG not detectable
10 CF ERG & VEP 2 subjects abnormal flash ERG’s, 1 subject prolonged VEP latency 
These subjects vitamin A sufficient but vitamin E deficient
(O'Donnell and 
Talbot, 1987)
case report, vitamin 
deficient subject
ERG ERG initially abnormal, normalised following 4 months of vitamin
A supplementation
(Spaide et al., 
1987)
17 CF VEP 29% CF reduced bilateral delays, associated with chloramphenicol 
associated optic nerve disease
(Kaplan et al., 
1988)
10 CF, all vitamin E 
deficient
VEP 3 subjects abnormal VEP’s
(Leguire et al., 
1991)
case report 1 vitamin A 
deficient CF patient
Scotopic & 
photopic ERG’s
ERG’s reduced, normalised following vitamin A supplementation
(Leguire et al., 
1992)
case report 1 vitamin A 
deficient CF patient
EOG Initially abnormal, normalised following vitamin A 
supplementation
(Miller et al., 
1992)
13 CF, 15 controls EOG FO significantly reduced (p<0.001) in CF
(Suttle and 
Harding, 1998) case report, CF infant
Scotopic & 
photopic ERG
Scotopic ERG absent before 19 weeks of age, photopic ERG 
normal. Restoration of scotopic ERG following vitamin A
treatment
(Tsinopoulos et 
al., 2000)
41 CF,
41 controls
Scotopic & 
photopic ERG
Vitamin A significantly lower in CF group, 66% abnormal. No 
significant differences in ERG responses between two groups.
(Schupp et al., 
2004)
9 CF, extensive age 
matched controls
mfERG Two CF patients showed delayed latencies but normal response
densities
(Constable et al., 
2006)
6 CF,
9 controls
light-EOG & 
acohol-EOG
Alcohol and light-EOG’s amplitudes normal. FO amplitude 
significantly higher & time to dark troughs significantly slower in 
AF508 heterozygotes compared to both controls and homozygotes.
(Tinley et al., 
2008)
case report 1 vitamin A 
deficient patient
Scotopic ERG Rod response restored following zinc supplementation
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2.4  Su m m ary
CFTR is a significant channel for C f efflux in the eye and is present in the corneal 
epithelium, corneal endothelium, conjunctival epithelium and the retinal pigment 
epithelium. CFTR is likely to facilitate a number of ocular processes (Figure 2.7) that 
rely on active C f transport to allow passive movement of water such as:
• basal tear production by the cornea and conjunctiva
• maintenance of normal comeal integrity by the comeal endothelium
• maintenance of the SRS by the RPE and normal photoreceptor function
Therefore, abnormal or complete absence of CFTR function in individuals with CF 
may result in abnormal basal tear production and dry eye, increased comeal thickness 
and reduced comeal transparency, increased SRS and abnormal photoreceptor 
function.
A number of small studies have investigated the ocular surface, posterior eye and 
visual function in subjects with CF. These studies have identified a number of ocular 
characteristics associated with the disease such as; dry eye and tear film abnormality, 
reduced lens transparency and contrast sensitivity and colour vision irregularities. 
However, it is unclear if these characteristics are primary or secondary manifestations 
of CF. These investigations have frequently been of a small scale, have not used 
healthy matched controls for comparison, or are dated in terms of modem CF therapy 
and management. Many have included confounding factors such as VAD or unknown 
serum vitamin A levels and others have undoubtedly included subjects with CFRD.
As the life expectancy of individuals with CF continues to increase eyecare 
professionals will encounter these subjects more frequently. In order to offer optimal 
care to these patients the ocular associations of CF must be researched.
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Retinal pigm ent epithelium
•CFTR normally facilitates 
maintenance of SRS
•In CF:
•Serous retinopathy? 
•Retinal detachment? 
•Impared
photoreceptor-RPE 
interaction?
•Reduced visual 
function?
Corneal & conjunctival 
epithelium
•CFTR normally facilitates 
secretion of basal tear fluid
| -In CF:
•Reduced basal tear 
secretion?
•Dry eye?
♦Ocular surface 
inflammation?
Corneal endothelium
•CFTR normally facilitates 
maintenance of comeal 
thickness and transparency
•In CF:
•Increased comeal 
thickness?
•Reduced corneal 
transparency?
Figure 2.7 A summary of the presence of CFTR, proposed function and potential 
ocular consequences in subjects with CF
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2.5 Objectives for this Ph.D
The approach to CF studies and literature with respect to the eye and visual system 
appear to have been considered in two distinct areas. Scientists have investigated the 
cellular activity of CFTR within various ocular structures with little consideration of 
the clinical consequences. Clinicians have explored the tear film and visual function 
in CF with little knowledge of the existence and consequence of CFTR in various 
ocular structures. This project aims to combine these two disciplines to 
comprehensively identify the primary and secondary ocular manifestations of CF.
The main objective of this work is to implement an observational study to investigate 
vision, visual function, ocular surface and tear film characteristics in children and 
adults with Cystic Fibrosis with known vitamin A and Cystic Fibrosis-related 
Diabetes status, genotype and disease severity.
2.6 Hypotheses
1. Dry eye is a primary manifestation of CF, even in vitamin A sufficient 
subjects: abnormal CF efflux by CFTR from the corneal and conjunctival 
epithelium results in reduced basal tear fluid secretion with a subsequent 
increase in tear film osmolarity. Increased tear film inflammatory cytokine 
concentration indicates sub-clinical inflammation of the ocular surface. Dry 
eye severity is likely to be correlated with CF genotype and therefore disease 
progression.
2. Abnormal visual function is a primary manifestation of CF due to anomalous 
C f secretion by CFTR from the RPE resulting in impaired regulation of the 
SRS and IPM leading to abnormal retinal photoreceptor function. However, 
visual function is proposed to be confounded by secondary disease 
characteristics including vitamin A deficiency and CFRD.
3. There is a greater incidence of ametropia and abnormal binocular vision in 
subjects with CF, associated with low birth weight and/or prematurity.
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Chapter 3 
Preliminary Experiments and Development of 
Protocols
3.1 Introduction
In order to investigate the tear film in subjects with Cystic Fibrosis (CF) it is essential 
to collect tear samples with proficiency. Therefore, the aims of these preliminary 
experiments were to:
• Identify suitable alternative tear collection material to glass capillary tubes for 
use in children and young adults with CF and controls
• Investigate subject comfort and sample absorbency of alternative tear 
collection material
• Optimise tear sample storage and recovery
Tear feming, a novel diagnostic dry eye test, was found to be abnormal in CF subjects 
(Rolando et al., 1988, Kalayci et al., 1996). However, a detailed methodology for the 
tear feming technique is not available from the literature. It is important to consider 
the effect of tear collection technique on tear film composition (Stuchell et al., 1984). 
Many components, such as cytokine concentration, are sensitive to the method of tear 
sample collection (Cook et al., 2001) and tear film osmolarity and various protein 
concentrations are dependant on factors such as stimulation (Stuchell et al., 1981,
Farris et al., 1981). Therefore, further aims for this work included:
• Development of a detailed tear feming protocol
• Assessment of the effect o f the new tear collection material on tear ferning
samples
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3.2 Suitable materials for tear sample collection in children 
and young adults
3.2.1 Introduction
Glass capillary tubes have traditionally been utilised to collect tear samples for tear 
feming, osmolarity, cytokine analysis, refractive index measurement, mucin 
concentration and protein analysis (Patel et al., 2000, Nom, 1988, Nichols and 
Sinnott, 2006, Yoon et al., 2007, Argueso et al., 2002, Glasson et al., 2003). 
Although the technique is well cited, the safe and effective use for tear collection in 
children, young adults or subjects lacking co-operation is questionable. Relatively 
few alternatives have been suggested in the literature and are summarised in Table 
3.1.
Absorbent sponges have proved to be effective alternatives to glass capillaries. Small 
and colleagues concluded surgical sponges were both easy to use, allowed rapid 
collection and the collected tear sample easily analysed (Small et al., 2000). In adults, 
cellulose sponges have been used successfully to collect tear samples from neonates 
(Esmaeelpour et al., 2008) and patient comfort has been cited as an advantage when 
using polyurethane minisponges in adults (Lopez-Cistemas et al., 2006). Therefore, a 
variety of alternative tear collection materials, including a number of sponge devices, 
were investigated for their suitability of tear collection in children and young adults.
3.2.2 Method
A number of suitable tear collection materials (Table 3.1) were sourced and their 
relative advantages and disadvantages investigated. Bench-top comparisons 
considered factors such as expense and material sterility. Materials were trialled for 
tear collection on a single subject (the author); features considered included; ease of 
use, if forceps were necessary to hold the material, relative material absorbency or 
capillary attraction. Absorbent sponges were centrifuged (method described in 
3.4.2.1.1) to investigate sample recovery.
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Table 3.1 Alternative tear collection materials to glass capillary tubes
Author and Year Alternative method for tear 
collection
Purpose
(Botelho et al., 1973) Plastic sponge Tear flow rate and ion 
analysis
(Webster and Kairys, 
1984)
Polyethylene tube with 
syringe
Improved tear collection for 
protein analysis
(van Agtmaal et al., 
1987)
Cellulose sponges Tear collection in neonates 
for protein analysis
(Boonstra et al., 1988) Schirmer strips & sponges
High performance liquid 
chromatography (HPLC) 
analysis of tear protein 
profile
(Tuft and Dart, 1989) Cellulose sponges Immumo globulin E (IgE) 
analysis
(Norn, 1992) Cotton, Spongostan & 
Schirmer strips
Analysis of various tear 
constituents eg. albumin, 
glucose
(Jones et al., 1997) Porous polyester rods Tear protein analysis
(Small et al., 2000) Surgical sponges & Schirmer 
strips
Pharmaceutical drug 
recovery from tears
(Zhao et al., 2001) Schirmer strips Quantification of the mucin 
MUC5AC
(Lopez-Cistemas et 
al., 2006)
Polyurethane minisponges Electrophoresis
(Esmaeelpour et al., 
2008)
Cellulose rods Tear collection in neonates 
for protein analysis
3.2.3 Results
Tear collection materials and their properties are summarised in Table 3.2. In 
particular the cellulose rods and triangular sponges appear to have optimal qualities 
for tear collection in children and young adults. The cellulose spears, although ideal 
for tear collection, must be excluded due to discolouring the tear sample after 
centrifuging, indicating contamination by the tear collection material.
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Table 3.2 Relative properties of the alternative tear collection materials
Material Relative Advantages Relative Disadvantages
lOpl glass pre-calibrated pipette tubes 
(LIP Ltd.)
-Well referenced, established 
method
-Excellent collection and retrieval of 
sample
-Minimal stimulation
-Not suitable for use with children 
-Difficult to obtain ethical approval for use in 
children?
Plastic capillary bores 
(Advanced Instruments Inc., MA, USA)
-Safer alternative to glass capillary? -Very poor capillary attraction
Absorbent dental paper points 
(Dentsply Int., PA, USA)
-Sterile
-Pointed tip easy to place in tear 
meniscus
-Poor absorbency
-Too small for easy use
-Difficult to retrieve sample, must be eluted
-Need to be held with forceps
Sno Strips
(Chauvin Pharmaceuticals Ltd., Kingston- 
upon-Thames, UK)
-Allows simultaneous assessment of 
tear flow rate
-Widely accepted clinically
-Difficult to use for tear collection in children
-Stimulated tears only
-Difficult to retrieve sample, must be eluted
Cellulose Spears 
(Eyetec, Network Ophthalmic Products, 
Rippon, UK)
-Sterile
-Easy to use, no forceps needed 
-Pointed tip easy to place in tear 
meniscus
-Excellent absorbency
-Discolour tear samples when centrifuged 
-Relatively expensive
Cellulose Rods 
(Filtrona Filter Products, Milton Keynes, 
UK)
-Have been used to collect tears in
neonates
-Inexpensive
-Not sterile (can be UV sterilised) 
-Small surface area for tear collection 
-Need to be held with forceps
Sugi steril rectangular sponges 
(Kettenbach GmbH & Co., Eschenburg, 
Germany)
-Sterile
-Excellent absorbency
-Relatively expensive
-Too large to accurately place in tear meniscus 
-Need to be held with forceps
Sugi steril triangular sponges 
(Kettenbach GmbH & Co., Eschenburg, 
Germany)
-Sterile
-Pointed tip easy to place in tear 
meniscus
-Excellent absorbency
-Relatively expensive 
-Need to be held with forceps
* Two suitable tear collection materials
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Figure 3.1 Alternative tear collection materials (from left to right); glass capillary 
tube, plastic capillary bore, dental paper point, Sno Strip, cellulose spears, cellulose 
rods, Sugi Steril rectangular sponge, Sugi Steril triangular sponge.
3.2 .4  D iscussion
A number of cellulose based materials have been cited in the literature as suitable 
alternatives to glass capillary tubes for tear film collection (van Agtmaal et al., 1987, 
Tuft and Dart, 1989, Esmaeelpour et al., 2008). Therefore, it is unsurprising that the 
two most appropriate materials identified were cellulose rods (Filtrona Filter Products, 
Milton Keynes, UK) and triangular cellulose sponges (Kettenbach GmbFI & Co., 
Eschenburg, Germany). Each product is highly absorbent and ideal to place at the 
inferior tear meniscus with forceps. However, further investigation into patient 
comfort and tear film sample absorbency was necessary to identify which would 
ultimately be the most suitable.
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3.3 Investigating subject comfort and tear film sample 
absorbency
3.3.1 Introduction
Patient comfort is essential during the tear collection procedure, particularly when 
considering children and young adults. Ocular discomfort would indicate corneal or 
conjunctival sensory nerve fibre stimulation resulting in reflex tearing (Acosta et al., 
2004), potentially diluting the tear film sample. The tear collection material also 
needs to be highly absorbent to maximise sample collection within a short time 
period. Subject comfort and the sample size during tear collection for both materials 
were investigated.
3.3.2 Method
3.3.2.1 Subjects
Healthy subjects (n=20; 7 male, 13 female: mean age 23.7 years ± SD 5.13 years) 
were recruited from the School of Optometry and Vision Sciences, Cardiff University. 
Informed consent was obtained from all subjects; favourable approval had been 
obtained from the School of Optometry and Vision Sciences Research Ethics 
Committee and all procedures conformed with the tenets of the Declaration of 
Helsinki. Subjects were free from ocular and systemic pathology known to affect the 
eye (apart from dry eye) and contact lenses were not worn two hours prior to tear 
collection. Subjects were excluded if they were using topical ocular medication, 
pregnant or breast feeding. These criteria apply to all experiments within this chapter.
3.2.2.2 Ultraviolet sterilisation of cellulose rods
Cellulose rods were ultraviolet (UV) sterilised before use by being placed into a UV 
Crosslinker for five minutes, energy 120 micro-Joules/centimetre2 (pJ/cm2), according 
to the manufacturer’s instructions (Jencons (Scientific) Limited, Leighton Buzzard, 
UK).
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3.3.2.3 Experimental design
Cellulose sponges (Kettenbach GmbH & Co., Eschenburg, Germany) and cellulose 
rods (Filtrona Filter Products, Milton Keynes, UK) were placed into individual 0.5ml 
Eppendorf tubes (Alpha Laboratories Ltd., Hampshire, UK) and the combined weight 
for each recorded. Tear samples were collected from the inferior tear meniscus with 
either a cellulose rod or cellulose sponge. Initial tear collection material and the first 
eye selected for tear collection were randomised. The subject was directed to fixate 
superior-nasally and the collection material applied to the outer third of the inferior 
tear meniscus with forceps for a period o f three minutes. Care was taken to avoid 
stimulation and subjects were instructed to blink as necessary. Following tear 
collection the subject was asked to indicate ocular comfort on a 10 centimetre visual 
analogue scale (VAS) (Figure 3.2) and the tear collection material was returned to the 
Eppendorf tube. After a resting period of five minutes the process was repeated with 
the second tear collection material. All Eppendorf tubes were re-weighed and the 
weight difference calculated to give tear sample weight. The indication mark was 
measured from the VAS with a ruler to the nearest millimetre and recorded as subject 
discomfort.
Figure 3.2 Visual Analogue Scale (VAS)
3.3.2.4 Standard curve
In order to accurately calculate the volume of each tear sample a standard curve was 
plotted. Saline was used to simulate tears due to the large volumes necessary. Known 
volumes of saline (Bausch & Lomb, Surrey, UK), from 1 to 20 microlitres (pi), were 
pipetted into pre-weighed Eppendorf tubes and re-weighed. The weight difference for 
each volume was calculated and plotted on a graph (Figure 3.3). The equation of the 
best fit line could then be used to convert tear sample weight into tear sample volume.
0
No discomfort
10
Unbearable
discomfort
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Figure 3.3 Standard curve used to calculate tear sample volume
3.3.2.5 Statistical analysis
A paired-samples (2-tailed) t-test (SPSS version 16, Incorporated, Chicago, Illinois, 
USA) was used to compare ocular comfort and tear sample volume for the two tear 
collection materials. Significance was set at the 0.05 level.
3.3.3 R esults
Ocular discomfort for the 20 subjects ranged from a minimum of 0.7 and maximum of
2.4 for tear samples collected with cellulose rods, and 0.4 to 1.7 with the cellulose 
sponges. Mean ocular discomfort for the two collection materials is shown in Figure 
3.4a and Table 3.3. The difference was statistically significant (Paired-samples t-test; 
p<0.005), indicating tear collection was more comfortable with the sponges compared 
to the rods. Considering sample volume collected with the two materials, a range of 
2.22 to 11.8 8 pl was recorded for the rods and 3.20 to 10.91 pi with the sponges. Mean 
sample size was significantly greater for tears collected with cellulose sponges 
compared to cellulose rods (Paired-samples t-test; p<0.0001). Mean sample size for 
the two tear collection materials is shown in Figure 3.4b and Table 3.3.
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Table 3.3 Ocular discomfort and sample volume for the two tear collection materials
Material Ocular discomfort Sample volume (pi)
Cellulose Rod mean 1.46 mean 5.80
SD 0.47 SD 2.14
Cellulose Sponge mean 0.84 mean 6.78
SD 0.36 SD 1.84
1.8 8
Cellulose Sponge Cellulose Rod Cellulose Sponge Cellulose Rod
T ear  co llect ion  m a te r ia l  ^  T ea r  collect ion  m ate ria l
Figure 3.4 Mean ocular discomfort (a) and mean sample size (b) for the two 
collection materials (Paired-samples t-test; p<0.005 and pO.OOOl respectively)
3.3.4 Discussion
Cellulose sponges appear significantly more comfortable and yield greater sample 
volume return than the cellulose rods. During tear collection with the cellulose 
sponges the triangular tip expanded as the material became saturated, improving 
comfort and increasing surface area for greater absorption. Furthermore, the material 
expansion gives a useful visual aid to the volume of tear sample recovered, unlike the 
cellulose rods which do not alter with saturation. Whilst the results indicate cellulose 
sponges are a favourable alternative to glass capillary tubes, the properties of the two 
materials for sample recovery must be investigated.
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3.4 Optimisation of tear film sample storage and recovery
3.4.1 Introduction
For tear samples to be analysed they must be extracted from the tear collection 
medium. Centrifuging has typically been the technique used previously (Lopez- 
Cistemas et al., 2006, Jones et al., 1997). The aim of this study was to compare the 
efficiency of sample return for the two selected materials and to investigate the 
optimal centrifuge duration. As tear samples would need to be stored at -80 degrees 
Celsius (°C) for short periods o f time before analysis it was important to investigate if 
the collection material needed to be centrifuged before storage for optimal volume 
return. Saline was used to simulate tears in the experiment due to the large volumes 
necessary. Two sample sizes of 10 and 20pl were used to simulate the volume 
expected for un-stimulated and stimulated tear collection.
3.4.2 Method
3.4.2.1 Experimental design
3.4.2.1.1 Sample recovery
Aliquots of lOpl or 20pl saline (Bausch & Lomb Inc., Surrey, UK) were pipetted onto 
each tip of 25 cellulose rods. Each rod was placed into a 0.2ml micro-centrifuge tube 
(Alpha Laboratories Ltd., Hampshire, UK) (all had the apex of the tube removed 
previously with a scalpel) and the cap closed. Each was placed into a pre-weighed 
0.5ml Eppendorf tube and into a tube rack on ice to minimise evaporation. Five of the 
lOpl and five of the 20pl samples were centrifuged (GS-15R, Beckman Coulter Ltd, 
Buckinghamshire, UK) for a period of three minutes at 14,000 revolutions per minute 
(RPM) at 4°C. This was repeated for centrifuge durations of five, 10, 15 and 30 
minutes with the other samples. The micro-centrifuge tubes were removed and each 
Eppendorf tube re-weighed and the regression curve (y = 966.4lx + 0.2834) created 
in 3.2.2 (Figure 3.3) was used to calculate sample volume. Finally, the entire process 
was repeated with the cellulose sponges.
7 4
Chapter 3 Preliminary Experiments
r
Figure 3.5 Eppendorf set up for centrifuging tear collection material
3.4.2.1.2 Sam ple storage
Aliquots of lOpl or 20pl saline were pipetted onto each tip of 10 cellulose rods and 10 
cellulose sponges and placed within a de-tipped 0 .2 ml micro-centrifuge tube and the 
cap closed and subsequently placed into a pre-weighed 0.5ml Eppendorf tube. Half of 
the samples were centrifuged at 14,000 RPM for a period of three minutes at 4 °C 
then all the samples placed into a tube rack inside a sealed container and stored at - 
80°C for a period of one month. Following storage, the remaining un-centrifuged 
tubes were then centrifuged (Figure 3.6). All micro-centrifuge tubes were removed 
and each Eppendorf tube re-weighed and the standard curve (Figure 3.3) created in
3.2.2 was utilised to calculate sample volume.
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10pl saline 20pl saline
I I
10 x rods/sponges in pre­
weighed Eppendorf tubes
/  \
10 x rods/sponges in pre­
weighed Eppendorf tubes
/  \
5 x not 
centrifuged
5 x not 
centrifuged 5 x centrifuged5 x centrifuged
All samples stored @ -80°cfor one month
10 x centrifuged
All samples re-weighed
Figure 3.6 Flow diagram of experimental design investigating sample storage
3.4.2.2 Statistical analysis
One-way analysis of variance (ANOVA) was used to investigate differences in 
sample return from increasing centrifuge duration. A paired-samples (2-tailed) t-test 
was used to investigate the effect of storage on sample recovery from the two 
materials and an independent-samples (2 -tailed) t-test compared the volume recovered 
from the rods to the sponges. Significance was set at the 0.05 level.
3.4.3 R esults
Figures 3.7a and b demonstrate the percentage of sample recovery with increasing 
centrifuge duration. There was no significant increase in the volume of saline 
recovered with increased centrifuging for either the rods (ANOVA; p=0.074 and 
p=0.055 for lOpl and 20pl saline respectively) or the sponges (ANOVA; p=0.465 and 
p=0.413). For both collection materials it can be seen the greater the initial sample 
volume the greater the sample return. For the cellulose rods a mean of 74.2% of the
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lOpl sample was recovered, compared to 88.2% of the 20pl sample, the difference 
being statistically significant (Independent-samples t-test; p<0.0001). A significant 
difference was also found with the cellulose sponges (Independent-samples t-test; 
pO.OOOl), with mean percentage recovery at 17.4% and 37.8% respectively. 
Comparing the sample recovery for the two materials, the rods appear to return 2-3 
times the volume of the sponges, the difference being statistically significant for all 
centrifuge durations and both lOpl and 20pl saline volumes (Independent-samples t- 
test; pO.OOOl for all). There was no significant effect of pre- or post-storage 
centrifuging on the volume of sample recovered from either the rods or sponges 
(Paired-samples t-test; 0.374<p<0.717).
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Figure 3.7 The percentage of sample recovered from lOpl (a) and 20pl (b) saline 
following various centrifuge durations for the two collection materials 
(error bars represent standard error o f  the mean)
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3.3.4 Discussion
For both collection materials, increased centrifuging had an insignificant effect at 
increasing volume return. Therefore, centrifuging tear samples for a period of three 
minutes appears sufficient for maximal sample recovery. Greater volume return was 
observed with the 20pl samples compared to the lOpl samples for both collection 
materials suggesting increased material saturation yields greater sample return. This 
implies that collection of larger volumes of stimulated tears or longer periods of un­
stimulated tear collection may be more effective. There was no significant effect on 
sample volume return with storage o f the materials at -80°C, either pre or post 
centrifuging. Therefore, for convenience it is considered acceptable to immediately 
store samples at -80°C for a period o f one month without compromising sample 
volume.
The increased efficacy of sample volume return with the cellulose rods compared to 
the sponges undoubtedly reflects the difference in material function; the sponges are 
primarily designed to absorb secretions without subsequent release. Therefore, even 
with extended centrifuge durations a considerable amount of solution remains 
“trapped” within the sponge. Furthermore, the increased surface area of the sponges 
during sample absorption could potentially have allowed increased evaporation of tear 
fluid during collection.
Although the cellulose sponges are significantly more comfortable for the subject and 
have greater absorbance, the rods appear to allow significantly greater sample volume 
return. As the materials have such contradictory properties, further investigation, 
such as the suitability for tear feming, is paramount.
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3.5 Optimisation of the tear ferning protocol
3.5.1 In trod u ction
A number of bodily secretions produce a distinctive ferning pattern when allowed to 
air dry on a glass microscope slide (Abou-Shabanah and Plotz, 1957). This ferning 
phenomenon was originally utilised to determine the ovulation period in women by 
evaluating cervical mucus ferning characteristics (Papanicolau, 1946). However, 
Tabbara and Okumoto used conjunctival scrapings to devise a test to aid differential 
diagnosis of acute forms of conjunctivitis by the presence or absence of tear ferns 
(Tabbara and Okumoto, 1982). Rolando (1984) later devised a qualitative grading 
scale based on the appearance of four different tear ferning (TF) patterns (Table 3.4 
and Figure 3.8). Type 1 and 2 patterns are considered normal and Type 3 and 4 
abnormal, typically observed in subjects with dry eye (Rolando, 1984). According to 
this criterion, the TF technique has demonstrated good sensitivity and specificity for 
the diagnosis of dry eye (Norn, 1994, Vaikoussis et al., 1994, Maragou et al., 1996). 
Although a number o f other grading scales have been suggested (Norn, 1994, 
Vaikoussis et al., 1994), Rolando’s original scale is highly repeatable (Pensyl and 
Dillehay, 1998) and remains popular (Srinivasan et al., 2007).
Table 3.4 Rolando’s tear ferning grading scale (Rolando, 1984)
Type Characteristics
1 Normal Tear 
Ferning
uniform and closely branching arborisation
2 single, smaller ferns with less branching and empty 
spaces beginning to appear
3 Abnormal Tear 
Ferning
small ferns with almost no branching and 
numerous empty spaces
4 ferns absent and clusters of mucus may be present
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Figure 3.8 Tear Ferning Grades for the four ferning “types” defined by Rolando 
(1984)
TF methodology within the literature varies considerably and is summarised in Table
3.5 later in the chapter. Tear samples of capricious size have been collected from the 
fornix or tear meniscus with an assortment of implements such as spatulas (Tabbara 
and Okumoto, 1982), pipettes (Norn, 1987), loops (Filipello et al., 1992) and glass 
rods (Jackson and Perrigin, 1999). Norn (1988) concluded a greater repeatability of 
feming grades could be achieved with glass capillary tubes (Norn, 1988). Golding 
and Brennan (1989) further recommended sampling a fixed volume of minimally 
stimulated tears from the inferior tear meniscus with a glass capillary (Golding and 
Brennan, 1989).
Collected tear samples were subsequently allowed to dry onto a clean, glass 
microscope slide nevertheless, the drying period, temperature for drying and the time 
for grading the sample after drying was inconsistent. Whilst the slide was typically 
viewed with phase contrast microscopy, magnification also varied from lOx - 400x 
(Srinivasan et al., 2007, Vaikoussis et al., 1994). Horwath et al. (2001) investigated
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the effect of environmental factors, such as temperature and relative humidity (RH), 
on the reproducibility o f Rolando’s tear feming grades (Horwath et al., 2001). It was 
concluded a temperature range of 20-26°C and RH not greater than 50% were 
necessary for ensuring feming quality. The time for viewing the sample for grading 
once dried is also relevant. Whilst Nom found ferns were stable in the refrigerator 
(4°C) for a period of up to four days (Nom, 1988), it was suggested ferns should be 
examined five to ten minutes after the sample was placed on the microscope slide 
(Golding and Brennan, 1989). Kogbe et al. (1991) found that tear samples formed 
reproducible feming patterns after storage at 4°C for a period of one month (Kogbe et 
al., 1991). However, reproducibility after storage at -80°C has not been investigated 
previously.
Increased levels of abnormal TF have been observed in subjects with CF (Kalayci et 
al., 1996, Rolando et al., 1988). However, it is apparent a number of factors needed to 
be investigated regarding the TF technique to produce a comprehensive protocol 
before TF could be investigated in subjects with CF. These include:
• Tear collection material
• The effect of magnification
• The effect of tear film sample volume
• The effect of stimulation
• Inter-eye comparisons
• The effect of diurnal variation
• The effect of tear film sample storage
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Table 3.5 Summary of tear feming methodology in the literature
Author Collection method Sample size
w
Magnificat­
ion (X)
Sample Preparation
(Tabbara and Okumoto, 
1982)
Conjunctival scrapings with platinum 
spatula
63
(Rolando, 1984) Lower fornix with spatula 40-100 Dried at 20°C ± 2°C
(Rolando et al., 1986) Lower fornix with cataract loop 40-100 Dried at 20°C ± 2°C, graded within 5-7 
minutes
(Kogbe and Liotet, 1987) Glass capillary conjunctival cul de sac 2-3 40 Dried at 20°C for 5-7minutes
(Nom, 1987) Pipette, inferior fornix 40-100
(Nom, 1988) Glass rod/pipette/capillary tube Glass 
capillary 2.5
100 Dried at room temperature, viewed within 
12 hours
(Rolando et al., 1988) Cataract loop
(Kogbe et al., 1991) 30-50pl stimulated tears Micropipette or 
capillary tube
2-4 40-100 Dried at room temperature for 5-7minutes
(Puderbach and Stolze, 
1991)
Iron loop 100 Graded 5-7 minutes after collection
(Filipello et al., 1992) Plastic loop, inferior fornix 4 40-100 Graded 6-7 minutes after collection
(Golding et al., 1994) Onion-stimulated, glass pipette
(Vaikoussis et al., 1994) Lower fomix capillary tube 100-400 Graded within 15minutes of collection
(Nom, 1994) Lacrimal meniscus, glass capillary 2.5
(Kalayci et al., 1996) Spatula 100 & 400 Dried at room temperature for 10 minutes
(Ravazzoni et al., 1998b) Micropipette, inferior meniscus 40-100 Dried at 23°C ± 2°C for 5-10 minutes
(Pensyl and Dillehay, 1998) Micropipette, non-stimulated 1 2 0 Graded within 10 minutes drying
(Jackson and Perrigin, 1999) Glass rod, inferior palpebral cul de sac 10 & 40
(Oguz et al., 2001) 2-3 pi capillary tube from lower fomix 2-3 400 Dried at room temperature
(Peponis et al., 2002) Glass capillary, lateral part of inferior tear 
meniscus
40-100 Dried at room temperature for 5-10 
minutes
(Peponis et al., 2004) Lateral tear meniscus capillary 40-100 Dried at room temperature for 10 minutes
(Li et al., 2005) 2-3 pi non-stimulated capillary pipette 
from inferior fomix
400
(Versura et al., 2007) Outer canthus, 5 pi micropipette
(Srinivasan et al., 2007) 2 pi inferior tear meniscus, glass capillary 
tube
0.5 10 Dried at room temperature
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3.5.2 Method
3.5.2.1 Tear collection procedure
Tear fluid was collected from the right eye (and also the left eye in experiment 
3.5.2.3.5) with a glass capillary tube by placing the tube tip at the outer two thirds of 
the inferior tear meniscus whilst the patient fixated away. Care was taken to avoid 
stimulation. Tear samples were aspirated into labelled 0.5ml Eppendorf tubes and 
centrifuged for 60 seconds at 4°C, 14,000 RPM to collect the tears at the bottom of the 
tube for ease of pipetting.
3.5.2.2 Slide preparation procedure
With the exception of experiment 3.5.2.4.3, 1.5pl tear samples were pipetted onto 
clean, glass microscope slides and allowed to air dry at 20-26°C and RH <50% 
(L55AJ Hygro Thermometer, Maplin, UK). Samples were observed at 20x 
magnification with a light microscope (Leica Microsystems GmbH, Wetzlar, 
Germany) and photographed within a 10 minute period of drying and categorised 
according to Rolando’s grading scale (Rolando, 1984).
3.5.2.3 Experim ental design
3.5.2.3.1 Tear collection m aterial
A 10pl tear sample was collected from a single subject. To investigate feming in a 
number of solutions 5 pi volumes of the tear sample, saline (Bausch & Lomb, Surrey, 
UK) and artificial tear solution (Vismed Light, TRB Chemedica Ltd., Staffordshire, 
UK) were each pipetted onto the tip o f individual sponges and rods. The rods and 
sponges were prepared as in 3.2.2 and centrifuged for three minutes at 14,000 RPM. 
Slides were prepared for all three solutions, examined and photographed.
3.5.2.3.2 The effect o f m agnification
A single lp l tear sample was prepared, observed and photographed at various 
magnifications (10, 20 and 40x) to identify which allowed for the greatest ease of 
grading.
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3.5.2.3.3 The effect o f tear film sample volume
Volumes of 2.5, 2.0, 1.5, 1.0, 0.5, and 0.25pl, from a single tear sample, were pipetted 
onto a labelled microscope slide. Observations were recorded to identify which tear 
sample volume allowed for the greatest ease of grading.
3.5.2.3.4 The effect o f stim ulation
Minimally stimulated tear samples were collected from the right eye of 10 subjects. 
Stimulated tear samples were subsequently collected by asking the subject to stare at a 
bright light to induce reflex tearing. 1.5 pi samples were pipetted onto labelled 
microscope slides and graded to allow comparison.
3.5.2.3.5 Inter-eye com parisons
Tear samples were collected from each eye o f 10 subjects. 1.5pl samples were 
pipetted onto labelled microscope slides and graded to allow comparison.
3.5.2.3.6 The effect o f diurnal variation
Tear samples were collected from the right eye o f 10 subjects in the morning, within a 
two hour period of waking. Tear samples were subsequently prepared and graded. 
This was repeated in the afternoon, following a minimum period of six hours, after 
which the TF grades from the two samples were compared.
3.5.2.3.7 The effect o f tear film  sam ple storage
A number of excess tear samples remaining from previous experiments were used to 
investigate the stability o f tear samples stored at 4°C, twenty of these samples were 
refrigerated at 4°C and the TF pattern checked after overnight, one week and one 
month storage to allow comparison. To investigate storage at -80°C, 5 pi tear samples 
were collected from 10 subjects and TF patterns were then recorded for each. The 
remaining samples were stored at -80°C for a period of one month. Samples were 
thawed at 4°C and centrifuged at 4°C, 14000RPM for 60 seconds, slides prepared and 
feming patterns graded and compared to original patterns.
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3.5.3 Results
3.5.3.1 T ea r collection m a te ria l
Microscope images of the three solutions collected by the various methods are shown 
in Figure 3.9. Considering the tear film samples; the glass capillary and sponge- 
collected tears appear similar, forming uniform and closely branched ferns typical of 
the Type 1 pattern (Figure 3.9a & c). The rod-collected tears show limited feming 
more typical of the Type 3 pattern (Figure 3.9b). The saline samples collected with 
the capillary tube and sponge formed long “twig-like” crystals (Figure 3.9d & f); the 
rod-collected saline formed a clumped crystal arrangement however (Figure 3.9e). 
Considering the Vismed light samples the difference is more apparent. Whilst the 
capillary and sponge samples produced regular “fan-like” formations (Figure 3.9g & 
i), the rod-collected sample formed a “bubble-like” crystal pattern (Figure 3.9h).
Tear sam ples
Saline sam ples
Figure 3.9 Feming images of the solutions collected with the three different materials
Glass Capillaries
a
Cellulose Rods
b
fl
Vismed Light sam ples
Cellulose Sponges
c
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3.5.3.2 The effect of magnification
TF images photographed at different magnifications are shown in Figure 3.10 (Figure 
3.10). Ideal magnification of the tear ferns was observed at lOx or 20x magnification. 
Above this point there was too little of the sample within the field of view to allow 
precise grading. With escalating magnification the images appeared increasingly 
dissimilar to Rolando’s grading scale (Figure 3.8) and hindered accurate grading.
Figure 3.10 Tear feming pattern from a single tear sample imaged at different 
magnifications; lOx (a), 20x (b), 40x (c)
3.5.3.3 The effect of te a r  film sam ple  volum e
The smaller the tear sample volume, the smaller the area of feming available to 
examine. It was observed the TF pattern varied throughout the sample area, with 
feming at the periphery typically inconsistent with feming within the centre of the 
sample (Figure 3.11). Figure 3.12 shows smaller sample volumes gave less central 
area within the field of vision impairing assessment.
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Figure 3.11 The difference in feming pattern from a single tear sample imaged at the 
centre indicating type 2 feming (a); and the periphery indicating type 3 feming (b)
Figure 3.12 Tear feming patterns from an identical tear sample of 0.25pl (a) and 
1 .Opl (b) volume. Both samples indicate type 2 feming although the larger volume 
has a greater central area within the field of view allowing easier grading
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3.5.3.4 The effect o f  stim ulation
The feming patterns for stimulated and non-stimulated tears were identical for all 10 
subjects as listed in Table 3.6. Therefore, there appeared to be no effect of 
stimulation on the TF pattern.
Table 3.6 The comparison o f tear feming patterns in stimulated and non-stimulated
tear samples
Sample number Tear ferning grade (Type)
Non-stimulated tear 
sample
Stimulated tear sample
1 1 1
2 1 1
3
4 1 1
5 1 1
6 1 1
7 1 1
8
9 1 1
10 1 1
3.5.3.5 Inter-eye com parisons
Table 3.7 indicates TF grades were identical for each eye of the 10 subjects.
Table 3.7 Inter-eye comparisons of tear feming patterns
Sample number Tear ferning jjrade (Type)
Right Eye Left Eye
1 2 2
2 1 1
3 1 1
4 1 1
5 1 1
6
7 1 1
8 1 1
9 1 1
10 1 1
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3.5.3.6 The effect of diurnal variation
The TF patterns were identical at both time intervals for all subjects (Table 3.8).
Table 3.8 Diurnal variations in tear feming patterns
Sample number Tear ferning grade (Type)
Morning tear collection 
(8:30 -  10:30am)
Afternoon tear collection 
(2:30-4:30pm )
1 1 1
2 1 1
3
4 1 1
5 1 1
6 1 1
7 1 1
8 1 1
9 1 1
10 2 2
3.5.3.7 The effect o f tear film sam ple storage
With increasing observer experience it became apparent TF patterns could be 
subdivided into 0.5 increments of Rolando’s grading scale. There was no alteration in 
the pattern following overnight storage (Table 3.9). After a week at 4°C two tear 
samples (10%) had altered. A greater change was observed for samples stored for a 
period of one month, where a change in feming was observed in 45% of samples. A 
change of normal to abnormal grading was observed in two (10%) samples. No 
difference in TF patterns was observed for the samples stored at -80°C for a period of 
one month (Table 3.10).
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Table 3.9 The effect of storage at 4°C on tear feming patterns
Sample
number
Tear ferning grade (Type)
Original Overnight
storage
One week 
storage
One month 
storage
1 2 2 2 2
2 2 2 2 2
3 1 1 1 2 *
4 1 1 1 2 *
5 1 1 1 1
6 1 1 1 1
7 1 1 1 1
8 1 1 1 1
9 1 1 1 1
10 1 1 1 2
11 1 1 1.5* 2 *
12 2 2.5**
13 1 1 1 1.5*
14 1 1 1 1
15 1 1 2 * 2
16 1 1 1 2 *
17 2 2
18 2 3 **
19 1 1 1 2 *
20 1 1 1 1.5*
* change in tear "eming pattern
** tear feming pattern changed from normal to abnormal
Table 3.10 The effect of storage at -80°C on tear feming patterns
Sample number Tear ferning grade (Type)
Initial Following storage
1 1 1
2 1.5 1.5
3 1 1
4 1 1
5 2
6 1 1
7 1 1
8 1 1
9 2 2
10 1 1
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3.5.4 Discussion
The rod collected samples produce atypical feming results compared to the “gold 
standard” glass capillaries. The TF pattern is believed to be determined by the 
proportion of various ions and macromolecules within the tear film (Pearce and 
Tomlinson, 2000). After centrifuging the rods the biochemical composition of the 
sample appears to have been altered, perhaps by retaining certain components within 
the cellulose matrix and adversely affecting the feming pattern. Although a 
considerably greater proportion of the sample is retained within the cellulose sponge, 
the composition is unaffected allowing for consistent feming patterns when compared 
with glass capillary collected samples. Therefore, cellulose sponges appear to be a 
suitable alternative to glass capillary tubes to collect tear samples in children for the 
tear feming technique.
A wide variety of microscope magnifications used to image tear ferns have been 
quoted in the literature, ranging from 10-400x (Table 3.3). It was observed that 
increasing the magnification beyond 20x actually hindered accurate grading by 
reducing the field of view of the ferns. A number of recent publications have 
similarly suggested either lOx or 20x (Srinivasan et al., 2007, Jackson and Perrigin, 
1999, Pensyl and Dillehay, 1998).
Kogbe et al. (1991) investigated the effect of sample droplet size on tear feming and 
whilst they concluded droplets smaller than 4pi dried rapidly and uniformly, they did 
not investigate the effect on sample grading (Kogbe et al., 1991). As cellulose 
sponges are particularly inefficient for sample return when centrifuged it was 
reassuring that small sample volumes still allowed for accurate tear feming. It was 
observed the feming pattern varied from the centre to the periphery. To maintain 
consistency, it was concluded grading should be assessed in the centre of the droplet. 
Although adequate grading could be achieved for a minimum volume of 0.5pi a larger 
droplet of at least 1.0-1.5pl is preferable due to the larger feming area within the 
centre of the droplet available for observation.
Stimulated tears have been used previously to investigate factors responsible for tear 
feming and x-ray and scanning electron microscopy of tear ferns (Kogbe et al., 1991,
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Golding et al., 1994). Due to the poor efficiency of sample return by the cellulose 
sponges it may be essential to stimulate patients in order to collect sufficient volumes 
for TF. This study showed no alteration of the feming pattern following tear 
stimulation in these subjects. The TF grade is thought to be the consequence of the 
ratio of inorganic salt to macromolecule (protein and mucin) concentration within the 
tear sample (Golding and Brennan, 1989, Golding et al., 1994, Pearce and Tomlinson, 
2000). Whilst the concentration o f the major lacrimal gland proteins, such as 
lysozyme and lactoferrin, are unaltered by tear stimulation (Fullard and Tucker, 1991, 
Kijlstra et al., 1983, Fullard and Snyder, 1990, Jones et al., 1997, Sitaramamma et al.,
1998) a significant increase in the serum derived proteins, such as IgG and tansferrin, 
has been observed (Fullard and Snyder, 1990). A number of mucins are known to be 
secreted by the lacrimal gland (Paulsen and Berry, 2006), although alteration of 
concentration following tear stimulation is unknown. The crystallisation process that 
forms the tear fem is the product o f water subtraction (Battaglia Parodi and Giusto, 
1993). An equal increase in the tear film aqueous phase, semm derived protein and 
possibly mucin concentration following stimulation may allow the salt to 
macromolecule concentration to be identical to that prior to stimulation. Nom 
similarly observed no difference in stimulated and non-stimulated tear feming 
patterns (Nom, 1988). However, his choice of stimulation method (inhalation of 
ammonia vapour) would not be suitable for use in children.
No inter-eye differences in TF were observed. A similar finding was reported in an 
investigation of tear feming in subjects with Down’s syndrome (Filipello et al., 1992). 
Therefore, only a single tear sample needs to be collected from the child to determine 
the tear feming grade. Ocular comfort is known to be subject to diurnal variation in 
patients with dry eye (Begley et al., 2002), suggesting that the open-eye state 
significantly affects the tear film and associated ocular comfort. However, there were 
no diurnal effects on the tear feming pattern within the six hour tear collecting period 
of this study.
Kogbe et al. (1991) successfully stored tears for one month at 4°C without altered tear 
feming (Kogbe et al., 1991). However in our investigation, after a period of one 
week, the tear feming pattern of a number of tear samples had altered. Tear samples 
were significantly altered after a period of one month, with two samples actually
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changing from normal to abnormal grades. Tear samples could be safely stored for a 
period of one month at -80°C however. It was also noted that with increasing 
observer experience of the tear feming patterns, smaller increments of Rolando’s 
grading scale could be used.
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3.6 Summary
Cellulose sponges are a suitable material for tear collection in children. They are 
comfortable for the patient and highly absorbent but unfortunately offer poor 
efficiency when centrifuged for sample release. Sponges can be centrifuged for three 
minutes at 14000 RPM at 4°C for maximum sample return. The collected tear sample 
can be stored at -80°C either pre- or post-centrifuging. The sponges do not appear to 
alter the chemical composition of the tear sample, unlike the cellulose rods, and are a 
suitable alternative to glass capillary tubes for the TF technique.
The TF protocol was finalised. The tear sample can be collected from a single eye 
with a cellulose sponge, stimulation is acceptable and collection time is not a factor. 
A sample of at least 1 pi should be pipetted onto a microscope slide and allowed to air 
dry at 20-26°C and RH <50%. Tears can be stored overnight at 4°C and up to a month 
at -80°C. The sample should be viewed at objective magnification x20 and graded at 
the centre of the droplet within a 10 minute period of drying.
Chapter 4 Investigating Dry Lye
Chapter 4 
Investigating Dry Eye and Ocular Surface 
Inflammation
4.1 Introduction
Ocular surface inflammation contributes to the pathogenesis of dry eye. Increased 
tear film cytokine concentration, indicating sub-clinical levels of ocular surface 
inflammation, have been observed in subjects with CF previously (Mrugacz et al., 
2006a, Mrugacz et al., 2006c). However, quantitative analysis of the tear film 
requires sophisticated biochemical techniques and the methodology typically requires 
development and refinement. Before implementing tear film investigations in subjects 
with CF it was important to practise these techniques and optimise the methodology to 
compare subjective and objective tests of ocular surface inflammation in a group of 
readily available subjects who could simulate the hypothesised dry eye anticipated in 
the CF patients.
Contact lens (CL) wearers are ideal candidates: in a recent survey, 43% of hydrogel 
CL wearers reported symptoms o f CL-related dry eye (Guillon and Maissa, 2005). 
Symptoms of discomfort and drying are regularly cited as the principal cause of CL 
wear drop out (Pritchard et al., 1999), and subjective symptoms of drying are reported 
in much higher frequency compared to objective, clinical signs of dry eye (Begley et 
al., 1999). Alterations of various tear film constituents indicate sub-clinical levels of 
ocular inflammation following CL wear (Thakur and Willcox, 2000), even in 
asymptomatic subjects (Pisella et al., 2001).
Therefore, the aim of the study was to investigate the relationships between tear film 
cytokine concentration, tear feming and traditional tear film stability tests amongst 
experienced contact lens wearers and non-contact lens wearers, expressing varying 
degrees of ocular comfort. A selection of the results from this study have been 
published in a peer reviewed journal (see Appendix).
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4.1.1 Tear ferning
Tear feming (TF) is a sensitive diagnostic dry eye test (Vaikoussis et al., 1994, 
Maragou et al., 1996, Nom, 1994). The technique has also demonstrated impressive 
sensitivity and specificity (78.95% and 78.35% respectively) for the prediction of 
successful contact lens (CL) tolerance in new CL wearers (Ravazzoni et al., 1998). 
The authors concluded that whilst CL patients with TF Types of 2, 3 and 4 often 
encountered tolerance problems, those with Type 1 TF patterns displayed good 
tolerance over a six month wearing period. Despite its apparent value, TF remains a 
relatively uncommon diagnostic test amongst traditional examinations of the tear film, 
and TF in habitual CL wearers has not been investigated previously.
4.1.2 Cytokines
The function of the immune system is to recognise the presence of a pathogen and 
eliminate infection and is essential for survival (Parham, 2000). The leukocytes 
(white blood cells) that mediate the immune response are shown in Figure 4.1. 
Cytokines are a collection of signalling molecules that promote communication 
between cells of the immune system (Hamblin, 1993). A group of cytokines, known 
as Interleukins, are released by certain leukocytes and exert a specific effect on other 
leukocytes. Cytokine activity can be autocrine (act on itself) or paracrine (act locally 
on another type of cell) (Meager, 1990). Individual cytokines are secreted by a 
number of different cells of the immune system and similarly, their receptors are 
found on a number of different cell types. Consequently, there is frequent overlap of 
their biological activities. Individual cytokines have several different and apparently 
unrelated functions, and can be responsible for both harmful and beneficial effects 
during the immune response (Playfair and Chain, 2001). Inflammation is an 
important procedure in this response and cytokines are known to mediate the 
inflammatory process.
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Figure 4.1 A schematic diagram of the leukocytes involved in the immune response
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Figure 4.2 demonstrates activated Tcells produce either CD8+ Tcells or CD4+ Tcells; 
the general function of which is to secrete cytokines to activate other cells (Parham, 
2000). ThI cytokines tend to activate macrophages to develop the cell mediated 
immune response with the cytotoxic CD8+ cells and induce inflammation. Th2 
cytokines tend to induce Bcell differentiation and antibody production to develop the 
humoral mediated immune response. ThI and Th2 cytokines exhibit negative 
regulation of each other; IFN-y, secreted by ThI cells, can inhibit cytokine secretion 
by Th2 cells and IL-10, secreted by TH2 cells has a similar effect on ThI cells 
(Hamblin, 1993).
Cells of the ocular surface secrete cytokines into the tear film (Uchino et al., 2006) 
(Malvitte et al., 2007) consequently, tear film cytokine concentrations reflect levels of 
in vivo ocular surface inflammation (Leonardi et al., 2006). Hyperosmotic stress has 
been demonstrated to function as a stimulant for inflammatory cytokine production 
(Shapiro and Dinarello, 1997) and elevated cytokine concentrations have been 
observed in the tear film of patients with dry eye and Sjogren’s syndrome (Pflugfelder 
et al., 1999, Jones et al., 1994, Yoon et al., 2007, Jones et al., 1998, Oshida et al., 
2004, Slepova et al., 1998, Solomon et al., 2001). Therefore, the secretion of pro- 
inflammatory cytokines promotes ocular inflammation in dry eye (Luo et al., 2005). 
These findings indicate dry eye is accompanied by sub-clinical levels of ocular 
surface inflammation and that cytokines perform a key role in the pathogenesis of dry 
eye (Solomon et al., 2001).
Contact lens wear, even in asymptomatic patients, is known to induce sub-clinical 
levels of ocular surface inflammation (Nguyen et al., 2004, Pisella et al., 2001, 
Versura et al., 2000) and increases in certain cytokine concentrations have been 
observed in the tear film o f contact lenses wearers (Thakur and Willcox, 2000, 
Schultz and Kunert, 2000). However, an investigation of a large range of cytokine 
concentrations in contact lens wearers and non-contact lens wearers has not been 
investigated previously.
Cytokines also mediate airway inflammation observed in subjects with CF and 
evidence suggests that cytokine production is altered or dysregulated in CF (Sagel and 
Accurso, 2002). The concentrations of three tear film cytokines, IFN-y, IL-8 and
9 9
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MIP-la, have been found to be up-regulated in tear film samples from subjects with 
CF compared to controls (Mrugacz et al., 2005c, Mrugacz et al., 2006a, Mrugacz et 
al., 2007d). However, there has been no previous investigation of a wide range of 
different cytokine concentrations in the tear film of subjects with CF.
4.1.2.1 Luminex cytokine analysis
Enzyme-Linked Immunosorbent Assay (ELISA) and Cytometric Bead Array (CBA) 
are biochemical techniques traditionally employed to quantify cytokine concentrations 
in tear film samples (Kallinikos et al., 2006, Solomon et al., 2001, Sonoda et al., 
2006). However, multicytokine assays are becoming more popular (Uchino et al., 
2006, Uchino et al., 2005). The Luminex 100 analyser (R&D Systems Europe Ltd, 
Abingdon, UK) can measure multiple cytokines simultaneously in small sample 
volumes. Specific sample cytokines bind to spectrally distinct micro-particle beads; 
each is then coated with a capture specific antibody and streptavidin-phycoerythrin 
(method shown in Figure 4.3). The analyser consists of two lasers; the first is bead 
specific and identifies the analyte, the second laser then detects the amount of bound 
analyte. The system can quantify selected cytokines with a sensitivity range of 
approximately 0-32,000 picograms/millilitre (pg/ml). The Luminex system is a 
suitable alternative method to ELISA and has a number of advantages such as smaller 
sample volume and lower cost (Dupont et al., 2005). Recently, Malvitte and 
colleagues successfully used the Luminex to analyse very small tear samples (2pl) 
from patients treated with topical drugs (Malvitte et al., 2007).
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4.1.3 Dry eye questionnaires
A number of dry eye questionnaires, including the Ocular Surface Disease Index 
(OSDI) (Walt et al., 1997) and Dry Eye Questionnaire (DEQ) (Begley et al., 2001), 
have been designed to identify dry eye subjects and quantify signs, symptoms and 
stimuli. The Contact Lens Dry Eye Questionnaire (CLDEQ) has been modified to 
investigate contact lens-related dry eye (Begley et al., 2001). McMonnies is a popular 
questionnaire designed to identify dry eye subjects that considers frequency of 
symptoms, sensitivity to environmental stimuli and epidemiological risk factors 
(McMonnies et al., 1998, McMonnies, 1986). However, the resulting score does not 
relate directly to symptom severity (Johnson and Murphy, 2007). The OSDI has been 
shown to be valid and reliable for the diagnosis of dry eye (Schiffman et al., 2000). 
Likewise, the McMonnies questionnaire has demonstrated fair reliability (Nichols et 
al., 2004c). However, ocular symptoms are known to relate poorly to clinical signs of 
dry eye (Nichols et al., 2004b) and contact lens-related dry eye (Narayanan et al., 
2005).
4.1.3.1 The ocular comfort index
The OCI was developed using Racsh analysis which is becoming a popular technique 
for questionnaire design within vision research and permits the conversion of ordinal 
Likert scores to a continuous interval scale (Court et al., 2007). This simple 12 item 
questionnaire investigates ocular comfort perceived within the preceding week by 
utilising a continuous scale of “Never (O)-Always (6)” for each question. Responses 
are analysed using an Excel computer programme (Microsoft; Redmond, WA). The 
OCI has demonstrated excellent correlation with the OSDI and FBUT and can detect 
improvements in patient symptoms following dry eye therapeutic intervention 
(Johnson and Murphy, 2007).
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4.1.4 Tear film stability
Tear break-up time (BUT) is typically used to assess tear film stability and is defined 
as the time interval for the occurrence of interruptions to the pre-comeal tear film 
following a blink (Norn, 1969). Two distinct methods can be employed; invasive, 
where sodium fluorescein is instilled into the tear film, and non-invasive, where a grid 
or other image is projected onto the tear film and observed.
4.1.4.1 Fluorescein break-up time
To assess the fluorescein tear break-up time (FBUT) a small volume of sodium 
fluorescein, from either a minim or strip pre-moistened with saline, is instilled into the 
tear film. Ocular surface fluorescence is observed with a slit lamp and cobalt blue 
filter. The subject is instructed to blink and the time recorded for dark, dry spots to 
develop on the cornea recorded as the FBUT. Typically, values below 10 seconds are 
considered abnormal and indicative o f dry eye (Lemp et al., 1970, Lemp et al., 1971).
Clinically, FBUT remains a popular diagnostic test (Korb, 2000, Nichols et al., 2000, 
Smith et al., 2008) and has been used successfully to predict contact lens intolerance 
(Andres et al., 1987). When applying a cut off value for the diagnosis of dry eye as 
less than 10 seconds, Vitali et al. reported a sensitivity and specificity of 77.8% and 
38.9% respectively (Vitali et al., 1994). The technique is considered an invasive 
assessment as fluorescein instillation is known to reduce tear film stability (Mengher 
et al., 1985). FBUT is dependant on the volume of fluorescein instilled (Johnson and 
Murphy, 2005) and results are frequently variable and unrepeatable (Mengher et al., 
1985, Vanley et al., 1977). Therefore, to improve diagnostic reliability a published 
methodology was followed whereby a fixed amount of fluorescein is delivered into 
the inferior fornix with minimal stimulation using a micro-pipette (Johnson and 
Murphy, 2005).
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4.1.4.2 Non-invasive break-up time
Estimation of the non-invasive tear break-up time (NIBUT) involves the observation 
of a projected image onto the pre-comeal tear film, whereby distortion of the image 
indicates localised thinning of the tear film. Frequently, the image of a keratometer 
mires have been utilised (Patel et al., 1985). The technique has demonstrated 
sensitivity and specificity of 82% and 86% respectively when applying cut off value 
of less than 10 seconds for the diagnosis of dry eye (Mengher et al., 1986). A 
commercial instrument, the Tearscope Plus (Keeler Ltd., Windsor, Berkshire) utilises 
a grid to allow indirect NIBUT assessments (Guillon, 1998). Elliott et al. (1998) 
reported a greater repeatability with the device compared to the fluorescein break-up 
time (Elliott et al., 1998).
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4.2 Method
4.2.1 Subjects
Measurements were recorded from the right eyes of 60 young, healthy subjects (17 
male and 43 female, mean age 23.2 ± SD 4.8 years). Thirty six subjects were non- 
contact lens (NCL) wearers (11 males, 25 females) and 24 habitual hydrogel contact 
lens (CL) wearers (6 males, 18 females). CL wearers wore contact lenses for a 
minimum of three days per week for a period of at least six months; contact lenses 
were removed one hour prior to tear film tests. Subjects were excluded if they had any 
other ocular or systemic condition known to affect the tear film, including pregnancy, 
conjunctivitis and blepharitis. Informed consent was obtained from all subjects; 
favourable approval had been obtained from the Human Science Research Ethics 
Committee, School of Optometry and Vision Sciences, Cardiff University and all 
procedures conformed to the tenets o f the Declaration of Helsinki.
4.2.2 Experimental design
Non-invasive tear break up time (NIBUT), measured with the Tearscope Plus (Keeler, 
UK), was recorded as the time taken after three natural blinks to disruption of the 
projected grid mires of the pre-comeal tear film (Guillon, 1998). The median of three 
readings was recorded for each subject. Using glass capillary tubes, up to 5pi non­
stimulated tear samples were collected from the inferior tear meniscus within a five 
minute period (to minimise stimulation) and expelled into 1.5ml eppendorf tubes. 
Tear samples were prepared and TF graded according to the protocol described in 
Chapter 3. Subjects then completed the Ocular Comfort Index (OCI) Questionnaire. 
Remaining tear samples were stored at -80°C for cytokine analysis.
After a recovery period o f 10 minutes following tear collection, fluorescein tear break 
up time (FBUT) was recorded following instillation of l.Opl 2% sodium fluorescein 
with a micropipette into the inferior fomix. Care was taken to avoid contact with the 
ocular surface or eyelid margin. The tear film was scanned for indications of 
disruption during the recording period using a slit lamp (SL.2F, Topcon, Tokyo,
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Japan); x l6  magnification, 10mm wide beam with cobalt blue filter. FBUT was 
recorded as the time taken after three blinks before disruption of the pre-comeal tear 
film and the median of three recordings was recorded for each subject. For both BUT 
measurements, subjects were reminded not to stare but hold their eyes open naturally. 
Measurement was repeated if the subject blinked before tear film break-up was 
observed.
4.2.3 Cytokine analysis
The tear film concentration of eight different cytokines, available as a pre-prepared 
multi-plex assay panel (Bio-Rad Laboratories Ltd., Hemel Hempstead, Hertfordshire, 
UK), was assessed. An overview o f different cytokine sources and effects is shown in 
Table 4.1. Sufficient tear film samples for cytokine analysis were obtained from 31 
subjects (9 male, 22 female); 18 were NCL wearers (6 male, 12 female) and 13 CL 
wearers (3 male, 10 female). Tear film samples were thawed at 4°C and 2pl of each 
was diluted with 48pl of phosphate buffered saline (PBS) containing 1% bovine 
serum albumin (BSA) giving a 1:25 dilution. 50pl PBS BSA solution was used as a 
negative control. The plate design is shown in Figure 4.4.
120pl stock beads were diluted with 2880 pi Bio-Plex assay buffer. Forty wells of a 
96-well filter plate were each wetted with 1 OOjul of assay buffer and placed on a 
calibrated filter plate vacuum manifold (pressure 1-2" Hg) to remove the buffer. 50pl 
of vortexed bead solution was added to each well and the plate vacuum filtered. 
lOOpl Bio-Plex wash buffer (Bio-Rad) was added to each well, removed by vacuum 
filtration and repeated.
500pl PBS containing 1% BSA was pipetted into the cytokine standard, vortexed and 
incubated on ice for 30 minutes. Eight 1.5ml Eppendorf tubes were labelled and 
12.8pl of standard added to the first tube containing 187.2pl of PBS containing 1% 
BSA and vortexed. Serial dilutions of the standard were prepared and vortexed after 
each dilution (shown in Figure 4.5).
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Table 4.1 An overview o f the principle cellular sources and effects of the eight 
cytokines analysed in the investigation (Hamblin, 1993, Mire-Sluis and Thorpe, 1998, 
Parham, 2000)
Cytokine Th group Sources Effects
IL-2
Interleukin-2
TH1 Activated Tcells
Stimulates proliferation 
and cytotoxic activity of 
activated CD8 Tcells
IL-4
Interleukin-4
Th2 T cells, eosinophils, 
basophils
Bcell proliferation and 
differentiation
IL-6
Interleukin-6
Th2 Monocytes/macrophages Stimulates Bcell 
antibody production
IL-8
Interleukin-8
(chemokine)
- Monocytes/macrophages,
lymphocytes
Neutrophil 
chemotaxis/activation, 
trigger basophils, Tcell 
chemotaxis, 
macrophage production
IL-10
Interleukin-10 Th2 Monocytes, Tcells, Bcells
Inhibit pro- 
inflammatory cytokine 
production. Inhibition 
of IL-2 production by 
Tcells
GM-CSF 
Granulocyte- 
Macrophage Colony 
Stimulating Factor
Th1>Th2 T lymphocytes, 
macrophages
Stimulates granulocytes 
and macrophages
IFN-y
Interferon-y
Th1 Leukocytes
Macrophage and Tcell 
activation
TNF-a 
Tumour Necrosis 
Facto r-a
Th1 and 
Th2
Macrophages, Tcells
Cytotoxic for tumour 
cells,
antiviral/antibacterial 
activity, activates 
macrophages
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Figure 4.4 Diagram of 96 well plate design (S = standard, T = tear film sample, N = 
negative control)
Standard 1
Figure 4.5 Diagram of the serial dilution procedure used to generate the standard 
curve
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50pl of each sample or standard was pipetted per well. The plate was covered with 
aluminium foil, placed onto a micro-plate shaker and incubated at room temperature 
for two hours at 300 RPM. The plate was filtered on the vacuum manifold and 
washed three times with 1 OOpl wash buffer, removing the buffer by vacuum filtration 
after every wash.
150pl stock detection antibody was diluted with 1350pl detection antibody diluent A 
and vortexed. 25pi was pipetted into each well, the plate covered with foil and placed 
onto the micro-plate shaker at 300 RPM for 30 minutes. The plate was filtered on the 
vacuum manifold and washed three times with lOOpl wash buffer, removing the 
buffer by vacuum filtration after every wash.
30pl Streptavidin-PE was diluted with 2970pl Bio-Plex assay buffer and vortexed. 
50pl was pipetted into each well, the plate covered with foil and incubated on the 
micro-plate shaker at 300 RPM for 10 minutes at room temperature. The plate was 
filtered on the vacuum manifold and washed three times with lOOpl wash buffer, 
removing the buffer by vacuum filtration after every wash.
To re-suspend the beads, 125 pi Bio-Plex assay buffer was pipetted into each well and 
placed on the micro-plate shaker at 1100 RPM for 30 seconds. The plate was loaded 
into the Luminex array reader and manufacturer’s instructions followed to allow 
cytokine quantification. Tear film cytokine concentrations obtained with the Luminex 
Analyser were all multiplied by 25 to correct for the initial dilution, with the 
exception of the negative control.
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4.2.4 Statistical analysis
Results were not normally distributed (Kolmogorov-Smimov; 0.070<p<0.200) with 
the exception of tear film stability (p<0.05; NIBUT and FBUT). Therefore, non- 
parametric and parametric statistical analysis was applied as appropriate. An 
Independent-samples t-test (2-tailed) was used to compare tear film stability between 
CL and NCL wearers and the Mann-Whitney U test (2-tailed) was used to compare 
cytokine concentration, TF and ocular comfort between the two groups. Pearson’s 
product-moment correlation coefficient or Spearman’s rank order correlation was 
used as appropriate to investigate the relationship between tear film tests and ocular 
comfort. Significance was set at the 0.05 level.
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4.3 Results
4.3.1 Tear ferning
The effect of gender was not significant across all tests (0.099<p<0.982). 
Significantly higher grades o f TF pattern and ocular discomfort (higher OCI scores) 
were observed in CL wearers compared to NCL wearers (Mann-Whitney U test, 
p<0.005 and p<0.05 respectively) (Table 4.2). However, the difference in tear film 
stability between the two groups was not significant (Independent-samples t-test; 
NIBUT, p=0.752; FBUT, p=0.243) (Table 4.3).
Table 4.2 Results for tear ferning (TF) and ocular comfort index (OCI) scores for
non-contact lens (NCL) and contact lens (CL) wearers
Diagnostic
Test
NCL Wearers
median
CL Wearers
median
Sig. (Mann- 
Whitney U Test)
TF (Type) 1.25 
IQR 1.00-1.750
2.13 
IQR 1.50-2.50
0.001*
OCI (score) 31.07 
IQR 26.97-34.33
34.02 
IQR 31.10-37.54
0.044*
* statistically significant at 0.05 level
Table 4.3 Results for non-invasive break up time (NIBUT) and fluorescein break-up
time (FBUT) for non-contact lens (NCL) and contact lens (CL) wearers
Diagnostic
Test
NCL Wearers
mean
CL Wearers
mean
Sig. 
(Independent- 
sample t-test)
NIBUT (secs) 9.61 
SD ± 2.45
9.28 
SD ± 4.64
0.752
FBUT (secs) 7.34 
SD ± 3.78
6.33 
SD ± 2.86
0.243
Using Rolando’s criteria of abnormal TF above Type 2, Figure 4.6 indicates 14% (5 
subjects) of NCL wearers and 50% (12 subjects) of CL wearers exhibited abnormal 
TF. TF of Type 3 or above was observed in 8% (2 subjects) of CL wearers (Fig. 4.7). 
The highest TF pattern observed in the NCL subjects was Type 2.75, recorded in a 
single subject. For all subjects, there was poor correlation between TF and NIBUT
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(Spearman’s; r=0.140, p=0.287), FBUT (Spearman’s; r=-0.053, p=0.690) and OCI 
scores (Spearman’s; r=0.002, p=0.989). Even when subjects were grouped according 
to CL status, correlations remained similar. For all subjects, FBUT and NIBUT 
displayed a significant positive correlation (Pearson’s; r=0.407, p<0.005). The 
correlation remained significant for CL wearers (Pearson’s; r=0.502, p<0.005) but not 
for NCL wearers alone (Pearson’s; r=0.391, p=0.059) (Fig. 4.8).
Normal TF (TF < Type 2) Abnormal TF (TF > Type 2)
Figure 4.6 Normal (< Type 2) and abnormal tear ferning (> Type 2) in non-contact 
lens (NCL) and contact lens (CL) wearers
90
TF Type 1-1.75 TF Type 2-2.75 TF > Type 3
Figure 4.7 The distribution of tear ferning (TF) Types for non-contact lens (NCL) and 
contact lens (CL) wearers
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Figure 4.8 Correlation o f fluorescein break-up time (FBUT) and non-invasive break­
up time (NIBUT) in all subjects, contact lens (CL) wearers and non-contact lens 
(NCL) wearers (Pearson’s; all subjects r=0.407, p<0.005: CL r=0.502, p<0.005: NCL 
r=0.391, p=0.059)
Subjects within the two groups were identified as asymptomatic or symptomatic for 
dry eye by the OCI score. Considering asymptomatic subjects (OCI score < 40), 
significantly higher grades o f TF patterns were observed in CL wearers compared to 
NCL wearers (Mann-Whitney U test; p<0.005). Higher TF types were also observed 
in symptomatic CL wearers compared to symptomatic NCL wearers. However, the 
difference was not statistically significant (Mann-Whitney U test, p=0.374) (Fig. 4.9). 
For NCL wearers alone, increased levels o f TF were observed in symptomatic 
subjects compared to asymptomatic subjects with mean ferning grades of 1.719 and 
1.411 respectively, although the difference was not statistically significant (Mann- 
Whitney U test; p=0.371). Considering CL wearers, similar patterns were observed 
for symptomatic and asymptomatic subjects, indicating TF in CL wear appears to be 
independent of ocular comfort.
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All su b jec ts  A sy m p to m a tic  su b jec ts  Sym ptom atic  su b jec ts  (High
(Low O CI s c o re )  OCI sco re )
Figure 4.9 The distribution o f TF Types for all subjects, asymptomatic subjects 
(Ocular Comfort Index (OCI) score < 40) and symptomatic subjects (OCI > 40) for 
the non-contact lens (NCL) and contact lens (CL) wearers (* p<0.005)
The TF technique demonstrates superior accuracy for the discrimination of CL and 
NCL wearers by tear film assessment (Table 4.4). Applying cut off values according 
to Rolando’s criterion where Type 1 and 2 are considered normal and Type 3 and 4 
abnormal (Rolando, 1984), TF demonstrated a sensitivity o f 50% and specificity of 
86% for the discrimination of tear film samples between CL and NCL wearers, with a 
positive predictive value (PPV) and negative predictive value (NPV) of 71% and 72% 
respectively. For the prediction o f dry eye symptoms (OCI score >40), TF displayed 
sensitivity and specificity o f 33% and 73% respectively (Table 4.5). The PPV was 
18% indicating a large number o f false positives however; the NPV was 86% 
indicating normal TF to be an accurate predictor o f good ocular comfort (low OCI 
score).
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Table 4.4 The accuracy o f the tear film diagnostic tests (non-invasive break-up time 
(NIBUT), Tear Ferning (TF), Ocular Comfort Index (OCI) and fluorescein break-up 
time (FBUT)) for the discrimination o f contact (CL) wear and non-contact lens (NCL) 
wear
Variable Significance Area Under 
Curve (AUC)
Standard 
Error (SE)
95% Confidence 
Interval
NIBUT 0.194 0.400 0.082 0.239-0.562
TF 0.001 0.748 0.064 0.623-0.874
OCI 0.045 0.654 0.072 0.512-0.796
FBUT 0.369 0.431 0.076 0.282-0.580
Table 4.5 The accuracy o f the tear film diagnostic tests for the presence of dry eye 
symptoms based on Ocular Comfort Index (OCI) score
Variable Significance Area Under 
Curve (AUC)
Standard 
Error (SE)
95% Confidence 
Interval
NIBUT 0.419 0.585 0.098 0.393-0.777
TF 0.992 0.501 0.105 0.296-0.707
FBUT 0.033 0.276 0.092 0.096-0.455
4.3.2 Cytokine concentration
The negative control sample contained levels o f cytokines: 0.26pg/ml IL-4, 0.17pg/ml 
IL-8 and 23.32pg/ml IFN-y. Five (IL-2, IL-4, IL-8, GM-CSF and IFN-y) of the eight 
different cytokines tested were detected by the Luminex Analyser. Levels of IL-6, IL- 
10 and TNF-a were below the sensitivity range of the standard curves. Different 
cytokine concentrations were not detected in all analysed tear samples and results for 
the NCL and CL groups are shown in Table 4.6. The concentration of the five 
detected analytes (IL-2, IL-4, IL-8, GM-CSF and IFN-y) were greater in the CL group 
compared to the NCL wearers, only the difference of IL-4 is statistically significant 
(Mann-Whitney U test, p<0.05). IL-2 and GM-CSF were detected in only three and 
eleven of the 31 tear film samples analysed respectively, and variance for all detected 
cytokines was considerable (Figure 4.10).
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Table 4.6 Median results for the cytokine concentration for the non-contact lens 
(NCL) and contact lens (CL) wearers.
Cytokine CL
status
N um ber
of
sam ples
M edian
C oncentration
(pg/ml)
Inter-quartile
range
P value 
(Mann- 
W hitney U 
Test)
IL-2 NCL 1 627.75 - 1.000
CL 2 690.75 487.50-894.00
IL-4 NCL 16 38.00 22.75-119.69 0.039*
CL 13 107.25 52.75-177.13
IL-8 NCL 17 269.00 136.50-870.00 0.305
CL 13 462.50 321.38-627.88
GM-CSF NCL 5 860.50 512.13-1507.75 0.273
CL 6 991.38 807.625-2617.75
IFN-y NCL 15 2182.75 1222.25-7257.00 0.124
CL 12 6125.63 2184.19-8501.88
* statistical y significant at 0.05 level
For all cytokines, there was a poor correlation o f analyte concentration, tear film tests 
and ocular comfort (Spearman’s; -0.500<r<0.258, 0.177<p<0.974). Correlations 
remained poor when subjects were grouped for CL wear (Spearman’s; CL - 
0.617<r<0.229, 0.101<p<0.957; NCL -0.445<r<0.247, 0.073<p<0.876). A number of 
cytokine combinations displayed a significant positive correlation including; IFN-y 
and IL-4 (Spearman’s; r=0.837, p<0.0001), IFN-y and GM-CSF (Spearman’s; 
r=0.851, p<0.005), GM-CSF and IL-4 (Spearman’s; r=0.890, p<0.005) (Figure 4.11). 
However, sample numbers for certain analytes, particularly IL-2, are small. 
Considering all subjects, cytokine concentrations were not significantly different 
between the asymptomatic and symptomatic groups. This was also the case when 
subjects were grouped according to CL wear status.
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Figure 4.10 Mean concentrations for the 
five cytokines (IL-2, IL-4, IL-8, GM-CSF 
and IFN-y) detected with the Luminex 
Analyser, in non-contact lens (NCL) and 
contact lens (CL) wearers (Mann- 
Whitney U test; p=1.000, p<0.050, 
p=0.320, p=0.329 and p=0.126
respectively)
Non CL W earer
(Box length indicates interquartile range containing the median value; whiskers represent the range of values)
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Figure 4.11 The correlation of various cytokine concentrations for the non-contact lens (NCL) and contact lens (CL) wearers (Spearman’s; 
r=0.837, p<0.0001; r=0.851, p<0.005; r=0.890, p<0.005 respectively)
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4.4 Discussion
4.4.1 Tear ferning
The exact contribution o f the numerous constituents of the tear film components to 
the feming phenomenon has been subject to some speculation. The tear feming 
pattern was originally proposed to be caused by the interaction of electrolytes, 
particularly sodium and chloride, with macromolecules such as tear film mucins and 
proteins (Golding and Brennan, 1989). Further investigations demonstrated that Type 
1 feming could be progressively changed into Type 4 feming with the addition of 
saline solution, suggesting tear film hyperosmolarity was responsible for altered tear 
feming observed in dry eye (Kogbe et al., 1991). X-ray and scanning electron 
microscope analysis has revealed proteinaceous material within the tear sample 
directly controls the formation o f sodium and potassium chloride crystals (Golding et 
al., 1994). More recently, Pearce and Tomlinson (2000) found the presence of 
macromolecules was limited to the periphery of the tear fern (Pearce and Tomlinson, 
2000). There is general agreement that abnormal feming occurs due to unfavourable 
ratios of salt and macromolecules within the tear film (Golding and Brennan, 1989, 
Golding et al., 1994, Pearce and Tomlinson, 2000).
There appear to be significant differences in observed TF patterns between CL and 
NCL wearers, even when comparing asymptomatic subjects, which are likely to result 
from distinct differences in the biochemical composition of the tears. There is 
considerable evidence to suggest that CL wear appears to induce “favourable” 
conditions for abnormal TF by altering the tear film salt to macromolecule 
concentration ratios.
Tear film hyperosmolarity is proposed to be the initiator of ocular surface damage 
observed in dry eye (Gilbard et al., 1988, Gilbard et al., 1984, Gilbard et al., 1987). 
Indeed, assessment o f the tear film osmolarity has been described as the “gold 
standard” for the diagnosis o f dry eye (Lucca et al., 1990) and the technique has 
demonstrated superior accuracy compared to single tests such as Rose Bengal staining 
and Schirmer’s test (Tomlinson et al., 2006). Increased osmolarity of the tear film of 
CL wearers compared to NCL wearers has been reported previously (Miller et al.,
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2004), and different mechanisms have been suggested. Reduced comeal sensitivity 
induced by CL wear (causing a reduction of tear secretion) could subsequently 
increase tear film osmolarity (Gilbard et al., 1986). Further studies have 
demonstrated increased tear film thinning and evaporation are likely to be responsible 
for tear film hyperosmolarity during CL wear (Thai et al., 2002). More recently, 
however, Srinivasan and colleagues found no correlation between TF and tear film 
osmolality in a cohort o f postmenopausal women (Srinivasan et al., 2007). The 
authors suggested this was because the TF pattern is defined by the interaction of the 
tear film salts and macromolecules rather than the tear film osmolarity.
A reduction of total mucin concentration in the tear film of CL wearers has been 
observed previously (Yasueda et al., 2005). In particular, MUC5AC is significantly 
reduced in tear film samples from symptomatic CL wearers (Berry et al., 2007) and 
altered forms of ocular mucins have been found adhered to the contact lens surface 
(Berry et al., 2003). This binding could be responsible for the reduction of tear film 
mucin concentration observed. Hori and colleagues reported similar tear film mucin 
concentrations between CL and NCL wearers, although the total tear protein 
concentration was significantly reduced in CL wearers (Hori et al., 2006). An 
alteration of mucin distribution has also been observed in the tear film of patients with 
dry eye (Danjo et al., 1998) and Sjogren’s syndrome (Argueso et al., 2002).
Traditional tear film stability tests are known to relate poorly to patient symptoms 
(Nichols et al., 2004b) and TF, like other diagnostic tests, appears to correlate poorly 
with ocular comfort symptoms. Increased levels o f ocular discomfort (higher OCI 
scores) were observed in CL wearers compared to NCL wearers. Similar findings 
have been published previously; with almost three times as many CL wearers deemed 
to be symptomatic and over five times as many reporting moderate to severe 
discomfort compared to non-lens wearers (Chalmers and Begley, 2006, Guillon and 
Maissa, 2005). Increased TF grades were observed whenever contact lenses were 
worn or symptom scores increased, but these differences lacked significance within 
each cohort (CL and NCL), except where all subjects were essentially comfortable. 
Such results have several possible interpretations. Successful, asymptomatic CL wear 
is likely to induce a significant alteration of the tear film salt to macromolecule 
concentration which is detectable by the TF technique. The lack of significant
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difference in TF between symptomatic CL and NCL wearers could suggest similar 
aetiology (tear film hyperosmolarity) in each cohort, or may be related to small 
sample size.
To summarise, although TF has been shown to be a good predictor of successful CL 
wear tolerance (Ravazzoni et al., 1998) the technique displayed a poor correlation 
with traditional tear film tests and ocular comfort in CL and NCL wearers. 
Significantly increased TF grades were observed in CL wearers compared to NCL 
wearers even when comparing those asymptomatic patients with good ocular comfort. 
This study demonstrates that TF potentially identifies differences between patient 
groups, but further significant findings may be somewhat restricted by the sample size 
and the semi-quantitative nature o f the grading scale.
4.4.2 Tear film cytokines
The study detected the presence o f five cytokines (IL-2, IL-4, IL-8, GM-CSF and 
IFN-y) in tear film samples from NCL and CL wearers. O f the eight cytokines tested 
with the Luminex Analyser, three remained undetected (IL-6, IL-10 and TNF-a). 
These cytokines have been detected in tear film samples from contact lens wearers 
previously. IL-6, IL-10 and TNF-a have been detected in the tear film of both CL and 
NCL wearers and TNF-a has been noted to be significantly increased in CL wearers 
(Lakkis et al., 2007). IL-6 has also been detected in CL wearers suffering from CL 
induced acute red eye (CLARE) and CL induced peripheral ulcer (CLPU), although 
the concentration was not significantly different to reflex tears from NCL wearers 
(Thakurand Willcox, 1998).
IL-10, typically secreted by Th2 cells, can inhibit macrophage activation, controlling 
the ThI response (Parham, 2000) and is often described as an anti-inflammatory 
cytokine (Cook et al., 2001). TNF-a is typically secreted by ThI cells and activates 
macrophages and increases their phagocytic ability leading to inflammation. IL-6 is 
also a pro-inflammatory cytokine but primarily activates Bcells (Parham, 2000). The 
literature demonstrates the three analytes have been found to be present in tear film 
samples previously. Lack o f detection could have occurred following excessive 
dilution of the tear film samples. However, this appears unlikely as a published
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methodology was followed where IL-6, IL-10 and TNF-a have been successfully 
detected (Malvitte et al., 2007). It is likely the analytes were undetected in this study 
because for each o f these analytes the generated standard curves were poor with a 
number of the most diluted standards being out of range for the Luminex Analyser. 
Sensitivity was significantly reduced to a minimum detection level of 139.63 pg/ml, 
220.95 pg/ml and 59.46 pg/ml for IL-6, IL-10 and TNF-a respectively. Therefore, 
any of the three analytes present in the tear samples below these concentrations would 
remain undetected in this investigation.
The five detected cytokines (IL-2, IL-4, IL-8, GM-CSF and IFN-y) were all found to 
be up-regulated in the tear film o f CL wearers compared to NCL wearers, although 
only IL-4 was significantly increased. The lack of significance observed here is likely 
to be caused by the small cohort size, especially for IL-2 and GM-CSF, and the high 
variance of the results. This wide variance o f cytokine concentration in tear film 
samples has been observed previously (Uchino et al., 2006, Uchino et al., 2005).
An increased concentration o f IL-8 has been observed previously in tear film samples 
from habitual silicone hydrogel (SiH) CL wearers following overnight wear when 
compared to neophytes or NCL wearers (Thakur and Willcox, 2000). IL-8 has also 
been found to be up-regulated in patients with CLARE and CLPU (Thakur and 
Willcox, 1998). Whilst IL-2, IL-4 and IFN-y have been detected in tear film samples 
from patients suffering from various forms o f conjunctivitis and control tear samples 
(Cook et al., 2001, Leonardi et al., 2006) they have not been analysed in CL wearers 
previously. The increase in IL-2 and IFN-y here indicates a cell mediated immune 
response and increased inflammation in the CL group.
IL-8 is described as a pro-inflammatory chemotactic cytokine or chemokine and has 
powerful chemotactic properties on neutrophils and Tcells. The ratio of pro- 
inflammatory to anti-inflammatory cytokines may be informative (Uchino et al., 
2006, Uchino et al., 2005) however, this cannot be investigated in this study as IL-10 
was not detected. A number o f positive cytokine-cytokine correlations were 
observed. The correlation o f IFN-y and GM-CSF could be expected, as both are 
primarily TH1 cytokines. A positive correlation of TH1 and TH2 cytokine 
concentrations (IFN-y and IL-4, GM-CSF and IL-4) is perhaps unexpected but has
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been observed previously in patients with seasonal and chronic allergic conjunctivitis 
(Leonardi et al., 2006).
For all detected cytokines there was a poor correlation between concentration and tear 
film tests. Yoon and colleagues demonstrated a significant correlation of IL-6 with 
BUT and Schirmer’s test for subjects with dry eye (Yoon et al., 2007), but no 
correlation was observed for TNF-a. Correlations have also been observed for 
various cytokines (IL -la , TNF-a, IL-6, IL-8 and TGF-pl) with fluorescein staining 
and Schirmer’s test (Pflugfelder et al., 1999). Narayanan and colleagues concluded 
that whilst dry eye subjects had significantly different symptom scores, tear film 
osmolarity and FBUT, the cytokine profiles were not different from control subjects 
(Narayanan et al., 2006). Unfortunately, ocular comfort also correlated poorly with 
cytokine concentration in this study and no significant differences were observed 
when patients were grouped according to ocular comfort symptoms or CL status. 
Again, the high variability and low cohort size may have masked any significant 
patterns in this study.
CL wear is known to induce an increase in tear film osmolarity (Miller et al., 2004). 
Tissue cultures and the mouse ocular surface have been shown to significantly up- 
regulate various cytokines following hyperosmotic stress (Luo et al., 2005, Shapiro 
and Dinarello, 1997). Therefore, increased tear film hyperosmolarity is likely to be 
the cause of the increased ocular surface inflammation observed in the CL group. 
Kallinikos and colleagues found IL-8 to be significantly increased in rigid gas 
permeable CL wearers compared to SiH CL wearers (Kallinikos et al., 2006) and in 
tear samples from rubbed eyes when compared to controls (Kallinikos and Efron, 
2004). They hypothesised mechanical stimulation of the ocular surface by the CL 
could account for the increase in cytokine concentration (Kallinikos and Efron, 2004, 
Kallinikos et al., 2006). It has also been suggested up-regulation may be caused by a 
response to the CL material, CL solutions or even bacterial contaminants (Lakkis et 
al., 2007). In reality, it is probable a combination of a number o f these factors that 
induce levels of allergy and sub-clinical inflammation in CL wearers.
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4.5 Summary
Tear feming (TF) identified fundamental differences in the tear film of NCL and CL 
wearers. Abnormal TF has been observed in CF patients previously. As the 
technique appears to have some diagnostic value it is justified to investigate TF in the 
CF cohort. Whilst the Luminex system detected five different cytokines from the tear 
samples, three remained undetected due to inaccurate standard curves. Cytokines 
were also observed in the negative control sample. These findings indicate the 
technique requires a greater level o f biochemical competence and further optimisation 
particularly regarding tear film dilution. The high variance of the results from a 
relatively small subject group is also likely to mask any statistical significance. As 
the kit is relatively expensive the Luminex does not appear to be viable method for 
tear film cytokine quantification in tear samples from CF patients.
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Chapter 5 
Investigating the Tear Film and Ocular Surface 
in subjects with Cystic Fibrosis
5.1 Introduction
A number of previous investigations have indicated the tear film and ocular surface is 
abnormal in vitamin A sufficient subjects with CF, with evidence of sub-clinical 
ocular surface inflammation in CF (Sheppard et al., 1989, Mrugacz et al., 2007b, 
Mrugacz et al., 2007c, Mrugacz et al., 2006b, Mrugacz et al., 2007d). Dry eye has 
been suggested to be a primary manifestation o f CF (Morkeberg et al., 1995, Ansari et 
al., 1999). However, the suggestion that ocular surface CFTR is responsible for the 
pathogenesis of dry eye in CF is novel. It is hypothesised that corneal and 
conjunctival epithelial CF secretion via CFTR is reduced or absent in subjects with 
CF, depending on the class o f CFTR mutation. Active trans-epithelial CT transport is 
known to provide the driving force for subsequent osmotically driven fluid secretion, 
such as basal tear production (Yang et al., 2000, Candia, 2004, Dartt, 2004, Dartt,
2002). Therefore, unless alternative epithelial Cl" channels compensate for defective 
CFTR function, subjects with CF would have reduced basal tear secretion with 
subsequent increased tear film osmolarity, ocular surface epithelial damage and 
inflammation.
If dry eye is a primary manifestation o f CF the degree o f CFTR dysfunction, would be 
expected to correlate with dry eye severity. The most common AF508 class 2 
mutation (see section 1.2.2) results in defective CFTR production, which cannot be 
subsequently processed to reach the membrane surface (Kulczycki et al., 2003). In 
the AF508 mutation, CFTR is completely absent from the epithelia resulting in a 
complete loss of normal channel activity. In other, less severe mutations, CFTR may 
reach the apical membrane but cause abnormal channel conductance or the volume of 
CFTR synthesis may be reduced resulting in a milder phenotype (Ratjen and Doring,
2003). Therefore, whilst AF508 homozygotes have a particularly severe phenotype,
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in AF508 heterozygotes, the other milder mutation is dominant over the AF508, 
typically resulting in a milder phenotype (Kerem and Kerem, 1995). A greater 
disruption to normal basal tear secretion would be expected in AF508 homozygotes 
compared to AF508 heterozygotes where some CFTR activity within the ocular 
epithelia is likely to be maintained. Therefore, increased levels of dry eye would be 
expected in AF508 homozygous subjects compared to AF508 homozygotes.
CF genotype correlates poorly with phenotype and there is considerable disease 
variability within patients o f identical genotype (McKone et al., 2003, Zielenski, 
2000) and CF genotype may not accurately predict disease severity in this study. 
Measures of clinical severity, such as lung function or Shwachman score could 
circuitously indicate the level o f CFTR disruption. Therefore, a correlation of disease 
clinical severity with signs and symptoms o f dry eye could be expected.
Disruption of the tear film and ocular surface has been observed secondary to vitamin 
A deficiency (VAD) in subjects with CF (Neugebauer et al., 1989, Rayner et al., 
1989, Castagna et al., 2001, Mrugacz et al., 2005b). Xerophthalmia refers to ocular 
signs of vitamin A deficiency, such as conjunctival and comeal xerosis (Sommer, 
1998). Conjunctival xerosis is characterised by keratinisation and loss of goblet cells 
and precedes comeal manifestations o f VAD. A number of tear film mucins are 
secreted by the goblet cells and ocular surface apical cells (Spurr-Michaud et al., 
2007, Gipson, 2004, Argueso and Gipson, 2001). Mucins facilitate ocular surface 
wetting and tear film stability (Watanabe, 2002, Sharma, 1998a, Sharma, 1998b). 
Other functions include prevention o f pathogen invasion and lubrication (Gipson and 
Argueso, 2003, Argueso and Gipson, 2001). Two ocular surface mucins, MUC5AC 
and MUC4, are down-regulated in experimental VAD in studies of the rat ocular 
surface demonstrating secretion is directly or indirectly regulated by vitamin A (Tei et 
al., 2000). Similarly, MUC16 secretion is also thought to be modulated by vitamin A 
(Hori et al., 2005).
In CF subjects with reduced serum vitamin A concentration or VAD, reduced goblet 
or apical cell densities within the cornea and conjunctiva could result in reduced 
mucin secretion with consequential tear film disruption. Therefore, observations of 
dry eye in patients with CF are likely to be increased in vitamin A deficient subjects
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or could correlate with serum vitamin A concentration. Serum vitamin A 
concentration is known to poorly reflect vitamin A liver stores in subjects with CF 
(Underwood and Denning, 1972). VAD in CF occurs following impaired absorption 
of the fat soluble vitamin in subjects with pancreatic insufficiency (Sinaasappel et al., 
2002) and subjects with CF liver disease may have compromised vitamin A liver 
stores (Lindblad et al., 1997). Therefore, a more accurate reflection of vitamin A 
status may be to compare individuals based on pancreatic and liver function.
Dry eye is a common ocular feature o f both adults and children with Type 1 and Type 
2 diabetes (Manaviat et al., 2008, Rahman et al., 2007, Akinci et al., 2007, Kaiserman 
et al., 2005, Grus et al., 2002). Tear film changes have been shown to increase with 
diabetes duration (Ramos-Remus et al., 1994) and the presence of dry eye correlates 
with glycaemic control (H bA lc) (Seifart and Strempel, 1994). However, no previous 
studies have investigated dry eye when subjects with CF were grouped according to 
diabetic status.
5.1.1 Objectives for this study
This study aimed to examine juveniles and adults with CF of known disease severity 
and status with respect to ocular surface signs and symptoms. The hypothesis was 
that dry eye is a primary manifestation o f CF.
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5.2 Method
5.2.1 Subjects
Children and young adults with CF (referred to as juveniles for the purpose of this 
chapter) (n=30; 20 male, 10 female; mean age 11.77 ± SD 3.39 years) were recruited 
from the Children’s Hospital for Wales, Cardiff. Age and gender matched juvenile 
controls (n=30; 20 male, 10 female; mean age 11.83 ± SD 3.25 years) were recruited 
through friends and colleagues.
Adults with CF (n=28; 19 male, 9 female; 27.07 ± SD 7.36 years) were recruited from 
the All Wales Cystic Fibrosis Centre, Llandough Hospital. Age and gender matched 
controls (n=28; 19 male, 9 female; 27.04 ± SD 7.29 years) were recruited from the 
School of Optometry and Vision Sciences.
Informed consent was obtained from all subjects or their parent/guardian as necessary; 
favourable approval had been obtained from the Cardiff and Vale Trust Research and 
Development Office, South East Wales Research Ethics Committee and the Human 
Science Research Ethics Committee, School of Optometry and Vision Sciences, 
Cardiff University and all procedures conformed to the tenets of the Declaration of 
Helsinki.
5.2.1.1 Inclusion and E xclusion C riteria
Juveniles were required to be between 5 to 18 years o f age. Adults were required to 
be between 18 to 50 years o f age. For subjects with CF the inclusion criteria included 
a positive diagnosis o f CF, regular outpatient attendance at the Children’s Hospital for 
Wales or the All Wales Adult CF Centre, and valid informed consent from the 
participant or parent/guardian where necessary.
For gender matched control subjects, inclusion involved date of birth within six 
months of their CF match, and good general health, free from systemic disease and a 
negative family history of CF. Exclusion for all subjects included pregnancy, breast 
feeding, and signs o f ocular infection or topical medication use.
128
Chapter 5 Tear Film and Ocular Surface
5.2.2 Experim ental D esign
Adult subjects were seen for a single session whilst juveniles were seen on two to 
three separate sessions due to out-patient clinic constraints. Data collection involved 
completion of the Ocular Comfort Index (OCI) for adults or face-to-face comfort 
questionnaire for juveniles which included complaints of soreness/grittiness, 
tiredness, watering or frequency o f eye rubbing.
Non-invasive tear break-up time (NIBUT) was measured with the Tearscope Plus 
(Keeler, UK) (as described in Section 4.2.2). The anterior eye was examined with a 
slit lamp (Juveniles SL.2F, Topcon, Tokyo, Japan; Adults SM-70N, Takagi Seiko Co., 
Ltd., Nagano, Japan) for evidence o f ocular surface xerophthalmia such as; 
conjunctival or corneal xerosis, punctate keratopathy and comeal ulceration (Sommer, 
1998). Blepharitis, conjunctival hyperaemia and limbal hyperaemia were graded 
according to 0.25 increments o f the Efron grading scale (Efron, 1998).
Tear samples were collected from the right eye of adults using glass capillary tubes 
(Section 4.2.2) and sterile cellulose sponges with juveniles (Chapter 3). Each tear 
collection device was applied to the inferior tear meniscus for a maximum period of 
up to 5 minutes. Saturated sponges and expelled tears from capillary tubes were 
placed in 1.5ml eppendorf tubes and stored at -80°C until analysis.
After a recovery period o f at least 10 minutes, fluorescein BUT (FBUT) was assessed 
(Section 4.2.2). Comeal fluorescein staining was subsequently investigated (xl6 
magnification, 3mm wide beam, cobalt blue filter) and graded according to 0.25 
increments of the Efron grading scale.
Collected tear samples were stored at -80°C and subsequently thawed at 4°C for 
analysis. Sponge collected tear samples were centrifuged for three minutes at 14000 
RPM at 4°C to extract the tear sample and glass capillary collected tear samples were 
similarly centrifuged for one minute to facilitate sedimentation and ease of pipetting. 
Tear feming samples were prepared and analysed according to the protocol stated in 
chapter 3 (Section 3.6).
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Information regarding subjects with CF was recorded from their medical records. 
This included:
• Genotype
• Medications and supplements
• Serum vitamin A concentration -  an indication of VAD; normal values range 
between 1.10-2.60 millimoles/litre (mmol/1)
• Glucose tolerance -  typically used for the detection of diabetes where <8.8 
mmol/1 indicates normal glucose tolerance (NGT), 8.9-11.1 mmol/1 indicates 
impaired glucose tolerance (IGT) and >11.2 mmol/1 is diagnostic of Cystic 
Fibrosis-Related Diabetes (CFRD) (Moran, 2002)
• Glycosylated haemoglobin (H bA lc) -  an indication of metabolic control,
normal levels range between 2.6-5.8% (Mansour, 2000)
• Forced Expiratory Volume in one second (FEVi %) -  an indication of lung 
function and is expressed as a percentage o f the predicted value
• Shwachman score - a general score o f clinical severity, assessed at annual 
review. Scoring consists o f assessment of the patient’s general activity, 
nutritional status, a physical examination, and x-ray findings; there is a 
maximum score o f 100 where above 86 is considered excellent and below 40 
severe (Shwachman and Kulczycki, 1958)
• Chrispin-Norman score - a chest radiograph scoring system to assess
respiratory disease progression in CF using the severity of 5 disease
characteristics in 4 zones o f a chest x-ray with a maximum score of 38 
(Chrispin and Norman, 1974)
• Northern score - based on the appearance of the lungs from a chest x-ray 
where severity is marked out o f a maximum score of 20 (Conway, 1994)
• Premature birth and gestation period in juveniles
To enhance subject participation and due to lack of access to a phlebotomist and 
laboratory analysis, blood samples were not drawn at the time of data collection. 
Therefore, vitamin A and H bA lc levels were recorded from the most recent blood 
test. FEVi was recorded from the most recent outpatient appointment. Chrispin-
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Norman, Shwachman or Northern scores were recoded from the preceding annual 
review.
5.2.3 Statistics
Data was checked for normality using the Kolmogorov-Smimov test (SPSS Version 
16). Results for the anterior eye assessment (blepharitis, conjunctival hyperaemia, 
limbal hyperaemia and comeal fluorescein staining) and OCI scores in adults were not 
normally distributed (p<0.005 for all) although tear break up times (NIBUT and 
FBUT) were (0.092 and 0.200 respectively). Therefore, non-parametric and 
parametric statistics were applied as appropriate.
Inter-ocular differences were explored with Wilcoxon Signed Rank (2-tailed) test or 
Paired-samples (2-tailed) t-test. The Mann-Whitney U (2-tailed) test or Independent 
samples (2-tailed) t-test was applied to compare data from the CF and control cohorts 
as appropriate. Correlation was assessed with Spearman’s Rank Order Correlation or 
Pearson’s Product Moment Correlation as appropriate. The Kruskal-Wallis test or 
One-Way Analysis o f Variance was used to compare the effect of vitamin A status, 
pancreatic status, CFLD, CFRD and genotype. Bonferroni’s test was used for post- 
hoc comparisons. Significance was set at the 0.05 level.
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5.3 Results
Measures of anterior eye assessment, ocular comfort and tear film stability were not 
significantly different when comparing values for each eye (Wilcoxon Signed Rank 
test, 0.053<p<1.00; Paired-samples t-test, 0.944<p<0.948). Therefore, only values 
from the right eye will be presented.
5.3.1 Subjects
An overview of CF disease status in juveniles and adults with CF is shown in Table
5.1 and 5.2 respectively.
Due to varying levels o f co-operation a small number of subjects did not participate in 
all procedures:
Juveniles
• 30 CF and 30 control subjects participated in the ocular comfort questionnaire
• 27 CF subjects took part in any tear film or ocular surface examination (3 CF
subjects dropped out following initial recruitment due to poor health or 
personal choice)
• 24 CF and 23 control subjects had comeal staining assessed (3 CF and 7
controls declined to have fluorescein inserted with the pipette)
• 25 CF and 28 control subjects performed NIBUT (2 subjects were excluded
from each group due to a lack o f understanding or uncontrolled blinking)
• 24 CF and 22 control subjects performed FBUT (a number did not have
fluorescein inserted and 1 control subject was excluded due to inadvertent 
blinking)
Adults
• 27 control subjects had corneal staining and FBUT assessed (one control
subject declined to have fluorescein inserted with the pipette)
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Table 5.1 Overview o f subject characteristics and clinical disease severity for the 
juvenile CF group
Variable Description
Genotype
n=l 1 AF508 homozygous 
n=17 AF508 heterozygous 
n=2 non-AF508
Pancreatic function n=6 pancreatic sufficient 
n=24 pancreatic deficient
Serum vitamin A 
concentration
range 0 .5 9 -2 .0 4  pmol/1 
mean 1.25 pmol/1 (SD ± 0.35)
Vitamin A status n=19 vitamin A sufficient 
n=8 vitamin A deficient 
(3 subjects unmeasured)
CFRD None
HbAlc 5 subjects assessed, range 5.2 -  5.9% 
mean 5.58% (SD ± 0.26)
FEV, range 19 -  123% 
mean 89.64% (SD ± 13.08)
Shwachman Score
score >86 (excellent) n=19 
score 71-85 (good) n=8 
no score n=3 
range 1 0 0 -7 1  mean score 88.17 (SD ± 8.43)
Chrispin-Norman
Score
range 0 - 1 0  
no score n=7 
mean 5.22 (SD ± 2.76)
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Table 5.2 Overview o f subject characteristics and clinical disease severity for the 
adult CF group
Variable Description
Genotype
n=13 AF508 homozygous 
n=l 1 AF508 heterozygous 
n=4 non-AF508
Pancreatic
function
n=3 pancreatic sufficient 
n=25 pancreatic deficient
Serum vitamin 
A concentration
range 0.35 -  2.34 pmol/1 
mean 1.31 pmol/1 (SD ± 0.58)
Vitamin A 
status
n=16 vitamin A sufficient 
n=12 vitamin A deficient
CFRD n=l 1 CFRD 
n=17 non-CFRD
HbAlc range 4.7 -  13.2% 
mean 6.68% (S D ± 0.2.16)
CFLD n=6 CFLD, all taking ursodeoxycholic acid
FEVi range 24 -  103% 
mean 58.61 % (SD ± 24.11)
Northern Score range 0/20 -  12/20 
mean 6.00 (SD ±3.58)
5.3.2 Ocular comfort
A total of 43% of juveniles (n=13) with CF and 50% of controls (n=15) reported at 
least one symptom of ocular discomfort including; soreness/grittiness, tiredness, 
watering or eye rubbing. The frequency o f reported ocular comfort symptoms is 
shown in Table 5.3. No significant difference was observed for all symptoms (Mann- 
Whitney U test; 0.200<p<1.000). No significant difference in the total number of 
subjects reporting symptoms of ocular discomfort was observed when control subjects 
were compared to vitamin A deficient and sufficient CF subjects (Kruskal-Wallis test; 
p=0.159). Similarly, no difference was observed when subjects were grouped
134
C hapter 5 'Fear Film and Ocular Surface
according to pancreatic status or genotype (Kruskal-Wallis test; p=0.082 and p=0.214 
respectively).
Table 5.3 The frequency o f reported ocular symptoms in juveniles with CF and 
healthy controls
Feature
Control 
(no. of 
subjects)
CF 
(no. of 
subjects)
Significance
(Mann-Whitney
U-test)
Soreness/Grittiness 4 4 1.000
Rubbing 6 9 0.375
Tiredness 5 2 0.232
Watering 8 4 0.200
Total no. of different 
subjects reporting ocular 
symptoms
15 13 0.608
In the adults, median Ocular Comfort Index (OCI) scores were slightly higher 
(indicating greater ocular discomfort) with greater variability in the CF group 
compared to the controls at 29.24 and 28.57 respectively, although the difference was 
not statistically significant (Mann-Whitney U test; p=0.491) (Figure 5.1). Four 
outliers can be observed in Figure 5.1 (two from each group) where subjects 
responded “Never” to all questions o f the OCI resulting in a negative score. An 
insignificant difference remained when these outliers were removed (Mann-Whitney 
U test; p=0.442).
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Figure 5.1 Ocular Comfort Index scores in adults with CF and healthy controls 
(Mann-Whitney U test; p = 0.491)
(Box length indicates interquartile range containing the median value; whiskers represent the range of 
values)
Significantly greater levels o f ocular discomfort were observed in the non-AF508 
subjects compared to the AF508 heterozygotes and the controls (Kruskal-Wallis; 
p<0.05) (Figure 5.2). Two negative OCI score outliers were recorded in both the 
AF508 heterozygote and the control group and median OCI scores were not 
significantly different when the four outliers were removed (Kruskal-Wallis; p=0.053) 
(Figure 5.3). Higher OCI scores can be observed in the AF508 homozygotes 
compared to the heterozygotes although the difference is not significant. Considering 
clinical severity in the CF cohort, the OCI scores showed poor correlation with the 
Northern Score and lung function (FEVi) (Spearman; r=0.032, p=0.684 and r=-0.11, 
p=0.956 respectively).
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Figure 5.2 Ocular comfort index (OCI) scores in the three different adult CF 
genotype groups and healthy controls (Kruskal-Wallis; p<0.05)
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Figure 5.3 Ocular comfort index (OCI) scores in the three different adult CF 
genotype groups and healthy controls following the removal of four outliers (Kruskal- 
Wallis; p=0.053)
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OCI scores did not significantly correlate with serum vitamin A concentration 
(Spearman’s; r=0.081, p=0.684) (Figure 5.4). OCI scores were not significantly 
different when vitamin A deficient and sufficient subjects were compared to controls 
(Kruskal-Wallis; p=0.769) (Figure 5.5). When the two negative outliers, in the 
vitamin A deficient groups were removed a higher OCI score was observed in this 
group (32.14) when compared to the sufficient or control group (29.24 and 29.11 
respectively) (Figure 5.6). However, the difference remained insignificant (Kruskal- 
Wallis; p=0.603). Similarly, ocular comfort did not differ significantly according to 
CF-related liver disease (CFLD) (Kruskal-Wallis; p=0.711). Adult CF participants 
were not compared according to pancreatic status as only three subjects demonstrated 
pancreatic sufficiency.
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S e r u m  Vitamin A C o n c e n t r a t i o n  (mmol/l)
Figure 5.4 The correlation o f serum vitamin A concentration and ocular comfort 
index (OCI) scores in adults with CF (Spearman’s; r=0.081, p=0.684)
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Figure 5.5 Ocular comfort index (OCI) scores in vitamin A deficient and sufficient 
adults with CF and healthy controls (Kruskal-Wallis; p=0.769)
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Figure 5.6 Ocular comfort index (OCI) scores in vitamin A deficient and sufficient 
adults with CF and healthy controls following the exclusion of four outliers (Kruskal- 
Wallis; p=0.603)
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OCI showed a small positive correlation with diabetic metabolic control (HbAlc) 
(Spearman’s; r=0.200, p=0.307) (Figure 5.7) although ocular comfort was not 
significantly different between controls and subjects with CF when grouped according 
to CFRD status (Kruskal-Wallis; p=0.401) (Figure 5.8). Following the removal of the 
two negative outliers, the correlation remained similar (Spearman’s; r=0.199, 
p=0.329) and differences when subjects were grouped according to CFRD status 
remained insignificant (Kruskal-Wallis; p=0.251).
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Figure 5.7 Correlation of glycaemic control (HbAlc) and ocular comfort index (OCI) 
score in adults with CF (Spearman’s; r=0.200, p=0.307)
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Figure 5.8 Ocular comfort index (OCI) scores in healthy control adults and CF 
subjects with and without CF-related diabetes (CFRD) (Kruskal-Wallis; p=0.401)
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5.3.3 Anterior ocular surface
The frequency of different Efron grades of blepharitis in juveniles and adults with CF 
is shown in Figure 5.9a. A higher prevalence of trace and mild blepharitis were seen 
in subjects with CF compared to controls. However, median grades are identical for 
all groups (Grade 0.0 normal) and the difference between CF subjects and controls 
was not significant for both juveniles and adults (Mann-Whitney U test; p=0.347 and 
p=0.422 respectively).
Levels of conjunctival hyperaemia tended to be greater in juveniles with CF compared 
to juvenile controls, with median grades o f 0.5 (normal) and 1.0 (trace) respectively 
although the difference failed to reach significance (Mann-Whitney U test; p=0.187) 
(Figure 5.9b). Whilst mild conjunctival hyperaemia was recorded in two adult 
subjects with CF, this grade was not observed in any o f the control adults. Median 
grades were identical (Grade 1.0 trace) and no significant statistical difference 
detected (Mann-Whitney U test; p=0.474).
Considering both adults and juveniles, levels o f limbal hyperaemia tended to be 
greater in subjects with CF compared to controls (Figure 5.10a). A median 
hyperaemia of Grade 0.5 was observed for all groups, and differences failed to reach 
significance (Mann-Whitney U test; juveniles p=0.866 and adults p=0.248).
Adults with CF exhibited a higher median level o f corneal staining (1.0) compared to 
both controls (0.0) and juveniles (0.0). Mild corneal staining was observed only in the 
CF adult group: median levels o f comeal staining were 1.0 in this group and 0.0 in the 
healthy adult controls (Figure 5.10b). Median grades were identical in the juvenile 
group (Grade 0.0). Whilst the difference in comeal staining approached significance 
in the adult cohort, the difference was not significant in juveniles (Mann-Whitney U 
test; juveniles p=0.794 and adults p=0.079 respectively).
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Figure 5.9 The prevalence o f blepharitis (a) and conjunctival hyperaemia (b) in 
juveniles and adults with CF and healthy controls according to the Efron grading scale
143
C hapter 5 Tear Film and Ocular Surface
<B
1  0)
2 o> a >» .c
"ton
E
Juvenile Control Juvenile CF Adult Control Adult CF
□  Normal (Grade 0 -  0.75)
□  Trace (Grade 1 -1 .7 5 )
□  Mild (Grade 2 -  2.75)
100%
90%
80%
70%
o>c
'E 60%
Ito 50%
"5a>cG 40%o
o
30%
20%
10%
0% u
Juvenile Control Juvenile CF Adult Control Adult CF
Figure 5.10 The prevalence o f limbal hyperaemia (a) and comeal staining (b) in 
juveniles and adults with CF and healthy controls graded according to the Efron 
grading scale
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Levels of blepharitis, conjunctival hyperaemia and limbal hyperaemia did not 
significantly differ according to genotype amongst the juvenile subjects (Kruskal- 
Wallis; 0.098<p<0.526). Considering corneal staining, severity was greater in the 
non-AF508 group (median grade 1.00) compared to the AF508 homozygotes, AF508 
heterozygotes and controls (median grade 0.00 each) although the difference just 
failed to reach significance (Kruskal-Wallis; p=0.051).
In the adult cohort, there was no difference in ocular surface signs in CF subjects with 
different genotypes and controls (0.073<p<0.268) apart from limbal hyperaemia, 
which was greater in the non-AF508 group compared to the AF508 homozygotes, 
AF508 heterozygotes and controls (Kruskal-Wallis; p<0.05) (Figure 5.11).
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Figure 5.11 Limbal hyperaemia in adult healthy controls and subjects with CF 
grouped according to genotype (Kruskal-Wallis; p<0.05)
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In the juvenile cohort, disease clinical severity (FEVi, Crispin-Norman and 
Shwachman score) correlated poorly with measures of anterior ocular surface 
(Spearman’s; -0.350<r<0.315, 0.141<p<0.968). Considering the adults, corneal 
staining significantly correlated with Northern score (Spearman’s; r=0.451, p<0.05). 
Blepharitis, corneal hyperaemia and limbal hyperaemia showed a poor correlation 
with Northern score and FEVi (Spearman’s; r=-0.266<r<0.275, 0.157<p< 0.960).
Although no subjects showed any ocular surface signs o f clinically significant 
xerophthalmia, results were still examined for differences according to vitamin A 
status. Considering the juvenile cohort, blepharitis and corneal staining was not 
significantly different between the vitamin A deficient, sufficient and control cohorts 
(Table 5.4) (Kruskal-Wallis; p=0.631 and p=0.642 respectively). Median 
conjunctival and limbal hyperaemia grades were significantly greater in the vitamin A 
sufficient group compared to the deficient and control subjects (Kruskal-Wallis; 
p<0.01 and p<0.005 respectively).
Table 5.4 Median grades o f blepharitis, conjunctival hyperaemia, limbal hyperaemia 
and comeal staining in juvenile healthy controls and vitamin A sufficient and deficient 
subjects with CF
Factor Control
n=30
CF
Significance
(Kruskal-
Wallis)
V itam in A 
sufficient 
n=16
Vitamin A 
deficient 
n=8
Blepharitis 0.00 0.00 0.00 0.631
Conjunctival 0.50 1.00 0.50 <0.010
hyperaemia
Limbal 0.50 1.00 0.50 <0.005
hyperaemia
Corneal 0.00 0.00 0.00 0.642
staining n=24 n=15 n=6
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A significant correlation was observed with serum vitamin A concentration and limbal 
hyperaemia (Spearman’s; r=0.459, p<0.05) (Figure 5.12). There was a poor 
correlation between serum vitamin A concentration and blepharitis (Spearman’s; r=- 
0.27, p=0.902) and a small positive correlation with conjunctival hyperaemia and 
comeal staining (Spearman’s; r=0.322, p=0.125 and r=0.105, p=0.652 respectively). 
The anterior ocular surface appearance was not significantly different when juvenile 
subjects were grouped according to pancreatic status (Kmskal-Wallis; 
0.167<p<0.966).
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Figure 5.12 The correlation o f limbal hyperaemia and serum vitamin A concentration 
in juveniles with CF (Spearman; r=0.459, p<0.05)
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In adults, median blepharitis grades were identical in the vitamin A deficient and 
sufficient groups (Table 5.5). Conjunctival and limbal hyperaemia and corneal 
staining grades were greater in the vitamin A deficient group compared to the other 
groups, but these differences only reached significance for corneal staining (Kruskal- 
Wallis, p<0.05).
Table 5.5 Median grades of blepharitis, conjunctival hyperaemia, limbal hyperaemia 
and comeal staining in adult healthy controls and vitamin A sufficient and deficient 
subjects with CF
Factor Control
n=28
CF
Significance
(Kruskal-
Wallis)
Vitam in A 
sufficient 
n=16
Vitamin A 
deficient 
n=12
Blepharitis 0.00 0.00 0.00 0.681
Conjunctival
hyperaemia
1.00 0.75 1.50 0.204
Limbal
hyperaemia
0.50 0.50 1.00 0.264
Corneal
staining
0.00 0.00 1.00 <0.050
Measures of anterior ocular surface positively correlated with serum vitamin A 
concentration (Spearman’s; 0.066<r<0.189, 0.334<p<0.740) and a significant 
correlation was observed with bulbar conjunctival hyperaemia (Spearman’s; r=0.405, 
p<0.05) (Figure 5.13). The anterior ocular surface appearance was not significantly 
different when subjects were compared according to CFLD status (Kruskal-Wallis; 
0.248<p<0.616).
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Figure 5.13 The correlation of conjunctival hyperaemia and serum vitamin A 
concentration in adults with CF (Spearman; r=0.405, p<0.05)
The presence/absence of CFRD did not seem to relate to any ocular surface findings; 
there were no significant differences observed between controls and those subjects 
with CFRD and those without (Kruskal-Wallis; 0.082<p<0.458).
5.3.4 T ear film  stab ility
For the juvenile cohort, mean non-invasive break-up time (NIBUT) and fluorescein 
break-up time (FBUT) were only marginally greater in the control group compared to 
the CF group (Independent-samples t-test; p=0.357 and 0.154 respectively (Figure 
5.14a). Tear film stability was significantly reduced in the adult cohort compared to 
the juveniles for both CF subjects and controls (ANOVA; NIBUT p<0.001 and FBUT 
p<0.001). In the adult group mean tear film stability times were greater in the 
controls compared to the subjects with CF (Figure 5.14b). Whilst NIBUT was not 
significantly different, the difference in FBUT reached significance (Independent- 
samples t-test; p=0.509 and p<0.05 respectively).
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Figure 5.14 Mean non-invasive tear break up time (NIBUT) and fluorescein tear 
break up time (FBUT) in juveniles with CF and healthy controls (a) (Independent- 
samples t-test; p= 0.357 and p=0.154 respectively) and adults with CF and healthy 
controls (b) (Independent-samples t-test; p= 0.509 and p<0.05 respectively)
(Error bars indicate 95% confidence intervals)
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Tear film stability was not significantly different when subjects were grouped 
according to genotype in the juvenile cohort (ANOVA; NIBUT p=0.555 and FBUT 
p=0.355). In adults, NIBUT was not significantly different when subjects were 
grouped by genotype (ANOVA; p=0.306), but FBUT appeared to be lower in the non- 
AF508 group compared to the other groups (ANOVA; p=0.053) (Figure 5.15).
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Figure 5.15 Mean non-invasive break-up time (NIBUT) and fluorescein break-up 
time (FBUT) in healthy control adults and CF subjects grouped according to genotype 
(ANOVA; NIBUT p=0.306 and FBUT p=0.053)
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Considering measures o f clinical severity in the juvenile group, tear film stability did 
not significantly correlate with lung function (FEVi), Shwachman score or Chrispin- 
Norman score (Pearson’s; -0.015<r<0.277; 0.224<p<0.952). In adults, tear film 
stability showed a negative correlation with Northern score and a positive correlation 
with FEVi however, the correlations were not significant (Pearson’s; NIBUT; r=- 
0.110, p=0.577 and r =0.280, p=0.149 respectively and FBUT; =-0.331, p=0.085 and 
r=0.343, p=0.074 respectively).
NIBUT did not appear to differ significantly when subjects were grouped according to 
vitamin A status in the juvenile cohort (ANOVA; p=0.240). However, FBUT was 
reduced in the vitamin A sufficient group (ANOVA, p<0.05) (Figure 5.16). Tear film 
stability did not significantly correlate with serum vitamin A concentration 
(Pearson’s; NIBUT 1^-0.333, p=0.131 and FBUT r=-0.205, p=0.374). There was no 
significant difference in tear film stability when pancreatic sufficient and deficient CF 
subjects and controls were compared (ANOVA; NIBUT p=0.610; FBUT p=0.349).
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Figure 5.16 Mean non-invasive break-up time (NIBUT) and fluorescein break-up 
time (FBUT) in healthy control juveniles and CF subjects grouped according to 
vitamin A status (ANOVA; NIBUT p=0.240 and FBUT p<0.05)
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Although tear film stability was reduced in the vitamin A deficient cohort compared 
to the sufficient group or the controls the difference failed to reach significance 
(ANOVA; NIBUT p=0.570; FBUT p=0.881) (Figure 5.17). Serum vitamin A 
concentration did not significantly correlate with tear film stability (Pearson’s; 
NIBUT r=0.189, p=0.336; FBUT r=0.235, p=0.229). NIBUT and FBUT were not 
significantly different when subjects were grouped according to CFLD status 
(ANOVA; p=0.533 and p=0.109 respectively).
Measures of tear film stability negatively correlated with HbAlc, although the 
correlation was not significant (Pearson’s; NIBUT; r=-0.118, p=0.551: FBUT; r=- 
0.228, p=0.243). NIBUT and FBUT were not significantly different amongst 
controls, and CF subjects with and without CFRD (Kruskal-Wallis; p=0.805 and 
p=0.108 respectively).
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Figure 5.17 Mean non-invasive break-up time (NIBUT) and fluorescein break-up 
time (FBUT) in healthy control adults and CF subjects grouped according to vitamin 
A status (ANOVA; NIBUT p=0.570 and FBUT p=0.881)
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5.3.5 Tear Ferning
Sufficient tear film samples to produce tear ferning (TF) images were collected from 
13 juveniles with CF and 15 healthy controls. All subjects had normal TF grades 
(Type 1 and Type 2) according to Rolando’s grading scale. Median TF grades of 1.25 
were observed in both the CF and control groups, the difference was not significant 
(Mann-Whitney U test; p=0.658) (Figure 5.18a). The incidence of the different TF 
Types in the two groups is shown in Figure 5.19a).
Sufficient tear film samples were collected from 24 adults with CF and 24 control 
subjects. All subjects had normal TF grades (Type 1 and 2) according to Rolando’s 
grading scale. Median TF grades were slightly greater compared to the juveniles. 
Identical median grades were observed in the adult CF subjects and controls groups at 
1.50 respectively (Figure 5.18b). Although there was no significant difference 
between the two groups (Mann-Whitney U test; p=0.190), a greater number of Type 
1.75 and 2.00 ferning patterns were observed in the CF group compared to the 
controls (Figure 5.19b).
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Figure 5.18 Tear ferning in juveniles with CF and healthy controls (Mann-Whitney U 
test; p=0.658) (a) and adults with CF and healthy controls (b) (Mann-Whitney U test; 
p=0.190)
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Figure 5.19 The prevalence of different tear ferning “Types” in juveniles with CF and 
healthy controls (a) and adults with CF and controls (b)
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TF was not performed in any juvenile subjects with a non-AF508 mutation. TF 
grades were not significantly different in the remaining three groups (Kruskal-Wallis; 
p=0.332). In the adults however, TF grades were significantly worse in non-AF508 
adults compared to AF508 homozygotes, heterozygotes and controls (Kruskal-Wallis; 
p<0.05) (Figure 5.20).
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Figure 5.20 Tear ferning in healthy control adults and subjects with CF grouped 
according to phenotype (Kruskal-Wallis; p<0.05)
Measures of clinical disease severity in juveniles, including FEVi, Shwachman and 
Crispin-Norman score did not significantly correlate with TF (Spearman; 
0.152<r<0.475, 0.140<p<0.636). Similarly in adults there was no correlation with 
measures of disease severity such as FEVi or Northern Score (Spearman; r=0.150, 
p=0.484 and r=-0.226, p=0.289 respectively).
In the juvenile cohort, TF was not significantly different when controls, vitamin A 
deficient and vitamin A sufficient subjects were compared (Kruskal-Wallis; p=0.224) 
(Figure 5.21) and there was no significant correlation of TF grade with serum vitamin
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A concentration (Spearman; r=0.491, p=0.105). Similarly, TF was not significantly 
different when subjects were grouped according to pancreatic status (Kruskal-Wallis; 
p=0.224).
TF did not significantly correlate with serum vitamin A concentration in the adults 
with CF (Spearman; r=0.214, p=0.314) and TF grades were not different between the 
vitamin A deficient and sufficient adults and the adult controls (Kruskal-Wallis; 
p=0.392) (Figure 5.22). Furthermore, TF was not significantly different in subjects 
when grouped according to CFLD status (Kruskal-Wallis; p=0.257).
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Figure 5.21 Tear ferning in vitamin A deficient and sufficient juvenile subjects with 
CF and healthy controls (Kruskal-Wallis; p=0.224)
158
C hapter 5 Tear Film  and Ocular Surface
2 .00-
1 .80-
1 60-
w 1 40-
150-
1 .00-
control sufficient deficient
V itam in A s ta tu s
Figure 5.22 Tear ferning in vitamin A deficient and sufficient adult subjects with CF 
and healthy controls (Kruskal-Wallis; p=0.392)
In the juvenile cohort, TF showed a moderate positive correlation with blepharitis, 
conjunctival hyperaemia and limbal hyperaemia (Table 5.6). Whilst TF showed a 
strong negative correlation with NIBUT (Spearman; r=-0.579, p<0.005), this failed to 
reach significance for FBUT (Spearman; r=-0.217, p=0.276). TF also showed a 
number of moderate positive correlations with anterior ocular observations and 
moderate negative correlations with measures o f tear film stability which are 
summarised in Table 5.7.
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Table 5.6 The correlation o f tear ferning with anterior ocular surface observations, 
non-invasive tear break-up time (NIBUT) and fluorescein tear break-up time (FBUT) 
in juveniles with CF and healthy controls
Factor C orrelation coefficient 
(r)
Significance
(P)
Blepharitis * 0.410 <0.050
Conjunctival hyperaem ia 0.401 <0.050
Limbal hyperaemia 0.480 <0.050
11
Corneal staining 0.175 0.373
NIBUT* -0.579 <0.005
FBUT* -0.217 0.276
* Spearman’s Rank Order Correlation
* Pearson’s Product M oment Correlation
Table 5.7 The correlation o f tear ferning with the ocular comfort index (OCI), 
anterior ocular surface observations, non-invasive tear break-up time (NIBUT) and 
fluorescein tear break-up time (FBUT) in adults with CF and healthy controls
Factor C orrelation coefficient 
(r)
Significance
(P)
OCI* 0.61 0.679
Blepharitis * 0.380 <0.01
Conjunctival hyperaem ia * 0.445 <0.005
Limbal hyperaemia 0.271 0.062
. . _  .  _ -----
Corneal staining -0.023 0.877
NIBUT* -0.442 <0.005
FBUT* -0.427 <0.005
"Spearm an’s Rank Order Correlation
* Pearson’s Product M oment Correlation
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5.3.6 Major findings of this study
• Significantly higher levels o f ocular discomfort in non-AF508 adult subjects 
compared to AF508 heterozygotes
• Generally increased levels o f hyperaemia and staining in subjects with CF 
compared to controls although the differences were not significant
• Significantly higher grades o f limbal hyperaemia in non-AF508 adult subjects 
compared to AF508 heterozygotes and homozygotes
• Significantly higher conjunctival and limbal hyperaemia in vitamin A 
sufficient juveniles compared to vitamin A deficient subjects and controls
• Significantly higher grades o f comeal staining in vitamin A deficient adults 
compared to vitamin A sufficient adults and controls
• Significant correlation o f comeal staining and Northern score in CF adults
• FBUT was significantly reduced in adult CF subjects compared to controls
• Tear film stability further reduced in vitamin A deficient adults compared to 
vitamin A sufficient adults although the differences were not significant
• FBUT was significantly reduced in juvenile vitamin A sufficient subjects 
compared to controls
• Generally higher TF grades in CF subjects compared to controls although the 
differences were not significant
• TF showed a number o f significant correlations with measures o f tear film 
stability and anterior ocular surface observations in juvenile and adults groups
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5.4. Discussion
5.4.1 Ocular com fort
The results indicate juvenile subjects with CF have similar perceived levels of ocular 
discomfort symptoms compared to controls. This is the first investigation to 
quantitatively assess ocular comfort in subjects with CF and controls. In adults, with 
increased levels o f disease severity and duration, it could be expected that dry eye 
symptoms may be more prevalent. Whilst median OCI scores were higher in the CF 
cohort, this was not significantly different. It is well documented that clinical signs 
and symptoms correlate poorly in dry eye (Nichols et al., 2004b) and this could be 
true in CF similarly. However, if  dry eye is a primary manifestation it is likely to be a 
chronic condition in CF subjects and adults may be well adapted or tolerant of 
symptoms. Significance could also be hindered by higher levels o f variance in the CF 
adult group or relatively small cohort sizes.
Specifically, the presence o f VAD, CFRD or CFLD did not appear relevant to ocular 
comfort. However, when adult subjects were grouped according to genotype, greater 
levels of ocular discomfort were observed in the non-AF508 subgroup. The non- 
AF508 genotype group consisted o f four individuals, three of unknown CFTR 
mutations and an individual with a R553X/R553X mutation. The R553X class 1 
mutation results in complete absence o f CFTR synthesis and is associated with a 
severe CF phenotype (Zielenski and Tsui, 1995, Aznarez et al., 2007). Therefore, the 
non-AF508 group could consist o f subjects with severe CFTR mutations resulting in 
complete absence o f CFTR activity in the apical corneal and conjunctival epithelium 
and maximally impaired basal tear secretion and more severe symptoms of dry eye in 
these subjects.
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5.4.2 Anterior ocular surface
This is the first study to utilise a quantitative grading scale to assess the anterior eye in 
subjects with CF. Blepharitis is frequently observed in dry eye subjects and 
meibomian gland dysfunction is the primary cause of evaporative dry eye (Lemp and 
Nichols, 2009). Previous investigations o f the prevalence of blepharitis in CF have 
been varied with a reported range o f 20-88% CF subjects affected (Mrugacz et al., 
2007c, Sheppard et al., 1989). Flowever, the clinical definition o f blepharitis was 
inconsistent in these studies. In this investigation, 30% juveniles and 29% adults with 
CF had trace or mild blepharitis (Grade 1-2.75) compared to 7% and 18% controls 
respectively. The results o f this investigation support previous reports that despite an 
increased incidence o f blepharitis in CF, the difference fails to reach significance 
(Kalayci et al., 1996, Mrugacz et al., 2005b, Mrugacz et al., 2007b).
Comeal staining, conjunctival and limbal hyperaemia are frequently observed in 
ocular surface inflammation. Corneal fluorescein staining is regarded as a popular 
diagnostic test for dry eye (Smith et al., 2008, Nichols et al., 2000). Whilst CF 
subjects tended to demonstrate higher levels o f hyperaemia and staining, particularly 
in the adults, differences failed to reach significance, although this could be a 
reflection of sample size. This study is in concurrence with earlier reports in that 
whilst the incidence o f comeal staining was greater in the CF cohort compared to 
healthy controls the difference was not significant (Kalayci et al., 1996, Mmgacz et 
al., 2005b).
Whilst no genotype differences were observed in the juvenile group, limbal 
hyperaemia was significantly increased in the non-AF508 adults. This could be due to 
reasons outlined previously and the lack o f associated significance in the increase of 
conjunctival redness and staining could be due to small subgroup size. According to 
disease severity, pancreatic, liver and diabetic status, there were no ocular surface 
differences apart from a correlation o f Northern Score and staining in adults. This 
could indicate disease severity contributes to the pathogenesis o f dry eye in CF. 
Reassuringly, features o f ocular surface xerophthalmia which occur following 
prolonged VAD were not observed in any subjects with CF. Whilst increased corneal 
staining was observed in vitamin A deficient adults, increased hyperaemia in juvenile
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vitamin A sufficient subjects was somewhat unexpected. This may have occurred 
because vitamin A status at the time may not have been represented by serum levels 
recorded from the patient’s medical records, or this could be an incidental finding in a 
relatively small cohort. VAD results in reduced goblet cell density and mucin 
secretion causing reduced ocular surface wetting (Sharma, 1998a) which is likely to 
be responsible for the increased epithelial damage observed in the vitamin A deficient 
adults.
5.4.3 Tear film stability
Whilst a number of previous studies have assessed FBUT in CF, NIBUT is novel to 
this investigation. In general, tear film stability was lower in CF subjects compared to 
controls although only FBUT in the adult cohort reached significance. The variances 
amongst measures of NIBUT tend to be larger than those of FBUT which would limit 
statistical significance of differences. Measures of tear film stability in juveniles are 
similar to published values in normal adults (mean NIBUT 11.2 and FBUT 7.6 
seconds) (Nichols et al., 2002). In this investigation tear film stability was 
significantly lower in the adults compared to juveniles. Whilst tear film stability is 
known to decrease with age (Ozdemir and Temizdemir, 2009, Cho and Yap, 1993), 
the difference compared to the findings o f Nichols et al. (2002) could reflect 
environmental differences as juvenile and adult data were collected in different 
locations.
The instillation of fluorescein into the tear film is known to reduce tear film stability 
(Mengher et al., 1985) and mean FBUT was lower than NIBUT in all cohorts. FBUT 
in subjects with CF were similar to previous reports where tear film stability was also 
significantly reduced (Mrugacz et al., 2007b, Mrugacz et al., 2007d, Mrugacz et al., 
2007c). The lack of significance in NIBUT could also be associated with poor 
repeatability of measures of tear film stability (Nichols et al., 2004a). Tear film 
stability was not significantly different amongst juveniles, and whilst increased levels 
of variance may have hindered significance this could also indicate disease duration 
or severity may contribute to the pathogenesis dry eye.
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Tear film stability was not different when subjects were grouped according to CFRD, 
CFLD, pancreatic status or genotype apart from reduced FBUT in the non-AF508 
adults. FBUT was significantly reduced in vitamin A sufficient juveniles, further 
suggesting that vitamin A levels o f this group may not have been truly representative 
of their status at the time o f this investigation. In the adult cohort, FBUT and NIBUT 
were reduced in the vitamin A deficient subjects, and tear film stability positively 
correlated with serum vitamin A concentration. The results did not reach significance 
however and again, may have been hindered by small subgroup size and time 
differences between blood analysis and tear film assessment.
5.4.4 Tear ferning
Significantly higher grades o f abnormal TF have been observed in subjects with CF 
compared to controls previously (Rolando et al., 1988, Kalayci et al., 1996). In this 
study, abnormal TF (above Type 2) was not observed in any subjects. Kalayci et al. 
(1988) observed almost 74% of CF subjects in their investigation also had normal TF. 
In the juvenile cohort, whilst the highest TF grade of 1.75 was only observed in 
subjects with CF, there was no significant difference in TF patterns between CF and 
control subjects. In the adult cohort, a shift towards higher TF types was observed in 
the CF group compared to the controls although the difference failed to reach 
significance. The increased presence o f higher TF grades in adults with CF compared 
to controls could reflect increased tear film osmolarity in these subjects.
TF was not significantly different when subjects were grouped according to genotype, 
CFRD or CFLD. Similarly, TF grades were not significantly different when subjects 
were grouped according to vitamin A status, and TF did not significantly correlate 
with vitamin A concentration. However, the categorical nature of the TF grading 
scale could be insensitive to such relationships. Rolando et al. (1988) suggested 
abnormal tear film mucin was responsible for the altered TF grades observed in 
subjects with CF (Rolando et al., 1988). Evidence suggests mucin secretion may be 
decreased in VAD (Tei et al., 2000, Hori et al., 2005) and reduced mucin secretion is 
likely to impair tear film stability leading to increased tear film evaporation and 
increased osmolarity. Therefore, increased electrolyte and reduced glycoprotein
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concentrations in the tear film o f vitamin A deficient subjects with CF would 
adversely affect the TF pattern. This suggests the abnormal TF observed by Rolando 
et al. was secondary to VAD. However, there was no indication of vitamin A status in 
this study. Kalayci et al. (1996) also recorded a poor correlation of TF and vitamin A 
concentration. Whilst serum vitamin A is known to be a poor measure of vitamin A 
liver stores (Underwood and Denning, 1972) statistical significance could also be 
restricted by sample size and the fact vitamin A was not measured at the point of tear 
film collection.
A significant negative correlation o f TF and measures o f tear film stability was 
observed in this study. Although a correlation with the Schirmer test has been 
documented previously (Puderbach and Stolze, 1991) a correlation of TF with tear 
break-up time is novel to this investigation. Similarly, this is the first report of a 
correlation of ocular surface observations and TF. TF did not correlate with ocular 
symptoms in adults and similar findings have been reported (Evans et al., 2009, 
Srinivasan et al., 2007, Jackson and Perrigin, 1999).
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5.5 Summary
This study provides some support for the hypothesis that dry eye is a primary 
manifestation of CF although substantial significant evidence is limited. Whilst CF 
subjects tended to demonstrate increased signs of ocular surface inflammation 
(hyperaemia and staining) differences failed to reach significance. Genotypic 
differences did not predict dry eye intensity and limited correlations were recorded 
with clinical disease severity. However, results could be hindered by relatively small 
cohort sizes and the variable nature o f the disease. CF subjects, particularly the 
juvenile cohort, were generally o f relative “good health”. This undoubtedly reflects 
modem therapeutic treatment and disease management.
The results could suggest alternative epithelial CF channels provide some level of 
compensation for defective CFTR function leading to sub-clinical levels of dry eye 
that were undetectable in this study. Dry eye may only be manifest during periods of 
exacerbation, poor health or following prolonged disease duration.
Tear film stability appears reduced in CF, but the finding that it was further reduced in 
adult CF subjects who were vitamin A deficient provides some evidence that vitamin 
A deficiency is likely to contribute to the pathogenesis o f dry eye in CF. Therefore, 
the aetiology of dry eye in CF is likely to be a combination of these primary and 
secondary manifestations.
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Chapter 6 
Investigating Visual Function in Children and 
Young Adults with Cystic Fibrosis
6.1 Introduction
Chapter 2 identified common ocular associations of Cystic Fibrosis (CF). However, 
existing studies have frequently been small scale or included confounding factors such 
as unknown vitamin A or diabetic status. Abnormal visual function in CF is 
hypothesised to be caused by impaired CF secretion from the apical retinal pigment 
epithelial membrane via CFTR. This primary manifestation o f CF is proposed to 
cause abnormal regulation o f the subretinal space (SRS) and inter-photoreceptor 
matrix (IPM) resulting in loss o f normal photoreceptor function and reduced visual 
acuity, colour vision and contrast sensitivity.
6.1.1 Objectives for this study
This study aimed to examine juveniles with CF of known disease status and severity 
with respect to refractive error, binocular vision and visual function. The hypotheses 
were that higher levels o f ametropia, strabismus and amblyopia would be expected in 
subjects with CF due to associated prematurity and low birth weight, and that 
abnormal visual function is a primary manifestation o f CF.
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6.2 Method
6.2.1 Subjects
See Section 5.2.1
6.2.2.1 Inclusion and exclusion  criteria
See Section 5.2.1.1
6.2.2 Experimental design
Subjects with CF were seen at the Children’s Hospital for Wales, and due to out­
patient clinic constraints juveniles were seen for two or three different data collection 
sessions each lasting approximately 10 to 15 minutes. This allowed subjects to be 
examined between different outpatient appointments to minimise inconvenience and 
increase participation. Control subjects were assessed during a single 30 to 40 minute 
session at the School o f Optometry and Vision Sciences, Cardiff University.
All subjects completed a face-to-face ocular health questionnaire with their parent or 
guardian which investigated previous and current ocular health, vision, colour vision 
and family ocular health. Medications and reports o f general health were also 
recorded in control subjects. Further information regarding subjects with CF was 
recorded from their medical record (see Section 5.2.2).
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6.2.2.1 Refractive error and binocular vision
Distance vision (right, left and binocular) was recorded with a Bailey-Lovie chart 
(Clement Clarke International Ltd., Essex, UK) set at three metres (luminance 160 
candelas/ metre2 (cd/m2), range 80-320 cd/m2, (Sheedy et al., 1984)). Patients were 
refracted and distance visual acuity was similarly recorded. Near visual acuity (right, 
left and binocular) was recorded with a Bailey-Lovie word near vision chart (Clement 
Clarke International Ltd., Essex, UK) chart at 25cm. Spherical equivalent refraction 
(SER) was calculated as spherical correction plus half the negative cylindrical 
correction. Myopia was defined as a mean sphere o f -0.50 Dioptres (D) and above 
and hypermetropia as a mean sphere of +2.00D and above (Fan et al., 2004). 
Correction between these values was recorded as emmetropia.
A cover-uncover and alternating distance and near cover test was performed whilst 
the patient fixated a single distance LogMAR letter or letter on a budgie stick two 
lines above that of their distance or near visual acuity with spectacle correction. 
Stereopsis was assessed with a Titmus Fly Test (Clement Clarke International Ltd., 
Essex, UK) with spectacle correction and polarised glasses.
6.2.2.2 Visual function
Contrast sensitivity (right, left and binocular) was recorded with spectacle correction 
using a Peli-Robson chart (Clement Clarke International Ltd., Essex, UK) at three 
metres (m) (luminance 160 cd/m2), which corresponds to a spatial frequency of 
approximately three cycles per degree (Pelli et al., 1988). Subjects completed 
saturated and de-saturated Farnsworth D15 colour vision tests (Clement Clarke 
International Ltd., Essex, UK) illuminated within a light box (CIE source C, 320-400 
lux). A BASIC computer programme was used to calculate quantitative scores 
(Vingrys and King-Smith, 1988) where the output included a Total Error Score (TES), 
Angle (indicating the type o f colour vision defect), S-index (indicating the lack of 
randomness) and C-index (indicating the degree of colour vision (CV) defect).
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6.2.3 Statistics
Data was checked for normality using the Kolmogorov-Smimov test. Results for 
vision, visual acuity, measures o f colour vision, contrast sensitivity, mean sphere and 
stereopsis were not normally distributed (0.000<p<0.016). However, the results were 
a small sample o f continuous data which is representative of a normal distribution. 
Therefore, Bland and Altman (2009) have suggested parametric statistics can be 
applied (Bland and Altman, 2009). A Paired-samples (2-tailed) t-test was applied to 
compare results from right and left eyes. An Independent-samples (2-tailed) t-test 
was used to compare data from the CF and control cohort. Correlation was assessed 
with Pearson’s product moment correlation coefficient. One-Way Analysis of 
Variance (ANOVA) analysis was used to examine data based on vitamin A status, 
pancreatic status and genotype. Bonferroni’s test was used for post-hoc comparisons. 
Significance was set at the 0.05 level.
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6.3 Results
All subjects participated fully, with the exception of colour vision assessment where:
• 25 subjects with CF participated (3 o f the younger subjects were excluded due
to lack o f understanding, 2 subjects were lost to follow up)
• 27 control subjects participated (3 o f the younger subjects were excluded due
to lack of understanding)
A Paired-samples t-test indicated distance vision, distance visual acuity, near visual 
acuity, mean spherical equivalent refraction and contrast sensitivity were not 
significantly different when comparing the right and left eyes of all subjects 
(0.065<p<1.000). From this point only values from the right eye are reported.
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6.3.1 O verview o f subjects w ith CF
Table 6.1 Overview o f subject characteristics and disease severity for the CF group
Variable Description
Genotype
n=l 1 AF508 homozygous 
n=17 AF508 heterozygous 
n=2 non AF508
Pancreatic function n=6 pancreatic sufficient 
n=24 pancreatic deficient
Serum vitamin A range 0 .5 9 -2 .0 4  pmol/1 
mean 1.25 pmol/1 (SD ± 0.35)
Vitamin A status n=19 vitamin A sufficient, n=8 vitamin A deficient 
(3 subjects unmeasured)
HbAlc 5 subjects assessed 
range 5.2 -  5.9% mean 5.58% (SD ± 0.26)
CFRD None
FEVi range 19 -  123 % 
mean 89.64 % (SD ± 13.08)
Shwachman Score
score >86 (excellent) n=19 
score 71-85 (good) n=8 
no score n=3 
range 100 -  71 mean score 88.17 (SD ± 8.43)
Chrispin-Norman Score
range 0 - 1 0  
no score n=7 
mean 5.22 (SD ± 2.76)
Premature birth n=2 at 31 weeks and 36 weeks gestation
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6.3.2 Refractive error
Of the CF cohort, 43% had undergone an eye examination with an optometrist within 
the previous 2 years and 20% were currently prescribed some form of spectacle 
correction. In the control cohort, these values were 70% and 23% respectively 
(Figure 6.1). Considering refractive error, in the CF group 25 subjects were 
emmetropic, 2 hypermetropic and 3 myopic. In the control group, 25 subjects were 
emmetropic and 5 were myopic (Figure 6.2). Whilst mean distance vision was 
identical in the two groups at -0.21 in each group, SER was higher in the CF group 
(Figures 6.3 and 6.4). Differences were not significant however (Independent- 
samples t-test; p=0.911 and p=0.153).
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Figure 6.1 The percentage o f subjects who had undergone an eye examination within 
the previous two years and percentage o f subjects currently prescribed glasses in the 
CF and healthy control groups
Eye Exam G lasses
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Figure 6.2 The distribution of emmetropia, hypermetropia and myopia in subjects 
with CF and healthy controls
-0 .10-
-0.15-
a>
®  -0 .20-
-0.30-
- 0 .35 -
CF
Figure 6.3 Distance vision in subjects with CF and healthy controls (Independent- 
samples t-test; p=0.911)
(Error bars indicate 95% confidence intervals)
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Figure 6.4 Spherical equivalent refraction (SER) in subjects with CF and healthy 
controls (Independent-samples t-test; p=0.153)
6.3.3 B in ocu lar  v is ion
Whilst none of the control subjects had been seen by an ophthalmologist, two CF 
subjects had been referred previously. A high (>+6.00D) hypermetrope (subject 
number 23) with a fully accommodative esotropia had been prescribed spectacle 
correction from 15 months o f age. A positive family history was reported; the 
subject’s mother had high hypermetropia and had undergone strabismus surgery and 
his brother was reportedly amblyopic. A second subject (subject number 20) was an 
anisometropic amblyope who had been treated with previous occlusion therapy. VA 
was slightly reduced in the affected right eye although a moderate level of stereopsis 
was recorded. There was no family history in this case.
With the exception of CF subject number 23, heterotropia was not detected in any 
participants, although a number o f individuals demonstrated heterophorias. The 
distribution is summarised in Table 6.2 and appears similar for the two cohorts. A 
moderate distance and near heterophoria was recorded in a single CF subject only;
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observed in the fully accommodative esotropic subject. Levels of stereopsis were 
slightly better in the control group compared to subjects with CF, however the 
difference failed to reach significance (Independent-samples t-test; p=0.426) (Figure 
6.5).
Table 6.2 The distribution of heterophoria in subjects with CF and healthy controls
H eterophoria Control subjects 
(num ber)
CF subjects 
(number)
Distance
Orthophoria (no detectable 
movement (NDM))
29 26
Small esophoria (3-5A) 1 1
Moderate esophoria (5-8 A) 0 1
Small exophoria (3-5A) 0 2
Near
Orthophoria (NDM) 21 20
Small esophoria (3-5A) 5 4
Moderate esophoria (5-8A) 0 1
Small exophoria (3-5A) 4 5
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Figure 6.5 Stereopsis in subjects with CF and healthy controls (Independent-samples 
t-test; p=0.426)
C o n tro l
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Two CF subjects were known to be bom prematurely, at 31 weeks and 36 weeks 
gestation. A single control subject was bom 8 weeks premature. Two subjects had 
low levels o f myopia but all had normal binocular and visual function and are 
summarised in Table 6.3.
Table 6.3 Visual function and binocular vision in subjects known to be born 
prematurely
Subject Group G estation SER DVA NVA Stereopsis
(weeks) (D) (LogMAR) (N) (sec of arc)
6 CF 31 +0.625 -0.42 4 40
12 36 -1.125 -0.30 5 40
35 Control 32 -1.75 -0.40 3 50
6.3.4 Visual Function
Distance visual acuity (DVA) was similar in the two cohorts, with mean acuity of - 
0.36 and -0.35 in the control and CF subjects respectively (Independent-samples t- 
test; p=0.721) (Figure 6.6). Near VA (NVA) was slightly better in the control group 
compared to the CF group although the difference failed to reach significance 
(Independent-samples t-test; p=0.089) (Figure 6.7). Contrast sensitivity (CS) was 
similar in the two groups at 1.61 and 1.59 in the control and CF cohort respectively 
(Independent-samples t-test; p=0.416) (Figure 6.8).
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Figure 6.6 Distance visual acuity in subjects with CF and healthy controls 
(Independent-samples t-test; p=0.721)
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Figure 6.7 Near visual acuity in subjects with CF and healthy controls (Independent- 
samples t-test; p=0.089)
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Figure 6.8 Contrast sensitivity in subjects with CF and healthy controls (Independent- 
samples t-test; p=0.416)
The confusion angle, indicating the type o f colour vision (CV) defect, was normal for 
all subjects for both the saturated and desaturated Farnsworth D15 tests indicating 
colour vision was normal in all subjects. Total error scores (TES) for each colour 
vision test were slightly higher with greater variance in the CF group compared to the 
control group (Figure 6.9). The difference was not significant for the saturated test 
and just failed to reach significance for the desaturated test (Independent-samples t- 
test; p=0.446 and p=0.051). The S Index, indicating the lack of randomness of the 
arrangement of the test “counters” were slightly higher for the desaturated test 
compared to the saturated (Independent-samples t-test; p=0.555 and p=0.772). 
However, mean results were similar for the two cohorts indicating all subjects clearly 
understood the colour vision test procedure (Figure 6.10). C Index scores, indicating 
the degree of defect, were higher in subjects with CF however, differences did not 
reach significance (Independent-samples t-test; p=0.470 and p=0.084 respectively) 
(Figure 6.10). Differences in visual function between subjects with CF and healthy 
controls are summarised in Table 6.4.
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Figure 6.9 Total error score (TES) for the saturated and desaturated Farnsworth D15 
test in subjects with CF and healthy controls (Independent-samples t-test; p=0.446 and 
p=0.051 respectively)
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Figure 6.10 S Index and C Index values for the saturated and desaturated Farnsworth 
D15 test in subjects with CF and controls (Independent-samples t-test; S Index 
p=0.555 and p=0.772 and C Index p=0.470 and p=0.084)
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Table 6.4 Summary o f differences in refractive error, stereopsis and visual function in 
subjects with CF and healthy controls
Factor Control CF Sig. 
(Ind t-test)Mean SD Mean SD
Vision -0.21 0.28 -0.21 0.27 0.911
SER +0.16 1.01 +0.60 1.33 0.153
Stereopsis 46.00 10.70 49.00 17.49 0.426
DVA -0.36 0.07 -0.35 0.08 0.721
NVA 2.90 0.88 3.37 1.18 0.089
CS 1.61 0.10 1.59 0.10 0.416
Saturated TES 12.13 0.90 12.47 2.11 0.446
Saturated S Index 1.48 0.13 1.51 0.25 0.555
Saturated C Index 1.09 0.11 1.12 0.25 0.470
Desaturated TES 7.79 1.87 9.09 2.67 0.051
Desaturated S Index 1.66 0.42 1.70 0.47 0.772
Desaturated C Index 1.30 0.39 1.52 0.50 0.084
6.3.2.1 The effect o f  genotype
To explore the effect o f genotype on visual function AF508 homozygotes, AF508 
heterozygotes and controls were compared. DVA and CS were not significantly 
different (ANOVA; p=0.705 and p=0.578 respectively) (Figure 6.11 and 6.12) and 
values for the saturated D15 test were not significantly different when subjects were 
grouped according to genotype (ANOVA; 0.188<p<0.238). Considering the 
desaturated test however, TES and C Index scores were higher in the homozygote 
group compared to the heterozygotes although only the S Index was significantly 
worse in the AF508 homozygotes compared to AF508 heterozygotes (ANOVA; TES 
p=0.075, S Index p<0.05 (Bonferroni’s; p<0.05) and C Index p=0.067) (Figure 6.13 
and 6.14). NVA was significantly worse in AF508 heterozygotes compared to 
controls (ANOVA; p<0.05: Bonferroni’s; p<0.05). Differences in visual function in 
the three groups are summarised in Table 6.5.
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Figure 6.11 Distance visual acuity in AF508 homozygotes, AF508 heterozygotes and 
healthy controls (ANOVA; p=0.705)
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Figure 6.12 Contrast sensitivity in AF508 homozygotes, AF508 heterozygotes and 
healthy controls (ANOVA; p=0.578)
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Figure 6.13 Desaturated D15 Total Error Score (TES) in AF508 homozygotes, AF508 
heterozygotes and healthy controls (ANOVA; p=0.075)
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Figure 6.14 Desaturated D15 S Index and C Index in AF508 homozygotes, AF508 
heterozygotes and healthy controls (ANOVA; p<0.05 and p=0.067 respectively)
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Table 6.5 Mean values o f visual function in AF508 homozygous and heterozygous 
subjects with CF and healthy controls
Factor C ontrol
CF Sig.
(ANOVA)AF508
heterozygous
AF508
homozygous
DVA -0.36 -0.35 -0.34 0.705
NVA 2.90 3.68 2.95 <0.050
CS 1.61 1.58 1.60 0.578
Saturated D15 TES 12.13 13.05 11.95 0.188
Saturated D15 
SIndex
1.48 1.58 1.44 0.238
Saturated D15 
C Index
1.09 1.19 1.06 0.199
Desaturated TES 7.79 8.81 9.67 0.075
Desaturated S Index 1.66 1.47 1.97 <0.050
Desaturated C Index 1.30 1.41 1.68 0.067
6.3.2.2 Correlation w ith CF disease severity
Lung function (FEVi) showed a small negative correlation with quantitative measures 
of the saturated D15 test (Pearson’s; -0.031<r<-0.027, 0.882<p<0.897). Similarly, 
poor correlations were observed with the desaturated test, CS and DVA (Pearson’s; 
0.004<r<0.218, 0.295<p<0.985). However, FEVi showed a significant positive 
correlation with NVA (Pearson’s; r=0.405, p<0.05) (Figure 6.15). When an outlier 
was removed, the correlation remained significant (Pearson’s; r=0.429, p<0.05).
Shwachman score negatively correlated with DVA and NVA (Pearson’s; r=-0.110, 
p=0.586 and r=-0.201, p=0.315 respectively). Measures of colour vision also 
negatively correlated with Shwachman score (Pearson’s; -0.343<r<-0.028, 
0.119<p<0.902; and correlations for the desaturated S Index and C Index reached 
significance (Pearson; r=-0.578, p<0.01 and r=-0.428, p<0.05 respectively) (Figure
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6.16 and 6.17). CS did not significantly correlate with Shwachman score (Pearson’s; 
r=0.163, p=0.417).
Whilst Chrispin-Norman score negatively correlated with CS and measures of the 
saturated D15 test, these failed to reach significance (Pearson’s; 0.095<r<0.188, 
0.428<p<0.666). Similarly, DVA and NVA and measures of the desaturated D15 test 
showed a weak correlation (Pearson’s; -0.320<r<-0.132, 0.169<p<0.549).
R Sq Linear = 0.164
FEV1 (%)
Figure 6.15 The correlation o f FEVi and near visual acuity (Pearson’s; r=0.405, 
p<0.05)
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Figure 6.16 The correlation o f Shwachman score and desaturated S Index in subjects 
with CF (Pearson’s; r=-0.578, p<0.01)
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Figure 6.17 The correlation o f Shwachman score and desaturated C Index in subjects 
with CF (Pearson’s; r=-0.428, p<0.05)
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6.3.2.3 The effect o f v itam in  A  status
To explore the effect o f vitamin A status on visual function vitamin A sufficient and 
deficient subjects with CF and controls were compared. NVA was worse in the 
vitamin A deficient group compared to the sufficient group, although the difference 
did not reach significance (ANOVA; p=0.250) (Figure 6.18). DVA and CS were not 
significantly different between the different subgroups (ANOVA; p=0.882 and 
p=0.679 respectively). Apart from the desaturated D15 S Index and C Index, 
measures of CV were generally significantly higher and with greater variability in the 
vitamin A deficient group compared to the vitamin A sufficient and control subjects 
(Bonferroni’s; 0.005<p<0.05) (Figure 6.19 and 6.20) (Table 6.6). Visual function was 
not significantly different when subjects were grouped according to pancreatic 
function (ANOVA; 0.059<p<0.840). Serum vitamin A concentration significantly 
correlated with saturated D15 TES, S Index and C Index although measures of the 
desaturated D15 colour vision test did not significantly correlate (Table 6.7). Vitamin 
A showed a negative correlation with DVA and NVA however a small positive 
correlation was recorded with CS although these correlations failed to reach 
significance (Table 6.7).
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Figure 6.18 Near visual acuity in vitamin A deficient and sufficient subjects with CF 
and healthy controls (ANOVA; p=0.250)
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Figure 6.19 Saturated and desaturated D15 Total Error Score (TES) in vitamin A 
deficient and sufficient subjects with CF and controls (ANOVA; p<0.005 and p<0.05)
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Figure 6.20 Saturated D15 S Index and C Index in vitamin A deficient and sufficient 
subjects with CF and controls (ANOVA; p<0.01 and p<0.005)
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Table 6.6 Mean values o f visual function in vitamin A sufficient and deficient 
subjects with CF and healthy controls
Factor Control
CF Sig.
(ANOVA)Vitamin A 
sufficient
Vitamin A 
deficient
DVA -0.36 3.16 3.56 0.882
NVA 2.90 -0.37 -0.35 0.250
CS 1.61 1.59 1.61 0.679
Saturated D15 TES 12.13 11.95 14.40 <0.005
Saturated D15 S Index 1.48 1.45 1.73 <0.010
Saturated D15 C Index 1.09 1.06 1.35 <0.005
Desaturated TES 7.79 8.82 10.34 <0.050
Desaturated S Index 1.66 1.68 1.75 0.924
Desaturated C Index 1.30 1.47 1.73 0.086
Table 6.7 The correlation of visual function and serum vitamin A concentration in 
subjects with CF
Factor Pearson’s product moment correlation
r P
DVA -0.054 0.789
NVA -0.110 0.586
CS 0.030 0.881
Saturated D15 TES -0.584 <0.005
Saturated D15 S Index -0.568 <0.010
Saturated D15 C Index -0.581 <0.010
Desaturated TES 0.080 0.724
Desaturated S Index 0.280 0.207
Desaturated C Index 0.126 0.576
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6.3.5 Major findings of this study
• Visual function was essentially normal in juvenile subjects with CF compared 
to healthy controls
• NVA was significantly worse in AF508 heterozygotes compared to controls
• Desaturated D15 S Index was significantly worse in AF508 homozygotes 
compared to AF508 heterozygotes
• Saturated D15 TES, S Index, and C Index was significantly worse in vitamin 
A deficient subjects compared to vitamin A sufficient subjects and controls
• Desaturated D15 TES was significantly worse in vitamin A deficient subjects 
compared to controls
• Saturated D15 TES, S Index and C Index showed a significant negative 
correlation with serum vitamin A concentration
• Desaturated S Index and C Index showed a significant negative correlation 
with Shwachman score
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6.4 Discussion
Whilst a similar number o f CF and control subjects were prescribed some form of 
spectacle correction, a lower percentage o f CF subjects had undergone an eye 
examination within the previous two years. This suggests eyecare may be neglected 
due to demand of the prevailing healthcare regime in CF. Mean SER indicated low 
levels of hypermetropia in each group. Mean SER in this investigation is similar to 
that for 12 year old children (the mean age o f the CF and control subjects) in a normal 
population (Saunders, 1981). Ideally, a cycloplegic refraction would have been 
employed but this was not implemented due to time restraints within the hospital 
clinic. Two subjects with CF had binocular vision abnormalities. However, mean 
levels of stereopsis and the prevalence o f heterophoria were similar in the two groups. 
Despite reports o f prematurity and low birth weight in subjects with CF (Festini et al., 
2005, Muller et al., 1999), which in themselves are associated with ametropia, 
strabismus and amblyopia (O'Connor et al., 2006, Robaei et al., 2006a, Huynh et al., 
2006), the incidence in this CF cohort appears to be low. Therefore, this could imply 
that normal emmetropisation (Brown et al., 1999) and orthophorisation (Dowley, 
1987) processes appear to take place in subjects with CF, but caution must be applied 
due to the relatively small sample size.
This is the first investigation to compare visual acuity in subjects with CF and 
controls. DVA in this study was similar to that o f reported logMAR values for 12 
year old children (Robaei et al., 2006b) but slightly lower than that of healthy adults 
aged 25-29 years (Lovie-Kitchin, 2002). Levels o f CS were similar to those reported 
for 10 year old children with the Peli-Robson chart (Myers et al., 1999). A number of 
studies have reported abnormal levels in subjects with CF (Spaide et al., 1987). After 
improvement in CS function following vitamin A supplementation, Leguire et al. 
(1991) suggested vitamin A deficiency (VAD) was responsible (Leguire et al., 1991). 
However, abnormal CS has been observed in vitamin A sufficient subjects with CF 
(Ansari et al., 1999, Morkeberg et al., 1995) suggesting abnormal visual function 
could be a primary manifestation o f CF caused by abnormal CFTR activity within the 
apical retinal pigment epithelium. In this study, VA and CS were only slightly 
reduced in subjects with CF, and significance when subjects were grouped according
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to genotype was limited. Similarly, VA and CS generally weakly correlated with 
measures of clinical severity.
Normal visual function in subjects with CF in this investigation suggests 
compensation for defective CFTR within the RPE. The abundance o f alternative CF 
secreting channels such as CLCA or C1C channels could provide an alternative route 
for CF efflux from the basal membrane. In particular, CLCA has been shown to have 
greater conductance com pared to CFTR (Loewen et al., 2003). However, a lack of 
significance could also indicate sub-clinical levels o f abnormal visual function in CF 
that remained undetected by the methods employed in this study. Electrophysiology 
techniques may be more sensitive and have recorded abnormal results from CF 
subjects receiving vitamin A  supplementation (Schupp et al., 2004, Constable et al., 
2006). Statistical significance in this study could be hindered by small cohort size and 
phenotype-genotype variability (McKone et al., 2003, Zielenski, 2000). However, the 
recruitment o f 30 subjects w ith  CF is still an achievement. The subjects in this study 
are essentially healthy (in term s o f CF) and differences in visual function may only 
become manifest following prolonged disease duration or periods of exacerbation.
Abnormal CV, attributed to  chloramphenicol associated optic neuritis has been 
recorded in CF previously (Spaide et al., 1987). As indicated by the confusion angle, 
no subjects had congenital or acquired colour vision defects in this study. Measures 
of CV were slightly worse in the CF group compared to the controls, however vitamin 
A deficient CF subjects had significantly reduced CV scores compared to sufficient 
CF subjects and controls. Abnormal colour vision has been reported in non-CF 
subjects with VAD previously (Reddy and Vijayalaxmi, 1977) but is not a 
documented feature of xerophthalm ia (Sommer, 1998). These results could indicate 
subtle levels of cone photoreceptor dysfunction secondary to VAD. The negative 
correlation of serum vitam in A concentration and CV scores supports this theory. 
Similarly, Leguire et al. (1991) suggested reduced CS in CF was caused by altered 
cone function as an improvement was observed following vitamin A supplementation 
(Leguire et al., 1991).
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6.5 Summary
To conclude, visual function, refractive error and binocular vision appear to be normal 
in juveniles with CF in this relatively small study although CV appears to be impaired 
by VAD. Due to modem therapeutics and considerable improvements in disease 
management, this juvenile CF cohort is relatively healthy with high Shwachman 
scores, good levels o f lung function and generally adequate vitamin A levels. Also no 
subjects were diagnosed with CF-Related Diabetes (CFRD). If previously observed 
ocular effects of CF are secondary manifestations of the disease, caused by diabetes or 
VAD, the relative “good health” o f the subjects could be responsible for the lack of 
significant findings in this study.
Further studies are necessary in CF subjects with longer disease duration and greater 
clinical severity in order to investigate secondary manifestations of CF. Adults with 
CF are more likely to have CFRD and could be less compliant without parental 
supervision leading to increased levels o f vitamin A deficiency. Furthermore, 
assessment of rod photoreceptor function, such as dark adaptation, is likely to be 
revealing as impaired dark adaptation is the earliest clinical manifestation of vitamin 
A deficiency. However, this could only really be implemented in adults in a 
controlled environment.
194
Chapter 7 Adults with Cystic Fibrosis
Chapter 7 
Investigating Visual Function and 
Morphological Characteristics in Adults with 
Cystic Fibrosis
7.1 Introduction
In the previous study, none o f the juveniles had been diagnosed with Cystic Fibrosis 
Related Diabetes (CFRD), and only a small proportion of the cohort was vitamin A 
deficient. A number o f clinical studies have observed a wide range of ocular 
characteristics of CF but many were o f a small scale and included confounding 
factors, such as CFRD and vitamin A deficiency (VAD). Published literature 
indicates that these conditions adversely affect visual function and they are reviewed 
below. As life expectancy increases in the adult CF population it is more important to 
understand which ocular effects may be considered primary manifestations of the 
condition or secondary to CFRD or VAD.
7.1.1 The ocular effects of diabetes
Diabetic retinopathy (DR) is a common micro-vascular complication observed in 
diabetic patients. Hyperglycaemia damages retinal vessels by causing basement 
membrane thickening and loss o f pericytes leading to microaneursym formation (Cai 
and Boulton, 2002). Small areas o f retinal non-perfusion result in capillary dilation 
with subsequent leakage and haemorrhage (Kohner, 1993): this is described as 
background DR (Figure 7.1). Retinal ischaemia, caused by capillary drop out and 
non-perfusion, is characterised by cotton wool spots and intra-retinal microvascular 
abnormalities (Garner, 1993). Venous loop formation, reduplication and venous 
beading indicate imminent neovascularisation (Kohner, 1993). In combination with 
signs of retinal ischaemia, these changes are described as pre-proliferative DR. 
Proliferative DR, however, is a serious sight threatening complication and is 
characterised by neovascularisation, vitreous detachment and haemorrhage (Kanski,
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1999). Diabetic maculopathy is a further clinical feature and is the most common 
cause of visual impairment in diabetic patients. DR adversely affects visual function 
and is currently the most prevalent cause o f blind registration in the working 
population in England and Wales (Bunce and Wormald, 2008).
   ^
Figure 7.1 Diabetic retinopathy (from www.cehjoumal.org; accessed on 13/03/2009)
Increased levels of cataract, crystalline lens density and thickness have been observed 
in diabetes (Beneyto et al., 2007, Klein et al., 1998, Fledelius and Miyamoto, 1987, 
Logstrup et al., 1997). Lens thickness appears to be positively correlated with 
diabetes duration (Pierro et al., 1996, Logstrup et al., 1996, Sparrow et al., 1990, 
Fledelius and Miyamoto, 1987); increased lens hydration following alterations in the 
osmotic gradient from raised blood glucose is thought to be responsible (Logstrup et 
al., 1996). Differing observations have been made when comparing Type 1 and Type 
2 diabetics (Weimer, 2008), and are likely to reflect pathophysiological differences 
(Sparrow et al., 1992). Whilst correlations with metabolic control have not been 
observed, poor control is a risk factor for nuclear and cortical cataracts in diabetics 
(Klein et al., 1998). Visual function is adversely affected by cataract formation; 
contrast sensitivity (CS) in particular, may be reduced despite normal visual acuity 
(VA) (Elliott et al., 1989, Cheng et al., 2001, Brown, 1993).
A number of studies have observed abnormal colour discrimination in diabetic 
patients, even in the absence o f diabetic retinopathy (North et al., 1997a, Hardy et al., 
1992, Verrotti et al., 1995). Tritan (blue-yellow) defects have typically been
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described (Muntoni et al., 1982, Kurtenbach et al., 2002, Bresnick et al., 1985, Fong 
et al., 1999, Utku and Atmaca, 1992, Ismail and Whitaker, 1998), and the degree of 
colour vision abnormality has been shown to correlate with glycaemic control 
(HbAlc) (Hardy et al., 1995, Trick et al., 1988, Muntoni et al., 1982) and disease 
duration (Kurtenbach et al., 1999). Similarly, CS is reduced in subjects with Type 1 
and Type 2 diabetes compared to healthy controls, even in those without retinopathy 
(Stavrou and Wood, 2003, Di Leo et al., 1992, North et al., 1997, Dosso et al., 1996, 
Ismail and Whitaker, 1998). Reduced CS has been observed despite normal VA 
(Sokol et al., 1985) and the effect on CS also correlates with HbAlc (Banford et al., 
1994). These abnormalities cannot be solely caused by diabetes-associated increases 
in crystalline lens optical density (Dosso et al., 1996), and have been suggested to be 
retinal or neural in nature (Hardy et al., 1994).
The slow recovery of visual sensitivity following photoreceptor bleaching is termed 
dark adaptation (DA). Elevated DA thresholds are observed in diabetics compared to 
healthy controls (Henson and North, 1979, Amemiya, 1977, Abraham et al., 1988). 
Reports of a correlation with diabetes longevity are variable however (Greenstein et 
al., 1993, Henson and North, 1979) and thresholds appear adversely affected in 
diabetic subjects with little or no diabetic retinopathy (Greenstein et al., 1993). 
Similarly, elevated thresholds occur following panretinal photocoagulation for the 
treatment of diabetic retinopathy (Pender et al., 1981). The DA function in diabetes 
has been suggested to be adversely affected by retinal ischaemia, hypoxia, metabolic 
or physiological abnormalities (Greenstein et al., 1993, Henson and North, 1979, 
Abraham et al., 1988).
7.1.2 The ocular effects of vitamin A deficiency
Xerophthalmia refers to the group o f ocular conditions caused by vitamin A 
deficiency (VAD) (Sommer, 1998). Impaired DA is the earliest clinical manifestation 
of xerophthalmia (Brooks et al., 1990). DA is primarily determined by the retinoid 
cycle of photopigment regeneration (Lamb and Pugh, 2004) (Figure 7.2). The rod 
pigment, rhodopsin, is composed o f 11-cis retinal (an oxidised form of retinol which 
is a compound of vitamin A) bound to a protein known as opsin. When a photon of
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light is captured the complex undergoes a conformational change to all-trans retinal 
resulting in a phototransduction cascade and neuronal signalling. Retinal is released 
from opsin and reduced to all-trans retinol before being transported to the retinal 
pigment epithelium (RPE). Within the RPE, it is converted to 11-cis retinol before 
being oxidised to 11-cis retinal and travelling back to the rod outer segment where it 
can bind to opsin to reform as rhodopsin (da Silva Diniz and Santos, 2000). In VAD, 
initially, the rate of pigment regeneration and the rate of dark adaptation decreases 
(Lamb and Pugh, 2004). However, following prolonged deficiency the threshold 
becomes permanently elevated and rod function may be lost. In severe deficiency, 
cone function can be similarly affected and after prolonged periods the photoreceptors 
may eventually degenerate (Kemp et al., 1988).
R e b n a l P y m o n t e p ith e liu m PtK3tor»ci>ptof (Rod) C#I
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Figure 7.2 A simplified diagram o f the retinoid cycle
(from http://lpi.oregonstate.edu/infocenter/vitamins/vitaminA/visualcycle.html; 
accessed on 13/03/2009)
Vitamin supplements have been implicated as providing a protective function against 
the development and progression o f cataract (Brown et al., 1998, Leske et al., 1998, 
Hodge et al., 1995). There is evidence that the carotenoid, beta-carotene (a pro­
vitamin A compound) protects against nuclear, cortical and mixed cataract (Leske et 
al., 1991, Leske et al., 1995) and the risk o f cataract surgery is elevated in subjects 
with low serum beta-carotene levels (Knekt et al., 1992). Vitamin A has anti-oxidant 
properties and protects cells from free radical damage, and supplementation has been 
shown to provide protection against nuclear sclerosis and cortical lens opacities
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(Kuzniarz et al., 2001, Mares-Perlman et al., 2000). Intraperitoneal vitamin A 
injections have been demonstrated to promote lens regeneration in animal models 
(Shekhawat et al., 2001, Jangir et al., 2005). A higher concentration of retinol is 
observed in the younger, more metabolically active lens epithelium and cortex in 
comparison to the older nuclear lens tissue (Yeum et al., 1999). Retinoic acid, a 
product of retinol, and its receptors have been shown to play a critical role in the 
regulation of certain genes within the lens (Gopal-Srivastava et al., 1998). Therefore, 
beta-carotene, vitamin A and its derivatives appear to have a role in normal lens 
physiology and provide some protection against cataract formation.
In the National Health and Nutritional Examination Survey, consumption of vitamin 
A rich foods was negatively correlated with AMD (Goldberg et al., 1988). A higher 
density of macular pigment has been observed in individuals with carotenoid-rich 
diets and higher serum carotenoid concentrations (Burke et al., 2005). Subjects with 
higher macular pigment densities have greater visual sensitivity and it is suggested 
that higher densities may retard age-related deterioration of visual function including 
AMD (Hammond et al., 1998). The outer segment membranes of the retinal 
photoreceptors and the RPE are particularly susceptible to oxidative damage (Strauss, 
2005). Oxidative stress has been suggested to be an important mechanism in the 
pathogenesis of AMD (Alfaro et al., 2006). Anti-oxidants are believed to prevent 
cellular damage by functioning as singlet oxygen and free radical scavengers 
(Sperduto et al., 1990). Beta-carotene has been shown to provide the RPE with 
protection from oxidative stress in cultured cells (Chichili et al., 2006). It has been 
hypothesised a high dietary or supplementary intake of certain vitamins and 
carotenoids may be associated with a reduced incidence of AMD. The risk of 
exudative AMD is reduced in subjects with high levels of carotenoids (Group, 1993). 
A combination of zinc and anti-oxidants, including beta-carotene, showed a 
significant reduction in the rates o f moderate visual acuity loss in the Age-Related 
Eye Disease Study (Kassoff et al., 2001). Therefore, vitamin A appears to provide 
protection for the RPE and is important for preserving normal macular function.
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7.1.3 O bjectives for this study
Whilst CFRD is known to be different to Type 1 and Type 2 diabetes, it does share 
common features o f the disease (Moran, 2002). Therefore, CFRD may similarly 
affect the crystalline lens and visual function in subjects with CF. Despite 
supplementation, VAD remains relatively common in subjects with CF (Rayner et al., 
1989) and visual function may be adversely affected in CF. The aim of this study was 
to investigate the visual function and corneal and lenticular morphological 
characteristics in subjects with CF with known diabetic and vitamin A status to allow 
comparison with healthy, matched controls. Furthermore, this prospective study 
aimed to distinguish between the primary and secondary ocular manifestations of CF.
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7.2 Method
7.2.1 Subjects
See Section 5.2.1
7.2.2.1 Inclusion and exclusion  criteria
See Section 5.2.1.1
7.2.2 Experimental design
Subjects attended the School o f Optometry and Vision Sciences for a single session of 
data collection. All participants completed a face-to-face ocular health questionnaire 
which investigated previous and current ocular health, vision, colour vision and 
family ocular health. Medications and reports o f general health were also recorded in 
control subjects. Information regarding subjects with CF was recorded from their 
medical record (see Section 5.2.2).
7.2.2.1 R efractive error and b inocu lar vision
Refractive error and binocular vision were assessed according to the methodology in 
Section 6.2.2.1.
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7.2.2.2 Visual function
Contrast sensitivity (CS) and colour vision (CV) were assessed according to the 
methodology in Section 6.2.22.
Dark adaptation (DA) was assessed monocularly (right eye with the exception of one 
CF subject with right diabetic maculopathy) with a Goldmann-Weekers Adaptometer 
(GWA) (Haag-Streit, Bern, Switzerland) following previously described methods 
(Peters et al., 2000, Boemel, 1999, Abraham et al., 1988). Pupils were not dilated and 
spectacle correction was worn as appropriate. Room lights were extinguished and 
after 5 minutes o f light adaption to the illuminated GWA bowl the subject was 
instructed to maintain primary gaze fixation and indicate when they could detect the 
presence of an 11° achromatic flashing stimulus. The light intensity was gradually 
increased by the examiner and a semi-logarithmic score sheet (on a rotating drum) 
marked when the subject identified the stimulus. This was repeated continuously for 
a 5 minute period. Fixation was subsequently changed to a small red light 10° 
superior to the original stimulus and thresholds recorded every minute for the 
remaining 20 minutes. Final log relative threshold was recorded to allow comparison 
(Greenstein et al., 1993).
1 .2 .2 3  Fundus photography
Fundus photographs were recorded from both eyes o f CF subjects using a Canon CR- 
DGi Non-Mydriatic Retinal Camera (Canon Inc., USA). Images were assessed by 
three registered optometrists and diabetic images were reviewed by an independent 
experienced grader according to the Diabetic Screening Service for Wales grading 
protocol (Table 7.1).
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Table 7.1 Diabetic retinopathy screening services for Wales screening grading 
protocol
Level Abbreviation Description
No retinopathy R0 No retinopathy
Background
Diabetic
Retinopathy
(BDR)
R l. l  
Mild BDR
<5 MA >1 DD from fovea 
<4 dot/blot HM >1DD from fovea 
Any exudates outside the macula 
with/without <5 CWS
R1.2 
Mod BDR
>5 MA >1 DD from fovea 
<8 dot/blot HM >1 DD from fovea 
<3 MA within 1DD from fovea (VA >6/12) 
Circinate/grouped exudates outside macula 
but within temporal arcade 
Questionable IRMA only in presence of 
MA/HM
Severe BDR R2
>8 HM outside 1 DD from fovea 
Venous irregularities, beading, 
reduplication, venous loops 
Definite IRMA 
With/without CWS
Proliferative BDR R3
NVD or NVE
Pre-retinal HM or Vitreous HM 
Pre-retinal fibrosis 
Traction retinal detachment
Maculopathy
M l
Any exudates/blot HM within macula 
(within 2 DD but outside 1 DD from fovea) 
>3 MA or any HM within 1 DD of fovea 
only with VA < 6/12
M2
Any exudates within 1 DD of fovea 
Retinal thickness changes within 1 DD of 
fovea (stereo)
Background Diabetic Retinopathy (BDR), Micro-Aneurysm (MA), Disc Diameter (DD), 
Haemorrhage (HM), Cotton Wool Spot (CWS), Visual Acuity (VA), Intraretinal 
Microvascular Abnormalities (IRMA), New Vessels on Disc (NVD), New Vessels Elsewhere 
(NVE)
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7.2.2.4 Corneal and lenticular morphological characteristics
The Oculus Pentacam (Oculus Optikgerate GmbH, Wetzlar, Germany) utilises a 
rotating Scheimpflug camera to image the anterior ocular surface and was used to 
record corneal thickness, corneal density and crystalline lens density. The Pentacam 
has been used previously to assess lens density abnormalities in subjects with diabetes 
(Beneyto et al., 2007, Tkachov et al., 2006) and has shown impressive accuracy and 
repeatability for the measurement o f corneal thickness (Miranda et al., 2009, Al- 
Mezaine et al., 2008, Lackner et al., 2005). A three dimensional (3D) Scan, 
consisting of 25 images per scan, was used to evaluate pachymetry. An Enhanced 
Dynamic Scheimpflug Image, consisting o f the mean of 15 images taken from a 
single camera position, allowed densitometric assessment o f the lens and cornea. A 
densitogram, a cross section o f ocular density along the plane from the apex of the 
cornea, is automatically generated. This can be altered manually to identify lens 
density at any point. Densitometry is based on a grey scale of the image with a 
standardised numerical range from zero to 100, where 100 is completely opaque.
For pachymetric analysis, comeal thickness at the pupil centre, minimum comeal 
thickness and peripheral comeal thickness at four locations (superior, inferior nasal 
and temporal cornea) were recorded. Anterior chamber volume, anterior chamber 
depth and angle were also recorded from the 3D scans. For densitometric analysis, 
maximum comeal density and anterior surface lens density along the axis of the 
comeal apex were recorded from locations automatically identified by the Pentacam 
software. Maximum lens density along the visual axis was identified manually from 
the densitogram.
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7.2.3 Statistics
All data were checked for normality with the Kolmogorov-Smimov test. Results 
recorded with the Pentacam were normally distributed (0.077<p<0.200) whereas 
results for visual function were not (0.000<p<0.019). Despite a non-normal 
distribution of the visual function results, the results are a small sample o f continuous 
data which is representative o f a normal distribution. Therefore, Bland and Altman 
(2009) suggest parametric statistics may be applied.
A Paired-samples (2-tailed) t-test was applied to compare results from right and left 
eyes. The Independent-samples (2-tailed) t-test was used to compare data from the 
CF and control cohort. Correlation was assessed with Pearson’s product moment 
correlation coefficient. One-Way Analysis o f Variance (ANOVA) analysis was used 
to examine data based on genotype, vitamin A status and diabetes. Bonferroni’s test 
was used for post-hoc comparisons. Significance was set at the 0.05 level throughout.
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7.3 Results
7.3.1 Subjects
An overview o f the disease involvement in adults with CF is shown in Table 7.2.
All subjects participated fully, with the exception of:
• Dark adaptation - 26 subjects with CF and 28 controls participated (2 subjects 
with CF could not participate due to time restrictions)
• Colour vision - 27 subjects with CF and 28 controls participated (1 subject 
with CF was excluded due to a congenital colour vision defect)
A Paired-samples t-test indicated measures o f refractive error, binocular vision, visual 
function and morphological recordings were not significantly different when 
comparing the right and left eyes o f all subjects (Paired-samples t-test;
0.063<p<0.859). Therefore, results are presented for the right eye only.
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Table 7.2 Overview of disease involvement for the CF group
Variable Description
Genotype
n=13 AF508 homozygous 
n=l 1 AF508 heterozygous 
n=4 non-AF508
Pancreatic
function
n=3 pancreatic sufficient 
n=25 pancreatic deficient
Serum vitamin A 
concentration
range 0.35 -  2.34 pmol/1 
mean 1.25 pmol/1 (SD ± 0.35)
Vitamin A status n=16 vitamin A sufficient 
n=12 vitamin A deficient
CFRD n=l 1 CFRD 
n=17 non-CFRD
HbAlc range 4.7 -  13.2 % 
mean 6.68 % (SD ±2.16)
CFLD n=6 CFLD, all taking ursodeoxycholic acid
FEVi range 24 -  103 % 
mean 58.61 % ( S D ±  24.11)
Northern Score range 0/20 -  12/20 
mean 6.00 (SD ± 3.58)
7.3.2 Refractive error
In the CF cohort, 50% o f subjects had undergone an eye examination within the 
previous two years compared to 64% of controls. Some form of spectacle correction 
was prescribed to 23% and 70% of CF subjects and controls respectively (Figure 7.3). 
Distance vision was better and near vision worse in the CF group compared to the 
control cohort, although the differences were not significant (Independent-samples t- 
test; p=0.144 and p=0.199 respectively) (Figure 7.4 and 7.5). A higher prevalence of 
myopia was recorded in the control group (Figure 7.6) and whilst the mean SER was 
more myopic with greater variance in the control group compared to the CF cohort, 
the difference was not significant (Independent-samples t-test; p=0.146) (Figure 7.7).
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Figure 7.3 The percentage o f subjects who had undergone an eye examination within 
the previous two years and the percentage o f subjects currently prescribed spectacle 
correction in the CF and healthy control groups
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Figure 7.4 Distance vision in subjects with CF and healthy controls (Independent- 
samples t-test; p=0.144)
(Error bars indicate 95% confidence intervals)
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Figure 7.5 Near vision in subjects with CF and healthy controls (Independent- 
samples t-test; p=0.199)
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Refractive Error 
■Emmetropic 
■Hypermetropic 
□  Myopic
Figure 7.6 The distribution o f emmetropia, hypermetropia and myopia in subjects 
with CF and healthy controls
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Figure 7.7 Spherical equivalent refraction (SER) in subjects with CF and healthy 
controls (Independent-samples t-test; p=0.146)
7.3.3 B in ocu lar  v is io n
Motility was grossly normal for all subjects, with the exception of a single control 
subject with Duane Syndrome. No subjects demonstrated a heterotropia, although a 
number exhibited heterophorias (Table 7.3). Stereopsis was worse with greater 
variability in the CF group compared to the control group; mean stereopsis was 44.29 
± 12.30 and 58.93 ± 68.71 seconds of arc respectively (Figure 7.8). The difference 
was not statistically significant however (Independent-samples t-test; p=0.272).
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Table 7.3 The distribu tion  o f  heterophoria in subjects w ith CF and healthy controls
H eterophoria Control subjects 
(number)
CF subjects 
(number)
Distance
Orthophoria (no detectable 
movement (NDM))
26 26
Small esophoria (3-5A) 2 0
Small exophoria (3-5A) 0 2
Near
Orthophoria (NDM) 19 21
Small esophoria (3-5A) 4 1
Small exophoria (3-5A) 5 6
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Figure 7.8 Stereopsis in subjects with CF and healthy controls (Independent-samples 
t-test; p=0.272)
o
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7.3.4 Visual function
Distance VA (DVA) and near VA (NVA) were significantly better in the control 
cohort compared to the CF cohort (Independent-samples t-test; p<0.05 each) (Figure 
7.9 and 7.10). Similarly, CS was significantly increased and DA thresholds 
significantly lower in the control group (Independent-samples t-test; p<0.005 each) 
(Figure 7.11 and 7.12). Statistical significance remained when a single CF subject 
with a history o f diabetic maculopathy was excluded (Independent-samples t-test; 
DVA p<0.05, NVA p<0.05, CS p<0.005, DA p<0.005).
- 0 .20 -
<  -0.25-
05
-0.30-
-0.35-
-0.40-
CFControl
Figure 7.9 Distance visual acuity in subjects with CF and healthy controls 
(Independent-samples t-test, p<0.05)
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Figure 7.10 Near visual acuity in subjects with CF and healthy controls (Independent- 
samples t-test; p<0.05)
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Figure 7.11 Contrast sensitivity in subjects with CF and healthy controls 
(Independent-samples t-test; p<0.005)
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Figure 7.12 Dark adaptation log thresholds in subjects with CF and healthy controls 
(Independent-samples t-test; p<0.005)
The confusion angle o f the D15 test confirmed a reported history of congenital 
deuteranopia in a single CF subject. This subject was excluded from further analysis. 
No other subjects had a congenital or acquired colour vision (CV) defect. Total error 
score (TES), S Index and C Index were higher in CF subjects compared to controls for 
the saturated D15 test, although the difference failed to reach significance 
(Independent-samples t-test; 0.086<p<0.145). As all control subjects completed the 
saturated D15 test accurately, there is no variability for those scores (Figure 7.13 and 
7.14). However, measures o f CV for the desaturated D15 test were significantly 
different between groups, with the CF cohort showing higher scores (Independent- 
samples t-test; TES p<0.005, S Index p<0.01, C Index p<0.005).
A summary of differences in refractive error, stereopsis and visual function in subjects 
with CF and healthy controls is presented in Table 7.4.
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I  DISDSatTES
Figure 7.13 Total error score (TES) for the saturated and desaturated Farnsworth D15 
test in subjects with CF and healthy controls (Independent-samples t-test; p=0.086 and 
p<0.005 respectively)
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Figure 7.14 S Index and C Index values for the saturated and desaturated Farnsworth 
D15 test in subjects with CF and healthy controls (Independent-samples t-test; S 
Index p=0.084 and p<0.01 and C Index p=0.145 and p<0.005 respectively)
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Table 7.4 Sum m ary o f  d ifferences in refractive error, stereopsis and visual function in
subjects with CF and healthy controls
Factor Control CF Sig. 
(Ind. t-test)M ean SD Mean SD
Distance vision 0.13 0.51 -0.05 0.38 0.144
Near vision 3.88 2.63 5.02 3.84 0.199
SER -1.26 2.64 -0.46 1.06 0.146
Stereopsis 44.29 12.30 58.93 68.71 0.272
Distance VA -0.33 0.09 -0.27 0.12 <0.050
Near VA 2.77 0.73 3.95 2.35 <0.050
CS 1.77 0.11 1.63 0.18 <0.005
DA 3.80 0.38 4.85 1.34 <0.005
Saturated TES 1.14 0.00 1.18 1.02 0.084
Saturated S Index 1.38 0.00 1.42 0.14 0.145
Saturated C Index 1.00 0.00 1.08 0.28 0.086
Desaturated TES 7.30 1.36 9.27 2.96 <0.005
Desaturated S Index 1.60 0.27 1.93 0.51 <0.010
Desaturated C Index 1.21 0.27 1.54 0.47 <0.005
7.3.4.1 The effect o f genotype
When subjects were grouped according to genotype, NVA, CS and DA were 
significantly poorer in the AF508 homozygote group compared to the control group 
(ANOVA; p<0.01, p<0.01 and p<0.05 respectively: Bonferroni’s; p<0.05, p<0.05, 
p<0.005 respectively) (Figures 7.15-7.17). Differences in DVA amongst the three 
groups did not approach significance, however (ANOVA; p=0.082).
Considering the saturated D15 test, the C index was not significantly different 
between the groups (ANOVA; p=0.053). The TES and S index were significantly 
higher in the AF508 heterozygote group compared to the controls (ANOVA; p<0.05 
each: Bonferroni’s; p<0.05 each). For the desaturated D15 test, TES was significantly 
worse in the control group compared to the AF508 heterozygotes (ANOVA, p<0.005:
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Bonferroni’s; p<0.005), the S index was significantly worse in the AF508 
homozygotes compared to the controls (ANOVA; p<0.01: Bonferroni’s; p<0.05) and 
the C Index was significantly worse in both CF genotype groups compared to the 
controls (ANOVA; p<0.005: Bonferroni’s; p<0.05 each).
These results are summarised in Table 7.5.
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DF508 hom ozygotesDF508 h e te ro zy g o tescontrol
G e n o ty p e
Figure 7.15 Near visual acuity in AF508 homozygotes, AF508 heterozygotes and 
healthy controls (ANOVA; p<0.01)
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Figure 7.16 Contrast sensitivity in AF508 homozygotes, AF508 heterozygotes and 
healthy controls (ANOVA; p<0.01)
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Figure 7.17 Dark adaptation in AF508 homozygotes, AF508 heterozygotes and 
healthy controls (ANOVA; p<0.005)
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Table 7.5 Mean values o f visual function in AF508 homozygous and heterozygous 
subjects with CF and healthy controls
Factor C ontrol
CF Sig.
(ANOVA)AF508
heterozygous
AF508
homozygous
Distance VA -0.33 -0.27 -0.26 0.082
Near VA 2.77 3.18 4.73 <0.010
CS 1.77 1.66 1.62 <0.010
DA 3.80 4.51 5.13 <0.005
Saturated TES 1.14 1.20 1.14 <0.050
Saturated S Index 1.38 1.45 1.38 <0.050
Saturated C Index 1.00 1.16 1.00 0.053
Desaturated TES 7.30 1.02 9.00 <0.005
Desaturated S Index 1.60 1.95 2.00 <0.010
Desaturated C Index 1.21 1.63 1.56 <0.005
7.3.4.2 C o rre la tio n s  w ith  C F  d isease  severity
Measures of visual function, including DVA, NVA, CS, DA and CV, did not 
significantly correlate with CF clinical severity as indicated by the Northern score 
(Pearson’s; -0.236<r<0.349, 0.074<p<0.966). Apart from DA, FEVi negatively 
correlated with measures o f visual function (Pearson’s; -0.353<r<-0.125, 
0.071<p<0.0.522; DA r=0.158, p=0.440). The correlation of FEV, with the 
desaturated D15 TES and C Index reached significance (Pearson’s; r=-0.500, p<0.01 
and r=-0.451, p<0.05 respectively) (Figure 7.18 and 7.19).
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Figure 7.18 The correlation o f lung function (Forced Expiratory Volume in 1 second 
(FEVi)) and Farnsworth desaturated D15 colour vision test Total Error Score (TES) in 
subjects with CF (Pearson’s; r=-0.500, p<0.01)
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Figure 7.19 The correlation o f lung function (Forced Expiratory Volume in 1 second 
(FEVi)) and Farnsworth desaturated D15 colour vision test C Index in subjects with 
CF (Pearson’s; r=-0.451, p<0.05)
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7.3.4.3 The effect o f v itam in  A  status
When subjects were grouped according to vitamin A status, NVA and CS were worse 
in the vitamin A sufficient group (n=16) compared to the control group (ANOVA; 
p<0.01: Bonferroni’s; p<0.01 and ANOVA; p<0.005: Bonferroni’s; p<0.0001 
respectively) (Figure 7.20 and 7.21). Differences in DVA just failed to reach 
significance (ANOVA, p=0.052). Measures of the saturated D15 test were not 
significantly different when the groups were compared (ANOVA; 0.142<p<0.238). 
For the desaturated D15 test, the TES was significantly higher in the controls 
compared to the deficient group (ANOVA; p<0.005: Bonferron’s; p<0.005). 
However, the desaturated S Index and C Index were significantly higher in the 
vitamin A deficient CF subjects (n=12) when compared to healthy controls (ANOVA, 
p<0.01 each: Bonferroni’s; p<0.01 for each) (Figure 7.22).
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Figure 7.20 Near visual acuity in vitamin A deficient and sufficient subjects with CF 
and healthy controls (ANOVA; p<0.01)
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Figure 7.21 Contrast sensitivity in vitamin A deficient and sufficient subjects with CF 
and healthy controls (ANOVA; p<0.005)
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Figure 7.22 Desaturated D15 S Index and C Index in vitamin A deficient and 
sufficient subjects with CF and controls (ANOVA; p<0.01 each)
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Log thresholds were significantly lower in the vitamin A deficient group when 
compared to controls (ANOVA; pO.OOOl: Bonferroni’s; pO.OOOl) (Figure 7.23). 
Abnormal DA, defined as thresholds two standard deviations (SD) greater than the 
mean of the controls, was observed in 9 CF subjects (35%) but no controls. A single 
subject had a log threshold o f 10.31; over 4 SD greater than the mean log threshold of 
the CF cohort. This subject had the lowest serum vitamin A concentration of the 
cohort at 0.35pmol/l, approximately three times below the normal minimum 
concentration of 1.10pmol/l. With the exclusion of this subject, DA thresholds 
remained significantly higher in the CF group compared to the healthy controls 
(Independent-samples t-test; pO.OOOl). Likewise, log threshold remained 
significantly higher in the vitamin A deficient group compared to controls with the 
exclusion of this subject (ANOVA; pO.OOOl).
Results are summarised in Table 7.6.
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deficient
Figure 7.23 Dark adaptation in vitamin A deficient and sufficient subjects with CF 
and healthy controls (ANOVA; pO.OOOl)
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Table 7.6 Mean values o f visual function in vitamin A sufficient and deficient 
subjects with CF and healthy controls
Factor C ontrol
CF Sig.
(ANOVA)Vitamin A 
sufficient
Vitamin A 
deficient
Distance VA -0.33 -0.25 -0.29 0.052
Near VA 2.77 4.47 3.25 <0.010
CS 1.77 1.58 1.69 <0.010
DA 3.80 4.51 5.40 <0.0001
Saturated TES 1.14 1.19 1.16 0.142
Saturated S Index 1.38 1.44 1.41 0.157
Saturated C Index 1.00 1.05 1.11 0.238
Desaturated TES 7.30 8.58 1.01 <0.005
Desaturated S Index 1.60 1.84 2.04 <0.010
Desaturated C Index 1.21 1.47 1.63 <0.010
DA threshold values negatively correlated with serum vitamin A concentration, 
although the correlations were not significant (Pearson’s; r=-0.282, p=0.162). 
Vitamin A concentration also showed a small negative correlation with other 
measures of visual function (Pearson’s; -0.333<r<-0.109, 0.089<p<0.589). NVA 
positively correlated with vitamin A (Pearson’s; r=0.386, p<0.05) (Figure 7.24) 
however, when outliers were removed the correlation was not significant (Pearson’s; 
r=-0.198, p=0.344).
2 2 4
Chapter 7 Adults with Cystic Fibrosis
12.00-
10.00-
5.
~  8 .00-
O(3
15
3
.52
>  6 .00-k.re<u
Z
4 00“
OO R Sq Lineal = 0.149
oo
o o2 .00-
0.00 0.50 1.00 1.50 2.00 2.50
S e ru m  v itam in  A c o n c e n tr a t io n  (m icrom ol/l)
Figure 7.24 The correlation o f near visual acuity and serum vitamin A concentration 
in subjects with CF (Pearson’s; r=0.386, p<0.05)
7.3.4.4 T he effect o f d iab e tic  s ta tu s
When subjects were grouped according to diabetic status, subjects with CFRD had 
significantly worse NVA, CS and DA compared to controls (ANOVA; p<0.05, 
pO.OOOl and pO.OOOl respectively) (Figures 7.25-7.27) (Bonferroni’s; 
0.000l< p O .05). DA was also significantly worse in the CFRD group compared to 
the non-CFRD subjects (Bonferroni’s; p 0 .0 0 5 ). The difference for DVA approached 
significance (ANOVA; p=0.071). Measures o f CV with the saturated D15 test were 
not significantly different when subjects were grouped according to diabetic status 
(ANOVA; 0.164<p0.205). However, considering the desaturated test, TES, S index 
and C Index were significantly worse in the non-CFRD group compared to the 
controls (ANOVA; p<0.01, p<0.005 and p<0.005 respectively: Bonferroni’s; 
0.001<p<0.05). Results are summarised in Table 7.7. Glycaemic control (HbAlc) 
positively correlated with DVA and DA (Pearson’s; r=0.163, p=0.408 and r=0.104, 
p=0.612 respectively) and the correlation with NVA approached significance 
(Pearson’s; r=0.364, p=0.057). For other measures of visual function correlations 
remained weak (Pearson’s; -0.085<r<0.213, 0.286<p<0.926).
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Figure 7.25 Near visual acuity in CF subjects with and without CFRD and healthy 
controls (ANOVA; p<0.05)
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Figure 7.26 Contrast sensitivity in CF subjects with and without CFRD and healthy 
controls (ANOVA; pO.OOOl)
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Figure 7.27 Dark adaptation in CF subjects with and without CFRD and healthy 
controls (ANOVA; p<0.05)
Table 7.7 Mean values o f visual function in Non-CFRD and CFRD subjects with CF 
and healthy controls
Factor C ontrol
CF Sig.
(ANOVA)Non-CFRD CFRD
Distance VA -0.33 -0.28 -0.25 0.071
Near VA 2.77 3.79 4.18 <0.050
CS 1.77 1.68 1.55 <0.0001
DA 3.80 4.36 5.64 <0.0001
Saturated TES 1.14 1.18 1.17 0.164
Saturated S Index 1.38 1.43 1.42 0.176
Saturated C Index 1.00 1.05 1.13 0.205
Desaturated TES 7.30 9.44 9.02 <0.010
Desaturated S Index 1.60 2.09 1.70 <0.005
Desaturated C Index 1.21 1.66 1.38 <0.005
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7.3.5 Fundus photography
One CF subject had a large choroidal naevus and was referred to an ophthalmologist 
for further investigation. Abnormalities were observed in two subjects: A 23 year old 
male subject had numerous bilateral drusen within the macular region and scattered 
drusen throughout the peripheral retina. A 24 year old female subject, had areas of 
macular hyper-pigmentation in the left eye and three scattered peripheral drusen in the 
right eye. This subject had previously been referred to an ophthalmologist due to a 
left macular lesion o f unknown aetiology (presumed to be a macular branch retinal 
vein occlusion by the ophthalmologist) with a reduction in VA. However, this had 
subsequently resolved, VA returned to normal and the subject had been discharged. 
Both subjects were diabetic but had normal serum vitamin A levels.
Of the 11 patients with CFRD, 4 individuals (7 eyes) had visible signs of diabetic 
retinopathy (DR). The specific features are summarised in Table 7.8. Subject number 
three had been treated with right sectorial pan-retinal photocoagulation and left grid 
and subsequent sectorial therapy photocoagulation. The highest HbAlc levels were 
observed in the subjects with DR. The mean diabetes duration o f subjects with DR 
was 13.3 years, compared to 6.6 years for those without DR. At the time of 
examination, 73% (n=7) o f the diabetic patients were currently part of a retinal 
screening programme.
Whilst DVA, NVA, CS and DA were lower in CF subjects with DR compared to 
those without DR, the difference was not significant (Independent-samples t-test; 
0.110<p<0.359). Similarly, CV was not significantly different when subjects were 
grouped according to DR status (Independent-samples t-test; 0.149<p<0.693).
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Table 7.8 Diabetic retinopathy features and grading according to the diabetic 
retinopathy screening services for Wales protocol
Subject Eye Grading Features
Diabetes
duration
(years)
HbAlc
(% )
2
R R l.l  Mild BDR 1 HM
10 10.2L R1.2 Mod BDR 1 MA within 1 DD from 
fovea
3
R R2 M l Severe 
BDR with 
Maculopathy
Numerous dot and blot 
HM, exudates, venous 
beading, MA and HM 
(>3) within 1 DD from 
fovea
20 10.9
L
R1.2 Mod BDR Blot and dot HMs, 2 
within 1DD from fovea
23
R R1.2 Mild BDR 1 MA within 1 DD from 
fovea 5 13.2
L RO No DR -
27
R R l.l  Mild BDR 1 HM
5 10.7L R1.2 Mod BDR 1 MA within 1 DD from 
fovea, 2 HM
Background Diabetic Retinopathy (BDR), Micro-Aneurysm (MA), Disc Diameter 
(DD), Haemorrhage (HM)
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7.3.6 Corneal and lenticular morphological characteristics
7.3.6.1 Pachymetry
Corneal thickness values are presented in Table 7.9. For all subjects comeal thickness 
was increased in peripheral locations compared to the pupil centre and is greatest at 
the superior comeal location. Comeal thickness was not significantly different when 
subjects with CF and controls were compared (Independent-samples t-test; 
0.370<p<0.997). Corneal thickness was not significantly different when subjects 
were grouped according to genotype (ANOVA; 0.229<p<0.824), vitamin A status 
(ANOVA; 0.667<p<0.969) or diabetic status (ANOVA; 0.638<p<0.877).
In all subjects, corneal thickness at the pupil centre negatively correlated with SER 
(Pearson’s; r=-0.168, p=0.216) and mean comeal thickness was significantly greater 
in myopic subjects (569.16pm) compared to emmetropic subjects (549.50pm) 
(Independent-samples t-test; p<0.05).
Table 7.9 Mean corneal thickness measurements at various comeal locations in 
subjects with CF and controls
Corneal
location
Mean corneal thickness (pm) Sig. (Ind- 
samples t- 
test)
Control CF
Mean SD Mean SD
Pupil
centre
560.43 37.18 558.50 36.52 0.845
Minimum 555.93 36.39 555.21 36.76 0.942
Superior 672.64 46.50 678.18 38.02 0.628
Nasal 645.89 44.39 634.93 37.47 0.997
Inferior 618.71 43.63 622.78 43.33 0.370
Temporal 631.71 42.13 600.68 33.14 0.621
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7.3.6.2 A n terio r cham ber analysis
Anterior chamber (AC) volume, depth and angle were significantly greater in the 
control cohort compared to the CF group (Independent-samples t-test; p<0.005 each) 
(Table 7.10). AC volume and AC depth significantly correlated with SER (Pearson’s; 
r=-0.463, pO.OOOl and r=-0.449, p 0 .0 0 5  respectively). Although AC angle also 
negatively correlated with SER, the relationship was not significant (Pearson’s; r=- 
0.231, p=0.087). AC volume was significantly greater in myopes compared to 
emmetropes (Independent-samples t-test; pO .05). Similarly, AC depth and angle 
were greater in the myopic group although the differences failed to reach significance 
(Independent-samples t-test; p=0.066 and p=0.125 respectively).
Table 7.10 Mean anterior chamber (AC) measurements in subjects with CF and 
controls
Factor
C ontrol CF Sig. (Ind- 
samples 
t-test)
M ean SD Mean SD
AC Volume (mm3) 209.11 33.15 178.96 41.19 <0.005
AC Depth (mm) 3.31 0.29 3.03 0.34 <0.005
Angle O 42.03 6.17 36.95 7.32 <0.005
7.3.6.3 D ensitom etry
Mean densitometry values are shown in Table 7.11. Anterior lens surface and 
maximum lens density were significantly higher in the subjects with CF compared to 
healthy controls (Independent-samples t-test; p<0.05 each). Similarly, maximum 
comeal density was higher in the CF group, although the difference did not reach 
significance (Independent-samples t-test, p=0.089). Densitometry was not 
significantly different between myopic and emmetropic subjects (Independent- 
samples t-test; 0.157<p<0.714) and values did not significantly correlate with SER 
(Pearson’s; -0.006<p<0.175). Similarly, when the two cohorts were analysed 
independently, there was no significant difference in corneal or lens density in the
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myopic or emmetropic subjects (Independent-samples t-test; 0.171<p<0.963 and 
0.228<p<0.771 respectively).
Table 7.11 Mean densitometry values in subjects with CF and healthy controls
Density
M ean density (relative units) Sig. (Ind- 
samples 
t-test)
C on tro l CF
M ean SD M ean SD
M aximum
corneal
31.49 10.07 37.44 15.13 0.089
A nterior lens 
surface
9.54 1.43 11.03 3.30 <0.05
M aximum lens 11.22 1.90 12.62 2.99 <0.05
Densitometry values were generally higher in the CFRD group compared to the non- 
CFRD group and controls, although differences failed to reach significance (ANOVA; 
0.099<p<0.220) (Table 7.12). Unexpectedly, values were higher in the vitamin A 
sufficient subgroup compared to the deficient and control groups and differences 
approached significance (ANOVA; 0.060<p<0.105) (Table 7.12). Densitometry 
values did not correlate with serum vitamin A concentration (Pearson’s; - 
0.102<r<0.218, 0.265<p<0.689) or H bA lc (Pearson’s; -0.178<r<0.129,
0.365<p<0.532). Anterior lens density and maximum lens density were not 
significantly different when CF subjects were grouped according to current steroid use 
and compared to control subjects (ANOVA; p=0.098 and p=0.109).
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Table 7.12 Mean densitometry values in subjects with CF grouped according to
diabetic and vitamin A status compared to healthy controls
Density
Mean density (relative units) ± SD Sig. (Ind- 
samples t-testControl CF
Non-CFRD CFRD
Maximum
corneal
31.49 ± 
10.07
36.63 ± 
14.11
38.68 ± 
17.22
0.220
Anterior lens 
surface
9.54 ± 
1.43
10.82 ± 
2.78
11.35 ± 
4.11
0.099
Maximum
lens
11.22 ± 
1.90
12.66 ± 
2.90
12.55 ± 
3.26
0.108
Density Control CF Sig. (Ind- 
samples t-testVit A suff Vit A def
Maximum
corneal
31.49 ± 
10.07
40.91 ± 
15.58
32.80 ± 
13.78
0.060
Anterior lens 
surface
9.54 ± 
1.43
11.42 ± 
4.18
10.50 ± 
1.57
0.074
Maximum
lens
11.22 ± 
1.90
12.73 ± 
3.86
12.48 ± 
1.23
0.105
Density values did not significantly correlate with any aspect of visual function 
(Pearson’s; -0.207<r<0.257, 0.088<p<0.956). Abnormal lens density was defined as 
a two SD above the mean maximum lens density o f the control group. According to 
this criterion, two control subjects and four CF subjects had abnormal lens density. 
Mean DVA, NVA and CS were worse in the abnormal lens density group compared 
to normal group although the difference was not significant (Independent-samples t- 
test; 0.151<p<0.381). Similarly, DA and CV were not significantly different in the 
two groups (Independent-samples t-test; 0.464<p<0.939).
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7.3.7 Major findings of this study
•  Visual function (DVA, NVA, CS, DA and desaturated D15 CV TES, S Index 
and C Index) was significantly reduced in CF subjects compared to controls
• NVA, CS and DA were significantly reduced in AF508 homozygotes 
compared to controls
• Saturated D15 TES and C Index were significantly worse in AF508 
heterozygotes compared to controls
• Lung function showed a significant negative correlation with desaturated D15 
TES and C Index
• DA and desaturated TES, S Index and C Index were significantly reduced in 
vitamin A deficient subjects compared to controls
• NVA, CS and DA were significantly worse in CFRD subjects to controls
• DA was significantly worse in CFRD subjects compared to non-CFRD 
subjects
• Anterior lens surface and maximum lens density were significantly higher in 
CF subjects compared to controls
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7.4 Discussion
7.4.1 Refractive error and binocular vision
Distance vision was better in the CF group compared to the control group and is likely 
to reflect the higher incidence and greater severity o f myopia in the control cohort. A 
large proportion o f the control group were undergraduates and a high prevalence of 
myopia has been observed in university students previously (Loman et al., 2002, 
Fledelius, 2000). Approximately 36% of the CF subjects were myopic, which is 
similar to previous findings (Fama et al., 1998, Morkeberg et al., 1995). No subjects 
with CF were hypermetropic and binocular function was similar to the control group. 
Therefore, similar to the juvenile CF group, normal emmetropisation and 
orthophorisation appear to have taken place in these adult CF subjects.
7.4.2 Visual function
Unlike the juvenile cohort, all aspects o f visual function were adversely affected in 
adults with CF suggesting rod and cone photoreceptor dysfunction in these subjects. 
CFTR, within the apical RPE membrane, mediates CF secretion to facilitate regulation 
of the SRS and IPM (Marmor and Wolfensberger, 1998, Wills et al., 2000a). In CF, 
CFTR function may be defective or completely absent depending on the level of 
mutation or genotype (McKone et al., 2003). Without compensation from other apical 
CF channels normal RPE and photoreceptor function may be affected. Whilst the lack 
of significance in the juvenile study could have been due to high variability or small 
cohort size, the juvenile subjects were “relatively” healthy. Therefore, disease 
severity and/or duration may have a cumulative adverse effect on normal RPE 
function and subsequent retinal photoreceptor maintenance.
Besides regulation o f the SRS, the RPE has a number of functions essential for the 
maintenance of normal visual function including; absorption o f scattered light, 
transport of nutrients to the photoreceptors, retinal regeneration, photoreceptor outer 
segments phagocytosis and recycling o f essential substances for the photoreceptors 
(Strauss, 2005). Failure o f any one of these functions could result in impaired 
photoreceptor function, photoreceptor degradation and reduced visual function. In
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CF, normal RPE metabolism and/or function may be altered in response to cellular 
compensation to abnormal CFTR CF transport. CF subjects with a more severe CFTR 
mutation are hypothesised to have greater levels of disruption to normal RPE CF 
efflux. In general, visual function appeared to be worse in subjects with the AF508 
homozygote mutation giving support to the hypothesis that abnormal visual function 
is a primary manifestation o f CF. There were no levels of metamorphopsia and no 
indication of serous retinopathy in subjects with CF however, the level o f RPE 
disturbance could be sub-clinical and remain undetected by retinal photographs.
Impaired RPE function results in drusen formation between the RPE and Bruch’s 
membrane. An early feature o f age-related macular degeneration (AMD), drusen are 
composed of metabolic waste products and are rarely observed in individuals before 
45 years of age (Hageman and Mullins, 1999). Two young CF subjects had bilateral 
scattered drusen indicating impaired RPE function. This atypical presentation could 
be caused by abnormal RPE function or metabolism in response to compensation of 
abnormal or absent CFTR function or through premature oxidative damage to the 
RPE following reduced carotenoid concentration. Altered trans-epithelial transport 
has been implicated in AMD pathogenesis (Strauss, 2005). Therefore, abnormal CF 
efflux by CFTR in CF could contribute to the development of premature drusen in 
subjects with CF. Incidentally, both subjects are diabetic, which is a known risk 
factor for AMD (Holz et al., 2004).
Similar to the juvenile group, certain measures o f CV were significantly reduced in 
vitamin A deficient CF subjects suggesting subtle levels of cone dysfunction. 
However, other measures o f visual function, such as NVA and CS, were worse in the 
vitamin A sufficient group. This may result from inaccurate assessment of current 
vitamin A status; it was recorded from the last known blood test, not directly at the 
time of assessment. Alternatively, this could reflect an overlap of the CF subgroups: 
DVA and CS were also significantly reduced in CFRD subjects and a third of the 
vitamin A sufficient subjects had CFRD, potentially skewing significance. Impaired 
DA and CS have been observed in CF subjects with VAD and supplementary vitamin 
A has been shown to improve both DA and CS in these subjects (Leguire et al., 1991, 
Fulton et al., 1982, Huet et al., 1997, Rayner et al., 1989). Whilst CS was not 
significantly different, impaired DA thresholds were observed in the vitamin A
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deficient CF group indicating rod photoreceptor dysfunction in these subjects. Other 
recent investigations have demonstrated DA function to be normal in subjects with CF 
(Morkeberg et al., 1995, Ansari et al., 1999), however this study indicates that despite 
intervention patients are still at risk of xerophthalmia. In particular, this finding 
highlights the importance o f vitamin A supplementation and patient compliance in CF 
in order to maintain normal visual function.
Certain aspects o f visual function, including NVA, CS, and DA, were significantly 
reduced in the CFRD group. Although some correlations were observed with 
glycaemic control (H bA lc), these failed to reach significance and are likely to be 
caused by the fact levels were not recorded at the time of assessment. DA thresholds 
and CS were particularly reduced in subjects with CFRD and similar findings have 
been observed in patients with Type 1 and Type 2 diabetes (Amemiya, 1977, Henson 
and North, 1979, Greenstein et al., 1993, Abraham et al., 1988, Di Leo et al., 1992, 
Dosso et al., 1996, Ismail and Whitaker, 1998, North et al., 1997, Stavrou and Wood, 
2003). Retinal hypoxia, caused by abnormal retinal perfusion and ischaemia, is 
thought to be responsible (Drasdo et al., 2002, Arden et al., 1998, Kurtenbach et al., 
2006). Temporary improvements in DA, CS and CV have been observed following 
the inhalation o f oxygen in diabetic patients (Kurtenbach et al., 2006, Arden et al., 
1998, Harris et al., 1996, Dean et al., 1997). In this study, certain measures of CV 
were negatively correlated with lung function in CF subjects and both CV and DA 
have previously been shown to deteriorate in experimental hypoxic conditions in 
healthy subjects (Connolly et al., 2008, Vingrys and Gamer, 1987, Karakucuk et al., 
2004, Ernest and Krill, 1971, McFarland and Evans, 1939). Therefore, visual 
function may be reduced in subjects with CFRD due to retinal hypoxia. DA may be 
particularly affected by CFRD as scotopic conditions are known to further increase 
the metabolic demands o f the rods (Arden et al., 2005).
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7.4.3 Retinal photography
In this study, 36% CFRD patients displayed varying degrees of DR. The reported 
incidence o f diabetic retinopathy (DR) in subjects with CFRD is variable ranging 
from 5 to 24% (Sullivan and Denning, 1989, Andersen et al., 2006). It is plausible 
that subjects with diagnosed DR were more motivated to participate in the study, 
hence potentially skewing the incidence. Poor metabolic control, a known risk factor 
for DR in Type 1 and Type 2 diabetes (Rodriguez-Fontal et al., 2009) was also 
observed in these subjects. Diabetes duration is a further risk factor for DR 
development in Type 1 and 2 diabetes (Lind et al., 2007). Mean CFRD duration in 
those with DR in this study was approximately 13 years. Therefore, this study 
supports previous findings that the incidence of DR in CFRD is greater in subjects 
with a diabetes duration greater than 10 years (Andersen et al., 2006, Yung et al., 
1998).
The 10 year incidence o f DR in insulin treated diabetic patients, diagnosed before 30 
years of age, is 89%. In comparison, the incidence of DR in CFRD is considerably 
lower. Although CFRD shares features with Type 1 and 2 diabetes it is distinctly 
different (Moran, 2002). It is probable CFRD subjects maintain better metabolic 
control, and a reduced DR risk, due to the persistence o f some insulin secretion 
(Schwarzenberg et al., 2007). Whilst Schwarzenberg (2007) suggested annual retinal 
screening should commence after a duration o f 5 years (Schwarzenberg et al., 2007), 
two subjects in this study had mild and moderate background DR before that 
milestone. Reassuringly, the majority o f subjects were receiving annual retinal 
screening.
7.4.4 Corneal and Lenticular morphological characteristics
Anterior chamber (AC) depth and volume were significantly increased in healthy 
controls. However, a negative correlation with refractive error and significant 
differences between myopes and emmetropes indicate the difference is due to the 
higher levels o f myopia and hence increased axial length in the control cohort. A 
correlation of refractive error and anterior chamber depth have been observed 
previously (Xu et al., 2008, Rabsilber et al., 2003, Touzeau et al., 2003, Ucakhan et
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al., 2008). Incidentally, CFTR is not present in the ciliary epithelium (Mitchell et al., 
1998, Coca-Prados et al., 1995) and does not facilitate aqueous humor production (Do 
and Civan, 2004, McCannel et al., 1992). Therefore, smaller AC depth and volume 
would not appear to be a primary manifestation of CF due to reduced aqueous 
secretion.
CFTR, located at the apical corneal endothelial membrane, facilitates fluid efflux to 
prevent corneal desturgesence (Sun and Bonanno, 2002). In CF, unless other CF 
channels provide compensation for reduced CF secretion via CFTR the cornea is 
likely to be thicker with increased density. Whilst Lass and colleagues (1985) 
observed increased corneal thickness in subjects with CF compared to controls with a 
contact video specular microscope (Lass et al., 1985), a significant difference was not 
observed in either central or peripheral comeal locations in this study. Mean central 
comeal thickness values were comparable to previous studies that utilised the 
Pentacam (Fujioka et al., 2007, Al-Mezaine et al., 2008, Miranda et al., 2009). 
Comeal thickness was significantly greater in myopes and negatively correlated with 
refractive error. A similar finding with the Pentacam has been documented (Ucakhan 
et al., 2008), although axial length and comeal thickness do not appear to correlate 
(Shimmyo and Orloff, 2005). As the control group consisted of a greater proportion 
of myopes any significance could be masked. This highlights the importance of 
matching subjects according to refractive error in further investigations.
Although not significantly different, comeal density was increased in CF. 
Significance could be hampered by high levels o f variation and the relatively small 
cohort size. Lass et al. (1985) recorded significantly increased endothelial cell density 
in subjects with CF compared to healthy controls (Lass et al., 1985). Increased 
endothelial cell density in CF could be responsible for the slight comeal density 
differences observed in this study. The findings by Lass et al. (1985) and this present 
study could indicate a level o f compensation or adaptation by the comeal endothelium 
to CFTR dysfunction in CF leading to sub-clinical differences in comeal thickness 
and density. An increased cell density could allow for a greater concentration of 
compensatory transporters (Sun and Bonanno, 2002), such as CLCA and C1C 
channels which also facilitate CF efflux from the apical membrane (Sun et al., 2003, 
Davies et al., 2004).
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Increased comeal thickness has been observed in Type 1 and Type 2 diabetic subjects 
previously suggesting hyperglycaemia impairs normal comeal endothelial transport 
(Su et al., 2008, Lass et al., 1985). However, this was not observed in CFRD subjects 
in this study, and pachymetry did not correlate with glycaemic control. Similarly, 
comeal density was not significantly different in subjects with CFRD. A lack of 
significance could be due to small sub-group size or differences in pathogenesis of 
diabetes mellitus and CFRD.
Increased levels o f lens opacity have been observed in subjects with CF previously 
(Fama et al., 1998, Castagna et al., 2001, Majure et al., 1989). Similar findings of 
increased anterior surface and maximum lens density in CF were observed in this 
study. To date, CFTR has not been detected in the lens epithelium and fluid transport 
within the lens is widely uncharacterised (Candia, 2004). Therefore, it is debatable if 
increased lens density is a primary manifestation o f CF. Increased levels or abnormal 
lens density did not appear to impair visual function however. Lens density did not 
correlate with refractive error in subjects with CF and was similar in myopes and 
emmetropes, suggesting increased lens density does not induce index myopia in these 
subjects. In the normal population, steroid use and diabetes are known risk factors for 
cataract formation (Beneyto et al., 2007, Fledelius and Miyamoto, 1987, Klein et al., 
1998, Logstmp et al., 1997, Harding, 1991, Harding et al., 1993) and vitamin A and 
beta-carotene have been shown to provide protection against some lens opacities 
(Leske et al., 1991, Leske et al., 1995, Mares-Perlman et al., 2000, Kuzniarz et al., 
2001). In this study, increased lens density in CFRD subjects approached 
significance; with a larger cohort size this could reach significance. Increased lens 
density also neared significance in the vitamin A sufficient group. This unexpected 
result could reflect an overlap o f the CF subgroups as discussed earlier. Lens density 
was not significantly different when subjects were grouped according to current 
steroid use. However, current steroid use does not reflect previous steroid history and 
the risk to increased lens density may be cumulative.
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7.5 Summary
Impaired DVA, NVA, CS, DA and certain measures of CV appear to be a primary 
manifestation o f CF as differences were exaggerated in AF508 homozygous subjects. 
This suggests normal rod and cone photoreceptor function are compromised by 
abnormal or absent CFTR function in the RPE. However, DVA, NVA, CS and DA 
were also significantly affected by diabetic status indicating complications from this 
secondary disease characteristic. DA and certain measures of CV were also reduced 
in vitamin A deficient CF subjects demonstrating further secondary manifestations. 
Therefore, it appears vitamin A deficiency has less detrimental impact on normal 
visual function in these CF subjects compared to CFRD. The cause o f increased lens 
density is less apparent although CFRD appears to be influential.
This investigation demonstrates binocular vision, stereopsis and refractive error are 
not significantly different in subjects with CF compared to healthy controls. 
Similarly, AC depth, volume and angle were also not significantly different. In 
conflict to the hypothesis, corneal thickness and density were not significantly 
different in CF and this could indicate comeal compensation for defective CFTR 
function.
DR is a common feature amongst subjects with CFRD and highlights the necessity of 
regular dilated fundus examination. The incidence o f CFRD increases with age 
(Lanng, 2001). Therefore, the incidence o f DR in CFRD is likely to increase in the 
future due to improving longevity. Similarly, subjects are increasingly susceptible 
due to persistent low carotenoid levels and further supplementation may be pertinent, 
especially for subjects with physical signs o f early AMD.
It is a concern that only half o f the CF cohort had had an eye examination within the 
previous two years, and this was typically in those requiring visual correction. In 
order to deliver optimal eye care to subjects with CF, eye care practitioners and CF 
consultants must be aware o f the ocular associations of CF. Likewise patients with 
CF need to be educated o f the importance o f regular, thorough eye examinations.
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8.1 Discussion
8.1.1 The corneal and conjunctival epithelium in CF
Active trans-epithelial Cl" transport is known to provide the driving force for 
subsequent osmotically driven fluid secretion that follows via the apical membrane 
(Yang et al., 2000). Cl' conductance plays an essential role in comeal and 
conjunctival epithelial fluid transport, maintaining normal comeal integrity and 
contributing to basal tear production (Candia and Zamudio, 1995, Shiue et al., 2000, 
Yang et al., 2000, Li et al., 2001, Dartt, 2002, Candia, 2004, Dartt, 2004). Therefore, 
it appears that Cl" transport has a critical role in the maintenance of the normal tear 
film (Shi and Candia, 1995). CFTR provides a major pathway for comeal epithelial 
Cf secretion from the ocular surface (Levin and Verkman, 2005). In CF patients, 
with hypothesised defective CF efflux from the comeal and conjunctival epithelium 
(unless other CF channels compensate) basal tear production could be abnormal, 
contributing to the condition o f dry eye.
Increased signs o f ocular surface hyperaemia, comeal staining and tear feming were 
observed in CF subjects compared to healthy controls. Whilst tear film stability was 
similar in juvenile CF subjects, fluorescein tear break-up time was significantly 
reduced in adult CF subjects compared to controls. This study provides some support 
for the hypothesis that dry eye is a primary manifestation of CF although substantial 
significant evidence is limited. The results could suggest alternative epithelial CF 
channels provide some level o f compensation for defective CFTR function. CLCA2 
and a number of C1C channels are known to be present in the comeal and conjunctival 
epithelium (Itoh et al., 2000, Davies et al., 2004). Although the precise location and 
function of a number o f these channels remain largely unknown, they could provide 
an alternative route for epithelial CF efflux in CF (Figure 8.1). CLCA2, in particular
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may provide compensation for defective CFTR, as studies have shown it to be the 
most abundant Cl channel in the human comeal epithelium (Itoh et al., 2000).
Figure 8.1 Diagram o f a simplified comeal/conjunctival epithelial cell in CF with 
proposed compensation for defective CFTR function by CLCA2 and C1C channels
Cellular levels o f compensation could result in sub-clinical levels of dry eye in CF 
that were undetectable in this study. Certainly, sophisticated biochemical techniques 
have previously shown increased levels o f sub-clinical, ocular surface inflammation in 
subjects with CF (Mrugacz et al., 2005c, Mrugacz et al., 2006a, Mrugacz et al., 
2006b, Mrugacz et al., 2006c, Mrugacz et al., 2007b, Mrugacz et al., 2007c, Mrugacz 
et al., 2007d). Furthermore, dry eye may only be manifest during periods of 
exacerbation, poor health or following prolonged disease duration. This theory could 
explain the lack of significant difference in tear film stability in the relatively 
“healthy” juvenile cohort. However, the finding that tear film stability was further 
reduced in adult CF subjects who were vitamin A deficient provides some evidence 
that vitamin A deficiency is likely to contribute to the pathogenesis of dry eye in CF.
STROMA/SCLERA
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8.1.2 The corneal endothelium  in CF
Fluid transport across the corneal endothelium, to counteract comeal swelling is 
secondary to ionic flux (Hara et al., 1999). It is well established that both CF and 
HCCV are essential for trans-endothelial fluid transport and the subsequent 
maintenance of corneal transparency (Riley et al., 1995, Hodson and Miller, 1976). 
CFTR is an important channel for CF transport via the apical membrane and is also 
found to directly facilitate HCCV flux (Sun and Bonanno, 2002). Therefore, unless 
other CF channels compensate, CF subjects with anticipated defective CF secretion 
from the comeal endothelium could experience comeal oedema and reduced levels of 
comeal transparency.
Comeal thickness was not significantly different in adult subjects with CF and 
controls. However, subjects were not matched for refractive error: comeal thickness 
was significantly increased in myopes and negatively correlated with spherical 
equivalent refraction. As the control group consisted o f a greater proportion of 
myopes, potential differences may be masked. Comeal density however, was 
increased in subjects with CF compared to healthy controls, although differences 
failed to reach significance. Therefore, these findings could indicate a level of 
compensation within the corneal endothelium to CFTR dysfunction in CF, leading to 
sub-clinical differences in comeal thickness and density. CLCA and C1C channels are 
likely compensatory candidates as they are believed to facilitate CF secretion from the 
apical membrane (Sun et al., 2003, Davies et al., 2004) (Figure 8.2).
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Figure 8.2 Diagram o f a simplified corneal endothelial cell in CF with proposed 
compensation for defective CFTR function by CLCA and C1C channels
8.1.3 The retinal pigment epithelium in CF
The inter-photoreceptor matrix (IPM) within the subretinal space (SRS) is essential 
for RPE and photoreceptor interaction and facilitates the exchange o f nutrients, ions 
and metabolites (Wimmers et al., 2007) and is thought to assist photoreceptor 
maintenance (Mieziewska, 1996). Maintenance o f the volume and chemical 
composition of the SRS and IPM is largely achieved by trans-epithelial transport of 
Cf, and the subsequent passive movement o f water, via the RPE to the choroid 
(Marmor and Wolfensberger, 1998). Therefore, C f transport is imperative for the 
maintenance of normal RPE integrity (Gallemore et al., 1997). CFTR, believed to be 
located on the basal membrane (Peterson et al., 1997), may in part mediate apical RPE 
membrane C f secretion (Weng et al., 2002, Wills et al., 2000b). Unless there is 
compensation from other C f channels in CF subjects, the anticipated defective Cl 
efflux and reduced fluid transport via the RPE could result in impaired regulation of 
the SRS. Subsequently, this could result in serous retinopathy, retinal detachment or
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abnormal RPE-photoreceptor interaction potentially leading to impaired visual 
function in subjects with CF.
Normal visual function in juvenile subjects with CF in this investigation suggests 
compensation for defective CFTR within the RPE. The abundance of alternative CF 
secreting channels such as CLCA or C1C channels could provide an alternative route 
for CF efflux from the basal membrane (Figure 8.3). In particular, CLCA has been 
shown to have greater conductance compared to CFTR (Loewen et al., 2003). 
However, the juvenile subjects in this study are essentially “healthy” (in terms of CF) 
and differences in visual function may only become manifest following prolonged 
disease duration, increased disease severity or periods o f exacerbation.
SUBRETINAL SPA C E
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Figure 8.3 Diagram o f a simplified retinal pigment epithelial cell in juvenile CF 
subjects with proposed compensation for defective CFTR function by CLCA and C1C 
channels
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Results from adults with CF would seem to support this argument: visual function was 
demonstrated to be adversely affected in adults with CF compared to healthy controls. 
Impaired visual function appears to be a primary manifestation as differences were 
exaggerated in AF508 homozygotes with predicted increased levels of CFTR 
disruption and disease severity. These results suggest proposed compensatory CF 
secretion mechanisms in juveniles are not sufficient to recompense for abnormal 
CFTR function in adults. A cumulative effect from prolonged disease duration could 
be accountable for these cellular differences. Abnormal regulation of the SRS by the 
RPE appears to compromise normal RPE function or RPE-photoreceptor interaction. 
Therefore, normal rod and cone function is likely to be impaired with the ultimate 
consequence o f impaired visual function in adults with CF (Figure 8.4). However, 
visual function was significantly affected by Cystic Fibrosis-related diabetes and 
vitamin A deficiency. Therefore, the visual function in adults with CF is further 
modulated by secondary disease characteristics.
(7 )  Abnormal V  
RPE- photorecept on  
interaction
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Figure 8.4 Diagram of a simplified retinal pigment epithelial cell in adult CF subjects 
with proposed mechanisms for abnormal visual function in such subjects
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8.2 Future work
There is considerable scope for further research of the effect of CF on the ocular 
surface, visual function and ocular structures.
It will always be o f benefit to examine larger numbers of subjects with CF in order to 
strengthen these novel findings, or to confirm that where no difference has been 
found, that one does not truly exist. However, recruitment will always remain 
problematic and multicentre studies should be considered in future. The cohorts 
recruited in this thesis represent almost 25% o f the CF population in South Wales. To 
maximise future participation, assessment during in-patient admission for intravenous 
antibiotic therapy would be favourable. Assessment could be co-ordinated to allow 
direct assessment o f serum vitamin A concentration, carotenoid concentration and 
HbAlc levels to allow for accurate analysis.
Portable equipment, such as a light emitting diode (LED) dark adaptatometer would 
be particularly of benefit to measure dark adaptation during the outpatient or inpatient 
setting. Assessment o f dark adaptation in juveniles with CF, before the complication 
o f CFRD onset, would be of interest and would indicate if  rod function is 
compromised in earlier disease stages. Sophisticated imaging techniques, such as 
optical coherence tomography (OCT), could allow visualisation of the (RPE) retinal 
pigment epithelium and sub-retinal space (SRS) in order to comprehend exactly how 
CFTR dysfunction in CF affects such structures.
Retinal hypoxia is proposed to be responsible for reduced visual function in subjects 
with Type 1 and Type diabetes (Drasdo et al., 2002, Arden et al., 1998, Kurtenbach et 
al., 2006). The inhalation of oxygen by such subjects has shown temporary 
improvement of visual function (Kurtenbach et al., 2006, Arden et al., 1998, Dean et 
al., 1997, Harris et al., 1996). The results here suggest that the presence of CFRD 
appears to enhance the visual function deficits observed in adults with CF. If retinal 
hypoxia similarly affects visual function in these subjects, it would be of considerable 
interest to repeat these oxygen inhalation studies in CF subjects with and without 
CFRD, to further understand how much o f the visual deficit is related to hypoxia.
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Furthermore, detailed assessment o f visual function with the inclusion of Type 1 and 
Type 2 diabetics for comparison could identify differences in the aetiology of CFRD.
Significant differences in corneal thickness in the myopic and hypermetropic 
participants highlight the necessity for the comparison of results in refractive error 
matched CF and control subjects. Furthermore, confocal microscopy could allow for 
detailed assessment o f the corneal endothelium in order to observe structural changes 
as a consequence o f CFTR dysfunction in CF.
Tear film hyperosmolarity is considered the “gold standard” for dry eye diagnosis 
(Farris, 1994). However, determination o f tear film osmolarity requires careful tear 
sample collection and specialist analytical equipment. OcuSense (San Diego, CA, 
USA) recently introduced the TearLab®, a handheld portable osmometer which 
utilises a disposable, microfluidic lab card giving instant tear film osmolarity from a 
50 nanolitre tear sample. The TearLab® device would be ideal to assess dry eye in an 
outpatient setting and the non-invasive nature would allow for significant subject 
participation.
Reduced mucin concentrations have been observed in CF airway mucus (Henke et al., 
2004). Similarly, tear film mucin distribution is altered in subjects with dry eye 
(Danjo et al., 1998, Berry et al., 2004). Mucin secretion is also thought to be 
regulated by ocular surface epithelial vitamin A (Tei et al., 2000). Therefore, it would 
be of interest to investigate tear film and ocular surface mucins in subjects with CF 
and healthy controls.
CFTR has been suggested as a potential target for dry eye therapy in non-CF subjects 
to increase tear secretion (Levin et al., 2006, Levin and Verkman, 2005). A number 
of studies report CFTR agonist activity or increased CFTR expression in animal 
studies or cell cultures (Al-Nakkash et al., 2008, Schmidt et al., 2008, Levin and 
Verkman, 2005, Rowe et al., 2007, Wang et al., 2005, Zegarra-Moran et al., 2002, 
Pedemonte et al., 2005). Therefore, further studies could investigate if such activity 
can modulate tear film secretion from the ocular surface.
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Tear ferning in contact lens wearers
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Contact Lens and Anterior Eye R esea rch  (CLAER) Unit, School of Optometry and Vision Sciences, 
Cardiff University, Maindy R oad, Cardiff, UK
Abstract
Tear ferning (TF) has show n good sensitivity an d  specificity in the  diagnosis of dry eye, but is a  
relatively uncommon test, especially  in con tac t lens w earers. T he aim of this study w as to investigate 
the relationship betw een TF, ocular com fort an d  te a r  film stability am ongst contact lens (CL) w earers 
and non-contact lens (NCL) w earers. S u b jec ts  (36 NCL, 24 CL; m ean ag e  23.2 ± 4.8 years) 
underwent a ssessm en t of non-invasive te a r  b reak  up tim e (NIBUT), fluorescein tea r b reak up time 
(FBUT) and completed the  O cular Comfort Index (OCI) questionnaire. N on-stimulated tea rs  w ere 
collected from the inferior tea r m en iscus with a  g la s s  capillary. Sam ples of 1.5 pL w ere air dried, 
observed by light microscopy and  the  TF pattern  quantified according to R olando’s  grading scale. 
Significantly higher g rades of TF pattern  an d  discom fort (higher OCI sco res) w ere observed  in CL 
wearers compared to NCL w earers (M ann-W hitney U-test; p < 0 .005 and  p  < 0.05 respectively). 
Differences in tear film stability w ere not significant betw een  groups. Even w hen asym ptom atic (low 
OCI scores) CL and NCL subjects w ere com pared , TF rem ained significantly different (p < 0.005). In 
both CL and NCL subjects, TF displayed poor correlation with te a r  film stability te s ts  and OCI scores. 
Higher TF grades in CL w earers, even  if asym ptom atic, indicate an  unfavourable ratio of salt to 
macromolecule concentration within th e  te a r  film of such  sub jec ts. T he lack of significant difference in 
TF between symptomatic CL and  NCL w eare rs  could su g g es t similar aetiology (tear film 
hyperosmolarity) in each cohort. T he TF techn ique d em o n s tra te s  limited sensitivity and specificity 
for the prediction of ocular surface com fort in both CL and  NCL w earers.
Keywords: contact lens, contact lens related  dry eye, dry eye, ocular comfort, te a r ferning, te a r film 
stability
Introduction
A number of bodily secretions produce a distinctive 
ferning pattern when allowed to air dry on a glass 
microscope slide (Abou-Shabanah and Plotz, 1957). 
This ferning phenomenon was originally utilised to 
determine the ovulation period in women by evaluating  
cervical mucus ferning characteristics (Papanicolau, 
1946). However, Tabbara and O kum oto (1982) used 
conjunctival scrapings to devise a test to aid differential 
diagnosis o f acute forms o f  conjunctivitis by the
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presence or absence o f  tear ferns. Rolando (1984) later 
devised a qualitative grading scale based on the 
appearance o f four different tear ferning (TF) patterns 
(Table 1 & Figure 1). Type 1 and 2 patterns are 
considered normal and Type 3 and 4 abnormal, typically 
observed in subjects with dry eye (Rolando, 1984). 
Although a number o f  other grading scales have been 
suggested (Norn, 1994; Vaikoussis et al., 1994), Rolan­
d o’s original scale is highly repeatable (Pensyl and 
Dillehay, 1998) and remains popular (Srinivasan et al., 
2007).
The TF technique has progressed from scrapings o f  
mucus from the inferior fornix with a spatula (Tabbara 
and Okum oto, 1982) to simple collection o f the tear 
sample from the inferior tear meniscus with a glass 
capillary tube (Norn, 1988). The sample is pipetted onto 
a clean microscope slide and allowed to air dry by 
evaporation (Kogbe et al., 1991). Within a 10 min 
period o f  drying, the sample must be observed by phase
© 2009 The Authors. Journal compilation © 2009 The College of Optometrists doi: 10.1111/j. 1475-1313.2008.00626.x
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Table 1. Rolando’s tear ferning grading scale (Rolando, 1984)
Type Characteristics
1 Normal Uniform and closely branching
tear ferning arborisation
2 Single, smaller ferns with less
branching and empty spaces
beginning to appear
3 Abnormal Small ferns with almost no branching
tear ferning and numerous empty spaces
4 Ferns absent and clusters of mucus
may be present
contrast light microscopy and quantified accordingly 
(Golding and Brennan, 1989). M agnification levels used 
in reported studies range from 10-100X  (N orn, 1987; 
Golding and Brennan, 1989; Ravazzoni et al., 1998; 
Srinivasan et al., 2007). TF has demonstrated good  
sensitivity and specificity (Table 2) for the diagnosis o f  
dry eye (Norn, 1994; Vaikoussis et al., 1994; M aragou  
et al., 1996). The TF technique has also dem onstrated  
impressive sensitivity and specificity (78.95%  and 
78.35% respectively) in the prediction o f  successful 
contact lens tolerance (Ravazzoni et al., 1998). The 
authors concluded that whilst contact lens (CL) patients 
with TF Types o f 2, 3 and 4 often encountered tolerance 
problems, those with Type 1 TF patterns displayed good  
tolerance over a 6-month wearing period.
Symptoms o f discomfort and drying are regularly 
cited as the principal cause o f  CL wear drop out 
(Pritchard et al., 1999) and subjective sym ptom s o f  
drying are reported in much higher frequency compared
Table 2. The sensitivity and specificity of tear ferning within the 
literature: cut-off values based on Rolando’s classification (Type 1 
and 2 normal, Type 3 and 4 abnormal) (Rolando, 1984)
Author Sensitivity (%) Specificity (%)
Maragou et al., 1996 90
Primary Sjogren’s 
syndrome (SS) 
81
Secondary SS
89
Norn, 1994 86
Keratoconjunctivitis
sicca
75
Vaikoussis et al., 1994 90
Primary SS 
80
Secondary SS
88
to objective, clinical signs o f  dry eye (Begley et al., 
1999). In a recent survey, the M cM onnies questionnaire 
identified 43% o f hydrogel CL wearers reporting symp­
toms o f  CL-related dry eye (Guillon and Maissa, 2005). 
Despite its apparent value, TF remains a relatively 
uncommon diagnostic test amongst traditional tests o f  
the tear film. The diagnosis o f  CL-related dry eye 
appears to be hindered by the lack o f an accurate, 
reliable tear film test and TF in experienced CL wearers 
has not been investigated previously.
The aim o f  this study was to investigate the relation­
ship between TF and tear film stability amongst 
experienced contact lens wearers and non-contact lens 
wearers, expressing varying degrees o f ocular comfort.
Figure 1. 1984).
100 pm Type 1
(a)
Tear ferning grades for the four ferning T ypes’ reproduced according to Rolando’s original grading scale (Rolando,
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Methods
Subjects
All measurements were recorded from  the right eyes o f  
60 young, healthy subjects, 17 males and 43 females, 
mean age 23.2 ±  4.8 years. 36 subjects were non- 
contact lens (NCL) wearers (11 males, 25 females) and 
24 were habitual hydrogel contact lens (CL) wearers (six 
males, 18 females). CL wearers wore contact lenses for a 
minimum of 3 days per week for a period o f  at least 
6 months; contact lenses were removed 1 h prior to tear 
film tests. Subjects were excluded if  they had any other 
ocular or systemic condition known to affect the tear 
film, including pregnancy, conjunctivitis and blepharitis. 
Informed consent was obtained from all subjects; 
favourable approval had been obtained from the 
Human Science Research Ethics Comm ittee, School o f  
Optometry and Vision Sciences, Cardiff University and 
all procedures conformed to the tenets o f  the Declara­
tion of Helsinki.
Procedure
Non-invasive tear break up time (N IB U T ), measured 
with the Tearscope Plus (Keeler, W indsor, Berks, U K ), 
was recorded as the time taken after a blink until 
disruption of the projected grid mires o f  the pre-corneal 
tear film (Guillon, 1998). The median o f  three readings 
was recorded for each subject. U sing glass capillary 
tubes, 2 pL non-stimulated tear samples were collected  
from the inferior tear meniscus and expelled into 1.5 pL 
eppendorf tubes. 1.5 pL tear samples were pipetted onto  
clean microscope slides and allowed to air dry at room  
temperature. Samples were observed by light m icroscopy  
(Leica DMRA2; Leica M icrosystems, Wetzlar, Ger­
many), photographed within a 10 min period o f  drying 
(20 x magnification) and the TF pattern quantified 
according to 0.25 increments o f  R olando’s original 
grading system. Tear ferning grading was performed 
blind. Subjects then completed the Ocular Com fort 
Index (OCI) questionnaire. This 12 item questionnaire 
investigates ocular comfort perceived within the preced­
ing week and has a continuous scale o f  ‘N ever (0)- 
Always (6)’ for each question. The OCI was developed  
using Rasch analysis which is becom ing a popular 
technique for questionnaire design within vision research 
and permits the conversion o f ordinal Likert scores to a 
continuous interval scale (Court et al., 2007). The OCI 
has demonstrated excellent correlation with the Ocular 
Surface Disease Index (OSDI) and F B U T  (Johnson and 
Murphy, 2007). After a recovery period o f  10 min 
following tear collection, fluorescein tear break up time 
(FBUT) was recorded following instillation o f  1.0 pL 
2% sodium fluorescein with a micropipette into the
inferior fornix (Johnson and Murphy, 2005). FBUT was 
recorded as the time taken after a blink before disrup­
tion o f the pre-corneal tear film was observed, and the 
median o f three readings was recorded for each subject.
Statistical analyses
D ata were checked for normality ( s p s s ,  Version 14); as 
all distributions were not normal non-parametric statis­
tical analysis was applied. M ann-W hitney U-test was 
used to compare TF, tear film stability and ocular 
com fort between CL and NCL wearers. Spearman’s 
rank order correlation was used to investigate the 
relationship between tear film tests and ocular comfort. 
Significance was set at the 0.05 level.
Results
The effect o f  gender was not significant across all tests. 
M ean TF types, BU T and OCI scores for the two 
groups are shown in Table 3. Significantly higher 
grades o f  TF pattern and ocular discomfort (higher 
OCI scores) were observed in CL wearers compared to 
N C L  wearers (M ann-W hitney U-test, p  < 0.005 and 
p  < 0.05 respectively). However, the difference in tear 
film stability between the two groups was not significant.
Using R olando’s criteria o f abnormal TF above type 
2, Figure 2 indicates 14% (five subjects) o f NCL wearers 
and 50% (12 subjects) o f  CL wearers exhibited abnor­
mal TF. TF o f type 3 or above was observed in 8% (two 
subjects) o f  CL wearers (Figure 3). The highest TF  
pattern observed in the N C L subjects was Type 2.75, 
recorded in a single subject. For all subjects, there was 
poor correlation between TF and N IB U T  (r — 0.140), 
F B U T  (r — -0 .053 ) and OCI scores (r =  -0.002). 
Even when subjects were grouped according to CL 
status, correlations remained similar.
Subjects within the two groups were identified as 
asymptomatic or sym ptom atic for dry eye by the OCI 
score. Considering asymptomatic subjects (OCI
Table 3. Mean results for tear ferning, non-invasive break up time, 
fluorescein break up time and Ocular Comfort Index scores for the 
non-contact lens and contact lens wearers
NCL w earers 
m ean ± S.O.
CL w earers 
m ean ± S.D.
p  value
(M ann-W hitney 
lAtest; 2 tailed)
TF (type) 1.48 ± 0.53 2.02 ± 0.60 0.001*
NIBUT (s) 9.61 ± 2.45 9.28 ± 4.64 0.194
FBUT (s) 7.34 ± 3.78 6.33 ± 2.86 0.369
OCI (score) 31.28 ± 7.31 33.88 ± 6.48 0.044*
NIBUT, non-invasive break up time; TF, tear ferning; OCI, ocular 
comfort index; FBUT, fluorescein break up time.
'statistically significant at 0.05 level.
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Figure 2. The distribution of normal tear ferning (TF) (<type 2) and 
abnormal tear ferning (>type 2) in non-contact lens (NCL) and 
contact lens (CL) wearers.
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Figure 3. The distribution of tear ferning (TF) types for non-contact 
lens (NCL) and contact lens (CL) wearers.
Table 4. The accuracy of the tear film diagnostic tests (non-invasive 
break up time, tear ferning, ocular comfort index and fluorescein 
break up time) for the discrimination of contact wear and non-contact 
lens wear
Area 95%
under Standard Confidence
Variable Significance curve error interval
NIBUT 0.194 0.400 0.082 0.239-0.562
TF 0.001 0.748 0.064 0.623-0.874
OCI 0.045 0.654 0.072 0.512-0.796
FBUT 0.369 0.431 0.076 0.282-0.580
NIBUT, non-invasive break up time; TF, tear ferning; OCI, ocular 
comfort index; FBUT, fluorescein break up time.
Table 5. The accuracy of the tear film diagnostic tests (non-invasive 
break up time, tear ferning and fluorescein break up time) for the 
presence of dry eye symptoms based on ocular comfort index score
Variable Significance
Area
under
curve
Standard
error
95%
Confidence
interval
NIBUT 0.419 0.585 0.098 0.393-0.777
TF 0.992 0.501 0.105 0.296-0.707
FBUT 0.033 0.276 0.092 0.096-0.455
NIBUT, non-invasive break 
fluorescein break up time.
up time; TF, tear ferning; FBUT,
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Figure 4. The distribution of TF types for all subjects, asymptomatic 
subjects (ocular comfort index (OCI) score < 40), and symptomatic 
subjects (OCI > 40), for the non-contact lens (NCL) and contact lens 
(CL) wearers (*p < 0.005). Numbers indicate the number of subjects 
within each subgroup.
score < 40), significantly higher grades o f  T F  p a tte rn s  
were observed in CL wearers com pared  to  N C L  w earers 
(M ann-W hitney C-test, p < 0.005). H igher T F  Types 
were also observed in sym ptom atic  C L  w earers com ­
pared to sym ptom atic N C L  wearers. H ow ever, the 
difference was not statistically significant (M a n n -W h it­
ney C-test, p  =  0.374) (F igure 4). F or N C L  w earers 
alone, increased levels o f T F  were observed in sym p­
tomatic subjects com pared to asym ptom atic  subjects 
with mean ferning grades o f l . 719 and 1.411 respec­
tively, although the difference was no t statistically 
significant (p = 0.371). C onsidering C L  wearers, 
similar patterns were observed for sym ptom atic and
asym ptom atic  subjects, indicating T F  in CL wear is 
independent o f  ocu lar com fort.
The T F  technique dem onstrates superior accuracy for 
the d iscrim ination  o f  C L  and N C L  wearers by tear film 
assessm ent (Table 4). A pplying cut o ff values according 
to  R o lan d o ’s criterion where Type 1 and 2 are consid­
ered norm al and Type 3 and 4 abnorm al (Rolando, 
1984), T F  dem onstrated  a sensitivity o f 50% and 
specificity o f  86%  for the d iscrim ination o f tear film 
sam ples between C L  and  N C L  wearers, with a positive 
predictive value (PPV) and  negative predictive value 
(NPV ) o f  71 % and 72%  respectively. F o r the prediction 
o f  dry eye sym ptom s (O C I score > 40) (Table 5), T F  
displayed sensitivity and  specificity o f 33% and 73% 
respectively. T he PPV was 18% indicating a large 
num ber o f  false positives however; the N PV  was 86% 
indicating  norm al T F  to be an  accurate predictor o f 
good ocular com fort (low O C I score).
Discussion
The exact con tribu tion  o f  the num erous constituents of 
the tear film com ponents to  the ferning phenom enon has 
been subject to som e speculation. The tear ferning 
p a tte rn  was originally p roposed  to  be caused by the 
in te raction  o f  electrolytes, particu larly  sodium  and 
chloride, w ith m acrom olecules such as tear film mucins 
and  p ro teins (G olding and  B rennan, 1989). F urther
© 2009 The Authors. Journal compilation © 2009 The College of Optometrists
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investigations demonstrated that Type 1 ferning could  
be progressively changed into Type 4 ferning with the 
addition o f saline solution, suggesting tear film hyper- 
osmolarity was responsible for altered tear ferning 
observed in dry eye (K ogbe et al., 1991). X-ray and 
scanning electron microscope (SEM ) analysis has 
revealed proteinaceous material within the tear sample 
that directly controls the form ation o f  sodium  and 
potassium chloride crystals (G olding et al., 1994). M ore 
recently, Pearce and Tom linson found the presence o f  
macromolecules was limited to the periphery o f  the tear 
fern (Pearce and Tom linson, 2000). H owever, there is 
general agreement that abnormal ferning occurs due to 
unfavourable ratios o f salt and m acromolecules within 
the tear film (Golding and Brennan, 1989; G olding  
et al., 1994; Pearce and Tom linson, 2000).
There appear to be significant differences in observed  
TF patterns between CL and N C L  wearers, even when 
comparing asymptomatic subjects, which are likely to 
result from distinct differences in the biochemical 
composition o f the tears. There is evidence to suggest 
that CL wear appears to induce ‘favourable’ conditions 
for abnormal TF by altering the tear film salt to 
macromolecule concentration ratios. Tear film hyper- 
osmolarity is proposed to be the initiator o f  ocular 
surface damage observed in dry eye (Gilbard et al., 
1984, 1987 Gilbard et al., 1988). Indeed, assessment o f  
the tear film osmolarity has been described as the ‘gold 
standard’ for the diagnosis o f  dry eye (Lucca et al., 
1990) and the technique has demonstrated superior 
accuracy compared to single tests such as rose bengal 
staining and Schirmer’s test (Tom linson et al., 2006). 
Increased osmolarity o f  the tear film o f  CL wearers 
compared to NCL wearers has been reported previ­
ously (Miller et al., 2004), and different mechanisms 
have been suggested. Reduced corneal sensitivity 
induced by CL wear (causing a reduction o f  tear 
secretion) could subsequently increase tear film osm o­
larity (Gilbard et al., 1986). Further studies have 
demonstrated increased tear film thinning and evapo­
ration are likely to be responsible for tear film 
hyperosmolarity during CL wear (Thai et al., 2002). 
More recently however, Srinivasan et al. (2007) found 
no correlation between TF and tear film osm olality in 
a cohort o f post-menopausal women.
A reduction o f total mucin concentration in the tear 
film o f CL wearers has been observed previously  
(Yasueda et al., 2005). In particular, M U C 5A C  is 
significantly reduced in tear film samples from symp­
tomatic CL wearers (Berry et al., 2007) and altered 
forms of ocular mucins have been found adhered to the 
contact lens surface (Berry et al., 2003). This binding 
could be responsible for the reduction o f  tear film mucin 
concentration observed. Hori et al. (2006) reported 
similar tear film mucin concentrations between CL and
N C L wearers, although the total tear protein concen­
tration was significantly reduced in CL wearers.
Traditional tear film stability tests are known to relate 
poorly to patient symptoms (Nichols et al., 2004). TF, 
like other diagnostic tests, appears to correlate poorly 
with ocular comfort symptoms. Increased levels o f 
ocular discomfort (higher OCI scores) were observed 
in CL wearers compared to N C L wearers. Similar 
findings have been published previously; with almost 
three times as many CL wearers deemed to be symp­
tomatic and over five times as many reporting moderate 
to severe discomfort compared to non-lens wearers 
(Guillon and M aissa, 2005; Chalmers and Begley, 2006). 
Increased TF grades were observed whenever contact 
lenses were worn or symptom scores increased, but these 
differences lacked significance within each cohort (CL 
and NC L), except where all subjects were essentially 
com fortable. Such results have several possible inter­
pretations. Successful, asymptomatic CL wear is likely 
to induce a significant alteration o f the tear film salt to 
macromolecule concentration which is detectable by the 
T F technique. The lack o f  significant difference in TF 
between sym ptom atic CL and N C L wearers could 
suggest similar aetiology (tear film hyperosmolarity) in 
each cohort, or may be related to small sample size.
To summarise, although TF has been shown to be a 
good predictor o f successful CL wear tolerance (Rav- 
azzoni et al., 1998) the technique displayed a poor 
correlation with traditional tear film tests and ocular 
com fort in CL and N C L  wearers. Significantly increased 
T F grades were observed in CL wearers compared to 
N C L  wearers even when comparing those asymptomatic 
patients with good ocular comfort. This small study 
demonstrates that T F potentially identifies differences 
between patient groups, but further significant findings 
may be somewhat restricted by the sample size and the 
semi-quantitative nature o f  the grading scale.
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